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Abstract 
Brewers’ spent grain (BSG) is a useful source of protein and phenolic compounds 
which can be obtained via different extraction methods. The aim of this thesis was 
to assess protein hydrolysates and phenolic extracts generated from BSG using 
various extraction procedures, for their potential as functional food ingredients 
with anti-inflammatory, antioxidant, anti-cancer and neuroprotective properties.  
Firstly, the anti-inflammatory effects of an alkaline-extracted BSG protein rich 
fraction and three ultrafiltration-generated fractions added to milk and subjected 
to simulated gastrointestinal digestion (SGID) was shown in Jurkat T cells. 
Enzyme extraction methods were then used to produce phenolic fractions with 
strong bioactivities. The cellular antioxidant potential of both black and pale BSG 
phenolic extracts isolated using carbohydrases was demonstrated in U937 cells 
and HepG2 cells. Following this, the ability of the most active phenolic extracts to 
enhance the antioxidant potential of flavoured water drinks before and after SGID 
was investigated. However, none of the phenolic extracts added to water drinks 
significantly increased antioxidant activity. In other studies the anti-cancer 
potential of a pale BSG phenolic extract was demonstrated, through the increase 
of apoptosis in U937 cells. Additionally, the neuroprotective potential of both 
black and pale BSG phenolic extracts was shown in SK-N-BE(2) neuronal cells, 
where extracts protected against hydrogen peroxide (H2O2)-induced cytotoxicity, 
H2O2-induced apoptosis and H2O2-induced lipid peroxidation.  
Finally, the cytotoxicity, anti-inflammatory activity and antioxidant potential of 
BSG protein hydrolysates generated using different extraction procedures was 
assessed and compared. Direct enzymatic hydrolysates demonstrated anti-
inflammatory activity in Jurkat T cells and RAW 264.7 cells. Alkaline-extracted 
BSG protein hydrolysates, as well as a 10kDa permeate showed anti-
inflammatory effects in RAW 264.7 cells. As well as this, unhydrolysed fractions, 
a direct enzymatic hydrolysate, alkaline-extracted BSG protein hydrolysates, as 
well as a 10kDa permeate also displayed cellular antioxidant effects in U937 cells 
and HepG2 cells. 
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The Immunomodulatory Potential of Cereal Grains 
Published in: Current Nutrition and Food Science (2017) 13.  
 
Abstract 
Inflammation is a normal response to tissue injury or infection and many chronic 
diseases are characterised to some extent by the presence of low-grade 
inflammation. Considerable interest exists in reducing chronic disease risk or 
managing illnesses through health-promoting dietary ingredients. Cereals are a 
source of macronutrients, minerals, vitamins and other micronutrients and are also 
known to contain a range of biologically active substances such as arabinoxylans, 
β-glucans, cellulose, lignans, lignin, sterols, tocopherols, tocotrienols, 
alkylresorcinols, phenolic acids and microelements. Cereal grains displaying anti-
inflammatory and immunomodulatory activity may have an important role to play 
in alleviating some of the primary symptoms of inflammation. This paper reviews 
some of the recent research conducted on cereal grains in relation to their anti-
inflammatory and immunomodulatory activity. 
 
Introduction 
Cereal grains and cereal grain products are staple constituents of the diet in many 
parts the world (Gani et al., 2012). Cereals are a source of macronutrients, 
minerals and vitamins (Carnevali et al., 2014). A range of biologically active 
substances such as arabinoxylans (AX), β-glucans, cellulose, lignans, lignin, 
sterols, tocopherols, tocotrienols, alkylresorcinols, phenolic acids and 
microelements are also found in cereal grains (Bartlomiej et al., 2012). It is 
recognised that, as well as their nutrient profile, cereals have the potential to 
enhance health and that cereal grain consumption can considerably lower diet-
related disease risk (Topping, 2007).  
The most common cereals are wheat, corn (maize), rice, barley, oats, sorghum, 
millet and rye. They are grown on almost 60% of cultivated land globally. 
Botanically, cereals are classed as grasses and belong to the monocot family 
Poaceae. Wheat, rye and barley are closely related, being part of the subfamily 
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Pooideae and the tribus Triticeae. Oats are categorized as a distant relative of the 
Triticeae, within the subfamily Pooideae, whereas rice, corn, sorghum and millet 
exhibit separate evolutionary lines. Buckwheat, wild rice, quinoa and amaranth 
are not classed as cereal grains, but often called pseudo-cereals owing to their 
similar composition and usage (Slavin, 2004; Frolich and Aman, 2010). Within 
each cereal species numerous varieties exist produced by breeding in order to 
optimize agronomical, technological and nutritional properties.  
Compositionally, cereals comprise of 12-14 percent water, 65-75 percent 
carbohydrates, 2-6 percent lipids and 7-12 percent protein. Cereals show 
similarities regarding gross composition, being low in protein and high in 
carbohydrates (Table 1). Oats and maize however contain substantial amounts of 
lipids. Various cultivars of a given type of cereal show compositional variability. 
The anatomy of cereal grains is quite uniform. Grains have a protective 
component known as the hull or husk containing the endosperm, bran and germ. 
Bran (fruit and seed coats) surrounds the germ and the endosperm and consists of 
the starchy endosperm and the aleurone layer. In oats, barley and rice the husk is 
attached together with the fruit coat and cannot be directly removed by threshing 
as seen with common wheat and rye. The chemical components of cereals are not 
evenly distributed in the grain (Table 2). The husk and bran are high in cellulose, 
pentosans and ash. The aleurone layer of wheat contains more minerals than the 
endosperm; whereas the lipids are generally found in the aleurone and germ. The 
endosperm, which mainly consists of starch, has lower protein content than the 
germ and the bran, and is low in fat and ash. 
The European Union HEALTHGRAIN consortium defines whole grains as 
‘Whole grains shall consist of the intact, ground, cracked or flaked kernel after the 
removal of inedible parts such as the hull and husk. The principal anatomical 
components – the starchy endosperm, germ and bran – are present in the same 
relative proportions as they exist in the intact kernel’ (Van der Kamp et al., 2014). 
In refined grains, the milling process removes the bran and germ fractions (Gani 
et al., 2012). 
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Table 1: Proximate composition of cereal grains
1 
Cereal Crude 
protein 
Crude fat Ash Crude fibre Available 
carbohydrate 
Wheat 10.6 1.9 1.4 1.0 69.7 
Brown Rice 7.3 2.2 1.4 0.8 64.3 
Maize 9.8 4.9 1.4 2.0 63.6 
Barley 11.0 3.4 1.9 3.7 55.8 
Oats 9.3 5.9 2.3 2.3 62.9 
Sorghum 8.3 3.9 2.6 4.1 62.9 
Rye 8.7 1.5 1.8 2.2 71.8 
Pearl Millet 11.5 4.7 1.5 1.5 63.4 
1 
percent dry weight; (Alais and Linden, 1991) 
 
Table 2: Distribution of major components of wheat grain   
Fraction Proportion Protein Lipid Minerals 
Whole grain 100 12 2.0 2.0 
Endosperm 80 10 1.2 0.6 
Aleurone 8 18 8.5 15.0 
Bran 8.5 6 1.0 3.5 
1
 percent dry weight; (Alais and Linden, 1991) 
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Major Cereal Grains - Wheat, Rice, Maize and Barley 
Wheat, rice, maize and barley, are among the principal cereal grains produced 
worldwide (Gani et al., 2012). Rice is an important staple food, particularly in 
Asia (Choi et al., 2010). There are a number of different rice types such as long-
grain white, long-grain brown, glutinous brown, wild, basmati, brown basmati, 
jasmine and risotto. According to Chen et al. (2010), a number of components 
from rice have different pharmacological and biological activities. Maize is one of 
the most important crops in the world and is consumed in a number of forms such 
as sweet corn, cooked kernels, tortillas, chips and polenta (Fardet et al., 2008). As 
discussed by Choi et al. (2013), barley is an important cereal grain and is grown 
as a human food source, however 80-90% of barley produced is consumed by 
animals (Fardet et al., 2008). Barley is more popular as a human food in Eastern 
compared to Western societies (Slavin et al., 2000). 
 
Lesser Cereal Grains - Oats, Rye, Millet, Sorghum, Buckwheat, Wild Rice 
and Amaranth  
Oats are usually consumed as a wholegrain cereal (Fardet et al., 2008) and are 
also extensively studied as a dietary source of the soluble fibre β-glucan, which 
has been shown to reduce elevated blood glucose, triglyceride and cholesterol 
(Ahmad et al., 2014). Rye is mostly consumed in Scandinavian countries, 
particularly in the form of whole-grain rye bread (Fardet et al., 2008). Sorghum is 
a cereal mostly consumed in semi-arid regions of the world, although human 
consumption is limited (Fardet et al., 2008). Sorghum is a source of phenolic 
compounds, including phenolic acids, flavonoids and proanthocyanidins (Dykes 
and Rooney, 2006).  
 
Diet and Inflammation 
Inflammation is a normal response to tissue injury or infection (Bullo et al., 
2007). Many chronic diseases are characterised to some extent by inflammation. 
The inflammatory process is initiated by the production and secretion of pro-
inflammatory cytokines which may be triggered by an inflammatory insult (e.g. a 
poor, unbalanced diet) (Bullo et al., 2007; Lee et al., 2013a). The increased 
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cytokine synthesis and the subsequent increase in reactive oxygen and nitrogen 
species are key elements of the inflammatory process. This process is controlled 
by a negative feedback mechanism and is in turn followed by anti-inflammatory 
cytokine secretion to counter the increase of reactive species. Likewise, the 
cellular anti-oxidant defence system is also initiated to curb the progression of 
chronic inflammation where the risk of metabolic syndrome and subsequently 
atherosclerosis is greatly increased (Bullo et al., 2007). 
 Dietary habits are likely to be one of the principal determinants of the balance 
that influences inflammation in chronic conditions. Genetic polymorphisms at 
numerous sites may influence the ability of bioactive food components to affect 
inflammation by modulating pro- and/or anti-inflammatory mediators (Bullo et 
al., 2007). There is a lot of interest in reducing chronic disease risk or managing 
illnesses through health-promoting dietary ingredients. The health-promoting 
properties of cereal grain consumption in lowering the risk of chronic diseases is 
the focus of many research laboratories (Masisi et al., 2016). Cereal grains 
displaying anti-inflammatory and immunomodulatory activity may have an 
important role to play in alleviating some of the primary symptoms of 
inflammation. 
 This review attempted to summarise recent findings on the anti-inflammatory 
and immunomodulatory components of different cereal grains. The primary 
objective of the review was to report on the latest evidence supporting the 
bioactivity of various cereal grain extracts, bran, aleurone, phenolic compounds, 
β-glucan, AX and peptides.  
 
Anti-inflammatory effects of cereal grain extracts 
Considerable evidence on the anti-inflammatory potential of cereal grains has 
been garnered from studies assessing various grain extracts. Different extraction 
methods have been applied such as ethanol, methanol and aqueous extraction. In 
many published studies however, the bioactive components have not been 
definitely identified.  
 Several studies have investigated the anti-inflammatory potential of extracts 
prepared from rice using various extraction procedures. An ethanolic extract of 
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whole grain, black rice inhibited lipopolysaccharide (LPS)-induced expression of 
pro-inflammatory mediators, inducible nitric oxide synthase (iNOS), 
cyclooxygenase-2 (COX-2), interleukin 6 (IL-6) and tumor necrosis factor alpha 
(TNF-α) in RAW 264.7 mouse macrophage cells through inhibition of the nuclear 
factor-κB (NF-κB) and activator protein 1 (AP-1) signalling pathway (Limtrakul 
et al., 2015). Further analysis showed that the extract demonstrating anti-
inflammatory activity was rich in the flavonoid, anthocyanin, and also 
hydroxybenzoic acid. An ethanolic extract of black rice was also found to reduce 
eosinophil infiltration and Type 2 helper T cell (Th2) cytokines and decrease 
airway inflammation, as evidenced by lung histological examination, in an 
ovalbumin (OVA)-induced mouse model of chronic asthma (Lee et al., 2006). 
The black rice extract also decreased Th2 cytokines in cultured splenocytes and 
bronchoalveolar lavage fluid in a concentration-dependent fashion. The dried hull 
of rice is a by-product of the rice milling process. Kim et al. (2011) generated a 
liquid smoke extract of dried rice hulls and found that the extract reduced nitric 
oxide (NO) production in LPS-induced RAW 264.7 mouse macrophage leukemia 
cells and decreased TNF-α, IL-1β and IL-6 in 12-O-tetradecanolylphorbol-13-
acetate (TPA)-induced edema in CD-1 mice. The bioactive compounds in the 
extract were not identified. Both a methanolic and an aqueous extract of red rice 
demonstrated a concentration-dependent inhibition of IL-1β, IL-6 and COX-2 
mRNA expression in LPS-stimulated RAW 264.7 macrophages (Niu et al., 2013). 
The red rice extracts were shown to have a high phenolic content. Overall, these 
data suggest that rice is a good source of anti-inflammatory compounds and given 
that it is one of the most consumed grains worldwide, the impact on health 
benefits are likely to be significant. 
 Delipidated wheat, rye, buckwheat, oat and corn aqueous extracts, were shown 
to increase levels of the anti-inflammatory cytokine IL-10 in peripheral blood 
mononuclear cells (PBMCs) obtained from healthy individuals; the IL-10 
secretion by PBMCs led to the inhibition of interferon gamma (IFN-γ), IL-5 and 
IL-13 production in T-cells (Yamazaki et al., 2008). An extract prepared from 
proso millet L. (Panicum miliaceum), using ultra-sonication, was fed to ob/ob 
(obese) mice at a concentration of 1% diet and was found to decrease serum levels 
of the cytokines, monocyte chemotactic protein 1 (MCP-1), IL-6 and TNF-α in 
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the mice (Park et al., 2011). An aqueous extract prepared from the thread-like 
strands on the ears of corn (corn silk) demonstrated anti-inflammatory activity 
during acute inflammation in a carrageenan-induced pleurisy rat model. Pre-
treatment with 2g/kg and 4g/kg body weight of corn silk extract significantly 
attenuated TNF-α, IL-1β, vascular endothelial growth factor alpha (VEGF-α), IL-
17, NF-κB activation and iNOS protein expression in a dose-dependent manner 
(Wang et al., 2012). Ethanolic extracts from buckwheat decreased inflammation 
in ethanol- and carbon tetrachloride (CCl4)-treated C57BL mice and Sprague-
Dawley rats. The major active components, identified as quercetin and rutin, were 
also administered to the test animals. The results indicate that the buckwheat 
extract and the individual flavonoids, quercetin and rutin countered the effects of 
ethanol- and CCL4-induced liver damage by a number of mechanisms including 
increasing antioxidant enzyme activity and inhibiting inflammatory cytokines 
(Lee et al., 2013b). In a similar study, male Sprague-Dawley rats fed with an 
ethanolic extract of buckwheat (Fagopyrum cymosum) had less severe clinical 
arthritis compared with the control group, as shown by reduced paw swelling and 
lower polyarthritis index. Serum levels of IL-1 and TNF-α were also reduced in 
the extract-treated group (Shen et al., 2013). The ability to inhibit enzymes 
involved in arachidonic acid metabolism has been identified as a potential 
mechanism of action of a number of plant extracts traditionally associated with 
the treatment of inflammatory and cardiovascular diseases. A butanolic extract 
prepared from oats was found to inhibit arachidonic acid metabolism in human 
blood platelets through an inhibition of the cyclooxygenase and lipoxygenase 
pathways (Ahmed et al., 2013). This effect was not observed in oat fractions 
prepared using water and hexane. In summary, these studies demonstrate positive 
effects of extracts prepared from a variety of grains including wheat, rye, 
buckwheat, oat and corn in cell, animal and human studies. 
 Recent years have seen an increase in the consumer demand for cereal sprout 
products as the germination of grains may increase the nutritional and functional 
properties of the food (Cornejo et al., 2015). Manukumar et al. (2014) studied the 
impact of germination time on the antioxidant and anti-inflammatory activity of 
sorghum grains and found that a methanolic extract of 48h-germinated sorghum 
grain demonstrated better hemolysis protection compared to the raw sorghum 
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extract in human erythrocytes. The authors associated the bioactivity of these 
extracts with their polyphenol content. An ethanolic extract of buckwheat sprouts 
demonstrated anti-inflammatory activity in a human intestinal epithelial cell line, 
CoLoTC cells, as determined by a reduction in LPS-stimulated IL-8 release (Ishii 
et al., 2008). The authors also reported an anti-inflammatory effect in mice using 
both oral and intraperitoneal LPS-treatment. The oral administration of buckwheat 
sprouts decreased IL-6 and TNF-α in the spleen and liver of LPS-administered 
mice. The mechanism involved was unclear and the authors could not identify a 
relationship between anti-inflammatory activity and the six flavonoids which were 
detected in the buckwheat sprouts. The anti-inflammatory effect of ethanolic 
extracts prepared from buckwheat sprouts were also assessed in LPS-stimulated 
RAW 264.7 macrophages and compared with the flavonoid, rutin (Karki et al., 
2013). The authors reported a significant inhibition of both COX-2 expression and 
the translocation of NF-κB p65 subunit in the nuclear fraction by buckwheat 
sprouts. They suggest that the buckwheat sprouts may interfere with the 
interaction of LPS with toll-like receptor (TLR)-4 in the cell culture model 
utilised. From the limited studies in this area, it appears that sprouting may 
enhance the amounts of anti-inflammatory compounds in certain grains. It is an 
interesting area and certainly warrants further investigation. 
 Cereals and cereal components may be used in functional food formulations as 
fermentable substrates to promote the growth of probiotic microorganisms or as 
sources of dietary fibre providing a number of physiological benefits (Das et al., 
2012). Fermentation of cereal grains may therefore be a useful technique for the 
generation of bioactive compounds. The fermentation of brown rice and rice bran 
(FBRA) with Aspergillus oryzae prevented large bowel shortening in a mouse 
model for human familial adenomatous polyposis (Phutthaphadoong et al., 2010). 
FBRA administration significantly decreased iNOS and COX-2 mRNA 
expression in colonic tissue of the treated mice. FBRA also decreased cell 
proliferation in colonic crypt cells. Red mold rice (Monascus-fermented rice) 
generates many functional secondary metabolites. Cheng and Pan, (2011) 
demonstrated the hepatoprotective effects of Monascus-fermented red mold rice 
(RMR) using a chronic alcohol-induced C57BL/6J mouse model. RMR 
supplementation attenuated the production of hepatic IL-6, IL-1β and TNF-α. In 
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addition, it was noted that RMR decreased hepatic transforming growth factor 
beta (TGF-β) production. Lin et al. (2011) showed that TNF-α-treated human 
aortic endothelial cells (HAEC) supplemented with different Monascus-fermented 
rice metabolites, exhibited lower adhesion with human monocytic cells U937; the 
effect of the metabolites was dose-dependent. Monascus-fermented rice 
metabolites also ameliorated TNF-α-induced vascular cell adhesion molecule 1 
(VCAM-1) and E-selectin protein expression. The proposed mechanism involved 
a suppression of NF-κB activation, preventing TNF-α-induced VCAM-1 and E-
selectin expression in HAECs, leading to a reduction in the monocyte 
adhesiveness to endothelial cells. In summary, research suggests that fermentation 
enhances the amount of anti-inflammatory compounds in cereal grains. Additional 
research is necessary to fully assess the potential value of this approach from a 
human health perspective.  
 A number of different extraction methods have been used to obtain cereal 
fractions with anti-inflammatory activity. Phenolic compounds have been 
identified as active compounds in a number of these studies. Future research 
should focus on optimising these extraction methods and identification of other 
compounds within these grains that offer anti-inflammatory activity. More 
information on the mechanisms involved in the anti-inflammatory activity is also 
necessary. In addition, few clinical trials on the anti-inflammatory potential of 
cereal grains have been carried out. Clinical trials would be beneficial to further 
substantiate and confirm the anti-inflammatory potential of cereal grains.  
 
Anti-inflammatory effects of various cereal fractions 
Extracts prepared from whole grains demonstrate anti-inflammatory activity in 
various model systems as reviewed above. Distribution of bioactive compounds in 
the grain fractions is therefore of interest. Wheat aleurone is an example of novel 
wheat grain fraction with high levels of potentially health-promoting compounds. 
This sections reviews studies on anti-inflammatory activity of bran, aleurone and 
phenolic fractions from various grains and on the anti-inflammatory potential of 
grain derived β-glucans and AX. 
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Bran Fraction 
The bran is the hard outer layers of the grain surrounding the germ and endosperm 
which protects the grain from the external environment (Slavin, 2004). Most 
bioactive compounds of whole-grain cereal grains are present in the bran/germ 
fraction (Gani et al., 2012). A number of studies have been published on the anti-
inflammatory potential of cereal bran fractions.  
 Rye bran is an excellent source of dietary fibres and phytochemicals and is a 
potential prebiotic. Håkansson et al. (2009) demonstrated that rye bran, both alone 
and in combination with blueberry husks, altered the dextran sulphate sodium 
(DSS)-inflammatory response in Sprague-Dawley rats by reducing the oxidative 
damage caused by reactive oxygen species (ROS) involved in the induction of 
colitis. The polyphenolic components of rye bran and blueberry husks may have 
been responsible for reducing oxidative damage. Oat bran consumption reduced 
soluble VCAM-1 in low density lipoprotein (LDL)-receptor-deficient mice 
(Andersson et al., 2010). Additionally, mice fed a typical Western-type diet 
(Research Diets Inc., NJ, USA) with the addition of oat bran (40% w/w) 
demonstrated reduced levels of fibrinogen. However, inclusion of oat bran in the 
diet of these animals had no impact on plasma concentrations of IL-6. The authors 
speculated that the effect on inflammatory markers may be more significant 
postprandially, rather than in the fasted state. They also suggested that oat 
components such as avenanthramides, vitamin E and other phenolic compounds 
may have been responsible for the anti-inflammatory effects. Wheat bran is also a 
good source of fatty acids, tocopherols, polysaccharides and phenolic compounds 
(Akhtar et al., 2012). Belobrajdic et al. (2011) assessed the effects of wheat bran 
on inflammation and oxidative stress in lean and obese Zucker rats. They found 
that in obese rats, the wheat bran diet decreased plasminogen activator inhibitor-1 
(PAI-1) levels in plasma but had no effect on leptin, IL-1β or IL-6. Hosoda et al. 
(2012) assessed the effects of methanolic extracts from the bran of foxtail millet, 
barnyard millet and proso millet on NO and inflammatory cytokine production in 
LPS-stimulated RAW 264.7 macrophages. Proso millet bran extract demonstrated 
the strongest inhibitory effect against LPS-induced NO production and LPS-
induced IL-6 secretion at 0.25-0.5% extract. Foxtail and proso millet bran extracts 
showed stronger inhibitory effects on LPS-stimulated TNF-α secretion compared 
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to barnyard millet bran extract. Again, the anti-inflammatory effects of the bran 
extracts were associated with the phenolic content of the brans. 
 Rice bran contains ferulic acid and is also high in dietary fibres. It is currently 
used to treat hyperlipidaemia, hypertension and obesity (Mizushina et al., 2013; 
Park et al., 2013). Many studies have investigated the anti-inflammatory effects of 
rice bran. The anti-inflammatory activity of methanolic extracts of bran from 
Njavara ‘black glumed’ type medicinal rice (NBb) and its corresponding rice 
(NBr) in a carrageenan-induced paw edema in rats was assessed by Mohanlal et 
al. (2013). At a dose of 5mg/kg body weight, NBb inhibited edema after 3 and 5 h 
to a greater extent compared to NBr and other staple rice varieties. An enzymatic 
extract of rice bran reduced vascular inflammation by decreasing aortic iNOS and 
TNF-α expression when consumed by obese Zucker rats (Justo et al., 2013). 
Similarly, Candiracci et al. (2014) investigated the impact of dietary 
supplementation of an enzymatic rice bran extract on adipose tissue inflammation 
markers in obese Zucker rats. The extract decreased the expression of TNF-α, IL-
6, IL-1β, and iNOS in the adipose tissue of these obese rats. Choi et al. (2010) 
assessed the anti-inflammatory effects of black rice bran (cv. LK1-3-6-12-1-1) 
against TPA-induced skin edema and 2, 4-dinitrofluorobenzene-induced allergic 
contact dermatitis in inflammatory mouse models. Intraperitoneal treatment with 
pigmented black rice bran ethanol extract, prior to TPA application in CD-1 mice, 
decreased neutrophil levels and the production of TNF-α, IL-1β and IL-6 in ear 
tissue. Black rice bran extract also decreased arachidonate 5-lipoxygenase (5-
LOX) mRNA and protein expression in ear tissue. Suppression of 5-LOX 
expression by black rice bran extract was thought to be linked to the down-
regulation of intercellular adhesion molecule-1 (ICAM-1) expression which 
contributes to a blockade of inflammatory neutrophil migration into the tissue and 
to the subsequent aggravation of inflammation induced by the infiltrated cells. A 
recently-developed enzyme-treated rice bran prebiotic, composed of dietary fibre 
(>70%) and a fat-soluble fraction decreased proinflammatory cytokines (TNF-α, 
IFN-γ, IL-1β, IL-6, IL-12p70) and anti-inflammatory cytokines (IL-4) in DSS-
treated female BALB/c mice (Komiyama et al., 2011). Additionally, the 
hydrophilic fraction (ethanol-methanol soluble fraction) of the prebiotic 
demonstrated the ability to down-regulate dendritic cell proliferation. The authors 
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speculated that the anti-inflammatory effects of the prebiotic were partly as a 
result of microbiota modulation and increasing short chain fatty acid production. 
 Mizushina et al. (2013) found that a component of the by-product of sake-
brewing, cycloartenyl trans-ferulate (CAF), demonstrated anti-inflammatory 
activity in a CAF suppressed TPA-induced inflammation in the mouse ear but 
ferulic acid did not. There was a larger quantity of CAF in the outer pericarp of 
sake-brewing rice compared to ordinary rice. Glycoproteins play a significant role 
as structural constituents of the cell wall in many plants. The glycoprotein fraction 
from rice bran (GFRB) was assessed in LPS-stimulated RAW 264.7 cells by Park 
et al. (2013) and was found to increase IL-6, IL-10, IL-1β and TNF-α in RAW 
264.7 cells. The authors speculated that glycans are likely to be the active 
component in GFRB, as treatment of hydrolysed GFRB with a combination of 
amylase and pectinase reduced the anti-inflammatory effect.  
 The bran fraction of cereal grains is a valuable source of compounds with anti-
inflammatory activity. Considering that bran, along with the germ fraction, is 
usually removed during the milling process, retaining this fraction for use, for 
example, in functional food formulation, would be worthwhile given the potential 
it has in treating inflammatory symptoms.  
 
Aleurone Fraction 
According to the American Association of Cereal Chemists (AACC), the aleurone 
is defined as “the outermost layer(s) of the endosperm in cereal grains, and 
surrounds the starchy endosperm and part of the embryo. Cereal aleurone tissue is 
separated from the germ and starchy endosperm by standard milling practices, 
starting with the grain kernel or starting with the bran, followed by further 
extraction processes’’ (AACC, 2010). Aleurone-rich fractions lowered pro-
inflammatory mediators to a greater extent than crude fractions of wheat bran in a 
mouse model of obesity (Neyrinck et al., 2008). A prebiotic made from the 
aleurone layer and scutellum fractions of barley malt, and containing glutamine-
rich and hemicellulose-rich fibre, reduced colitis in immune-deficient female mice 
(Kanauchi et al., 2008).  
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 Mateo Anson et al. (2010) digested wheat fractions (aleurone, bran and flour) 
using an in vitro model, simulating the upper gastrointestinal (GI) tract. Dialysates 
were retrieved from jejunal and ileal sections at 1 hour intervals and represented 
the bioaccessible components from digested wheat fractions. The aleurone 
fraction was the only fraction to demonstrate an anti-inflammatory effect 
following 3-4 hr digestion as determined by a suppressed LPS-stimulated TNF-α 
production in U937 macrophages. This would indicate that the aleurone may be 
the most suitable wheat fraction to provide a sustained release of anti-
inflammatory compounds during gastrointestinal digestion. The inclusion of 
wheat aleurone in the diet of apparently healthy, older, overweight men and 
women produced a small but significant decrease in the fasting blood 
concentration of the inflammatory marker, C-reactive protein (CRP) (Price et al., 
2012). The authors suggested that the observed CRP-lowering activity may be due 
to a number of potentially bioactive components present in aleurone, which may 
function individually or synergistically. 
 Similar to bran, the aleurone component of cereal grains holds potential as a 
source of bioactive compounds that can be used to target inflammation. Further 
research is necessary to fully clarify and identify the anti-inflammatory 
compounds in this portion of the grain. 
 
Phenolic Fraction 
Phenolic compounds are secondary metabolites which play a role in the growth 
and reproduction of plants, as well as in plant defence mechanisms and 
pigmentation (Gani et al., 2012). Phenolics are concentrated in the bran fraction 
of the cereal grain where they are present in either the free, soluble conjugated or 
insoluble forms bound to arabinosyl chains of the cell wall (De la Fuente et al., 
2011). Phenolic acids are one type of phenolic compound found in cereals and 
consist of two main classes: hydroxybenzoic acids and hydroxycinnamic acids. 
Flavonoids are another class of phenolic compounds and are found in the pericarp 
(Dykes and Rooney, 2007). Phenolic acids and flavonoids are among the most 
ubiquitous phenolic compounds in whole-grain cereals. They are thought to act as 
stabilisers within the cell wall structure, as well as playing a role in the defence 
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against microorganisms. The amount of phenolic acids present in cereals is 
dependent upon the variety and type of cereal as well as the growing conditions 
and the time of harvest (Andersson et al., 2014). Among cereal grains, sorghum 
and millet have the greatest variety of phenolic acids (Dykes and Rooney, 2007). 
Phenolic compounds may be unique to particular cereal grains, for example tricin 
in rice and avenanthramides in oats, whereas certain phenolic acids, such as 
ferulic and cinnamic acid are found in a diverse range of cereals and other plants. 
Table 3 summarises the various methods reported for measuring and identifying 
the anti-inflammatory phenolics of cereal grains. 
 Whent et al. (2012) demonstrated that whole wheat flours contained phenolics, 
as well as lutein and α-tocopherol, and reported that ethanol extracts from these 
wheat flours had both anti-inflammatory and anti-proliferative activity in cell 
culture models. In particular, an extract from a WestBred 936 wheat cultivar 
significantly inhibited IL-1β mRNA expression in mouse J774A.1 macrophages. 
Methanol extracts from the aerial parts of barley showed anti-inflammatory 
effects in LPS-stimulated RAW 264.7 macrophages and in a septic mouse model 
(Choi et al., 2013). Gas chromatography-mass spectrometry analysis 
demonstrated the presence of derivatives of benzoic and cinnamic acids and fatty 
acids in the extracts. Brewers’ spent grain (BSG), a by-product of the brewing 
industry has been highlighted as a useful source of phenolic compounds. 
McCarthy et al. (2014) demonstrated that two phenolic extracts from BSG 
generated via sodium hydroxide (NaOH) extraction, caused significant alterations 
in inflammatory cytokine production in concanavalin A (ConA)-stimulated Jurkat 
T cells. The extracts contained high levels of hydroxycinnamic acids. In a follow-
up study, food digestates containing the phenolic extracts from BSG, altered 
cytokine production in ConA-stimulated Jurkat T cells (McCarthy et al., 2015). 
 A number of phenolic compounds with anti-inflammatory potential have also 
been identified in the bran fraction of various cereals. An aqueous maize husk 
extract demonstrated an anti-inflammatory effect in rats which was associated 
with the content of tannins and polyphenols in the extracts (Owoyele et al., 2010). 
Hole et al. (2012) identified the main free and bound phenolic acids in methanol 
and hydrolysed extracts of wheat, barley and oat flour as ferulic, caffeic,  
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Table 3: Anti-inflammatory activity of phenolic compounds from cereal grains 
Cereal grain Phenolic 
compound 
Model Anti-inflammatory effect Reference 
Wheat (flour) Ferulic acid LPS-stimulated 
J774A.1 
macrophages 
Inhibited IL-1β mRNA expression Whent et al., 
2012 
Barley Derivatives of 
benzoic acid and 
cinnamic acid 
LPS-stimulated 
RAW 264.7 
macrophages 
and LPS-
injected septic 
mouse model 
Suppression of NO, iNOS, TNF-α, IL-6, IL-1β and DNA-
binding activity of NF-κB. Improved survival rate of LPS-
injected mice. 
(Choi et al., 
2013) 
Brewers’ 
spent grain 
Ferulic acid, p-
coumaric acid and 
caffeic acid 
ConA-
stimulated 
Jurkat T cells 
Reduced IL-2, IL-4, IL-10 and IFN-γ production McCarthy et 
al., 2014 
Brewers’ 
spent grain 
(food 
digestates) 
Ferulic acid, p-
coumaric acid and 
caffeic acid 
ConA-
stimulated 
Jurkat T cells 
Increased IL-4 production. Decreased IL-10 and IFN-γ 
production 
McCarthy et 
al., 2015 
Maize (husk 
extract) 
Tannins and 
polyphenols 
Cotton pellet 
granuloma and 
carrageenan-
induced paw 
edema in rats 
Inhibition of paw edema and granuloma formation Owoyele et 
al., 2010 
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Oat, barley 
and wheat 
(flour) 
Ferulic acid, 
caffeic acid, p-
coumaric acid and 
sinapic acid 
LPS-stimulated 
U937-3κB-LUC 
cells 
Inhibition of NF-κB activity Hole et al., 
2012 
Pearl millet Polyphenols Splenic T-cells 
from Wistar rats 
Decreased PMA- and Ionomycin-induced MAPK 
phosphorylation and IL-2 mRNA expression. Increased 
intracellular free calcium 
Nani et al., 
2015 
Adlay (bran) Syringaldehyde, 
vanillic acid, 
ferulic acid, 
protocatechuic 
acid, caffeic acid, 
p-coumaric acid 
and luteolin 
A23187-
stimulated rat 
basophilic 
leukemia 
(RBL)-2H3 
cells 
Suppressed mast cell degranulation. Decreased IL-4, IL-6 and 
TNF-α secretion. Reduced ROS production, phosphorylation 
of Akt and expression of protein kinase C 
Chen et al., 
2012 
Maize (bran) p-Dicoumaroyl 
putrescine, 
diferuloylputresci
ne, p-coumaric 
acid and ferulic 
acid 
LPS-stimulated 
RAW 264.7 
macrophages 
Decreased NO production and iNOS expression Kim et al., 
2012 
Sorghum Benzoic acid and 
cinnamic acid 
derivatives 
LPS-stimulated 
RAW 264.7 
macrophages 
Inhibited NO production. Decreased iNOS and COX-2 
expression 
Nguyen et 
al., 2015 
N/a Morin MSU crystal-
induced acute 
gouty arthritis 
Decreased secretion of TNF-α, IL-1β, IL-6, MCP-1, VEGF 
and PGE2. Lowered NF-κB p65 and p-NF-κB p65 expression 
Dhanasekar 
et al., 2016 
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in Wistar albino 
rats 
N/a Lignan 
(hydroxymatairesi
nol and 7-
hydroxymatairesi
nol 2) 
TNF-α-
stimulated 
HAECs 
Inhibited TNF-α-stimulated ICAM-1 and VCAM-1 protein 
expression in HAEC. Reduced U937 cells adhesion to HAECs 
Spilioti et 
al., 2014 
Rye Alkylresorcinols Human 
lymphocytes 
Increased lymphocyte subpopulation numbers Gasiorowski 
et al., 2000 
Rice 
(Koshihikari) 
γ-Oryzanol, 
cycloartenyl 
ferulate and 
ferulic acid 
DSS-induced 
colitis in 
C57BL/6J mice 
Suppressed a number of inflammatory parameters including 
TNF-α, IL-1β and IL-6 transcription and COX-2 expression 
Islam et al., 
2008 
Rice 
(Njavara) 
Tricin LPS-stimulated 
human PMBCs 
Inhibited COX-2 and iNOS expression. Down-regulated TNF-
α, IL-6, PGE2 and NO production. Inhibited MMP-2 and 
MMP-9 activation and NF-κB signalling 
Shalini et 
al., 2012 
Rice 
(Njavara) 
Tricin LPS-stimulated 
RAW 264.7 
macrophages 
and TPA-
induced ear 
edema in ICR 
mice 
Decreased ROS, NO and PGE2. Inhibited iNOS and COX-2 
expression and NF-κB DNA-binding activity. Reduced TPA-
induced ear reddening in mice 
Jung et al., 
2014 
Rice (bran) Feruloylated 
oligosaccharides 
Murine BMDCs Induced IL-12 production in BMDCs. Promoted dendritic cell 
maturation. Induced NF-κB signalling pathways 
Lin et al., 
2014 
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Oats Avenanthramides IL-1β-
stimulated 
HAECs 
Decreased expression of adhesion molecules, chemokine and 
pro-inflammatory cytokine production and HAEC adherence 
to U937 cells 
Liu et al., 
2004 
Oats Avenanthramides TNF-α-induced 
keratinocytes 
and 
resiniferatoxin-
induced ear 
edema in ICR 
mice 
Inhibited NF-κB, p65 activation and NF-κB luciferase 
activity. Inhibited neurogenic inflammation in mice 
Sur et al., 
2008 
N/a Avenanthramides 
(dihydroavenanth
ramide D) 
Cytokine-
induced 
RINm5F 
insulinoma 
cells, isolated 
Sprague–
Dawley rat 
islets and STZ-
treated ICR 
mice 
Prevented NF-κB activation Lv et al., 
2009 
Oats None* TNF-α-induced 
human 293T 
cells 
Inhibited NF-κB activation Chu et al., 
2013 
Oats Avenanthramides TNF-α-
stimulated 
mouse myoblast 
Inhibited NF-κB activation Yang et al., 
2014 
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C2C12 cells 
Oats Avenanthramides Postmenopausal 
women 
undertaking 
downhill 
walking 
Decreased exercise-induced neutrophil respiratory burst 
activity, plasma CRP concentration, IL-1β levels and 
mononuclear cell NF-κB activation 
Koenig et 
al., 2014 
N/a, not assessed. * no correlation between phenolic content and anti-inflammatory activity. 
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p-coumaric and sinapic acids. The authors then showed that a combination of 
these phenolic acids modulated LPS-induced NF-κB activity in the U937-3κB-
LUC cell line. Millet polyphenols demonstrated immunosuppressive effects in 
splenic T-cells from Wistar rats via the inhibition of IL-2 mRNA expression and 
mitogen-activated protein kinase (MAPK) phosphorylation (Nani et al., 2015). 
 Ethyl acetate-soluble fractions of ethanolic extracts of adlay bran decreased IL-
4, IL-6 and TNF-α secretion in rat basophilic leukemia (RBL)-2H3 cells (Chen et 
al., 2012). Using 1-D nuclear magnetic resonance and mass spectroscopy spectral 
analysis, the authors identified a number of phenolic acids (syringaldehyde, 
vanillic acid, ferulic acid, protocatechuic acid, caffeic acid, and p-coumaric acid) 
and one flavone (luteolin) present in the adlay bran. With the exception of ferulic 
acid and caffeic acid, all of these compounds demonstrated an ability to suppress 
mast cell degranulation activity. Kim et al. (2012) found that an 80% ethanolic 
extract of corn bran (EECB) significantly repressed NO production and iNOS 
expression in a dose-dependent fashion in LPS-stimulated RAW 264.7 
macrophages. All four hydroxycinnamic acid derivative (HAD) components 
found in EECB (p-dicoumaroyl putrescine, diferuloylputrescine, p-coumaric acid 
and ferulic acid) attenuated NO production and iNOS expression in a dose-
dependent fashion. 
 There are a number of studies in which individual phenolic acids were isolated 
from cereals and their anti-inflammatory activity was assessed. Benzoic acid and 
cinnamic acid derivatives isolated from methanolic extracts of sorghum displayed 
potential inhibitory effects against NO production in LPS-induced RAW 264.7 
cells (Nguyen et al., 2015). Morin (2′,3′,4′,5,7-pentahydroxyflavone), a 
bioflavonoid found in cereals, showed anti-inflammatory effects in a Wistar 
albino rat model of acute gouty arthritis (Dhanasekar et al., 2016) as determined 
by decreased levels of TNF-α, IL-1β, IL-6, MCP-1, VEGF and prostaglandin E2 
(PGE2) in serum. 
 Lignans are plant polyphenols which have demonstrated positive health 
benefits. Spilioti et al. (2014) found that hydroxymatairesinol (HMR) – a lignan, 
and its major isomer 7-hydroxymatairesinol 2 (HMR2) were effective at blocking 
TNF-α-induced ICAM-1 and VCAM-1 expression in HAECs. HMR is found in 
wheat, triticale, oats, barley, millet, corn bran and amaranth whole grain. 
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Alkylresorcinols are also a class of phenolic compounds found in whole grain 
cereals (Gani et al., 2012). Gasiorowski et al. (2000) isolated and purified the 
alkylresorcinols (5-n-alk (en) ylresorcinols) from a milled rye bran fraction and 
demonstrated the immunomodulatory action of alkylresorcinols in human 
lymphocyte cultures. 
 γ-Oryzanol (γ-ORZ) is comprised of phytosteryl ferulates, made up of 24-
methylenecycloartanyl ferulate, CAF, β-sitosteryl and campestanyl ferulate. Oral 
supplementation with γ-ORZ, purified from the Japanese rice, Koshihikari, 
decreased TNF-α, IL-1β and IL-6 transcription and also decreased COX-2 
expression in DSS-induced colitis in mice (Islam et al., 2008).  
 The flavonoid, tricin, was isolated from Njavara rice bran, and was found to 
attenuate LPS-stimulated PGE₂ and NO production in human PMBCs through the 
inhibition of COX-2 and iNOS expression (Shalini et al., 2012). Subsequently, 
Jung et al. (2014) examined the anti-inflammatory effects of a methanol-extracted 
tricin, 4’-O-(erythro-β-guaiacylglyceryl) ether (TTGE), from Njavara rice bran in 
LPS-treated RAW 264.7 macrophages and in an experimental edema model in 
mice. TTGE dose-dependently decreased ROS, NO and PGE2 in LPS-stimulated 
RAW 264.7 macrophages. Additionally, TTGE decreased the ear reddening 
induced by TPA in mice. Lin et al. (2014) demonstrated the stimulating effect of 
feruloylated oligosaccharides (FOs) isolated from rice bran on dendritic cells and 
also found that FOs induced IL-12 production in bone marrow-derived dendritic 
cells (BMDCs).  
 Avenanthramides are the principal phenolic antioxidants found in oats (Liu et 
al., 2004). The main role of avenanthramides is thought to relate to host protection 
as they exhibit anti-microbial activity (Jung et al., 2014). Avenanthramides range 
from 40-132 μg/g in cereal grains (Gani et al., 2012). Liu et al. (2004) reported 
that pre-treatment of HAECs with an ethanol-extracted avenanthramide-enriched 
mixture decreased IL-1β-stimulated HAEC expression of adhesion molecules, 
chemokine and pro-inflammatory cytokine production and HAEC adherence to 
U937 cells in a dose-dependent manner. In another study, the pre-treatment of 
keratinocytes with avenanthramides prevented degradation of inhibitors of NFκB-
α (IκB-α) (Sur et al., 2008). It was also shown that topical application of 
avenanthramides inhibited 0.05% resiniferatoxin-induced neurogenic 
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inflammation in ICR mice (Sur et al., 2008). A study assessing 
dihydroavenanthramide D (DHAvD), the synthetic form of avenanthramide, 
demonstrated that DHAvD protected pancreatic β cells (RINm5F insulinoma cells 
and isolated Sprague–Dawley rat islets) from the toxic effects of cytokines (Lv et 
al., 2009). However, there was no correlation between avenanthramide levels in 
whole oat groats and NF-κB inhibitory activity in human 293T cells, suggesting 
that other components are involved in the anti-inflammatory activity (Chu et al., 
2013). Yang et al. (2014) demonstrated the anti-inflammatory activity of three oat 
avenanthramides in TNF-α-stimulated NF-κB activation in mouse myoblast 
C2C12 cells and noted that variation in the NF-κB-suppressive effects of the three 
avenanthramides were related to their structural differences. Avenanthramide 
supplementation decreased exercise-induced neutrophil respiratory burst activity, 
plasma CRP concentration, IL-1β levels and mononuclear cell NF-κB activation 
in in postmenopausal women (Koenig et al., 2014). 
 It is clear that phenolic compounds present in cereal grains may play an 
important role in the attenuation of inflammation. Considering also, that the 
amount of phenolic compounds present in cereals depends on the variety and type 
of cereal grain, for example, tricin in rice and avenanthramides in oats, there may 
be scope to focus on certain cereal types and manipulate growing conditions in 
order to maximise the phenolic compound yield. 
 
β-Glucans 
β-Glucans are large, viscous, water-soluble cell wall constituents (soluble fibre) 
present in certain cereal grains, including oats (Rieder et al., 2011; Fardet et al., 
2008). β-Glucan possesses a number of functionalities and roles that make it 
unique as a plant cell wall component. There are a limited number of studies 
which indicate that β-glucan has immunomodulatory properties. 
CD3+ T cells co-cultured with dendritic cells which had been exposed to the 
barley polysaccharide, MSK-BG (a pure, linear (1→3), (1→4)-β-glucan) 
demonstrated increased IFN- and IL-4 secretion (Chan et al., 2007). The authors 
proposed that MSK-BG may be used to compliment antibody-based
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targeted therapy in cancer treatments. Barley β-glucans from whole barley flour 
had a more pronounced inhibitory effect on TNF-α-stimulated VCAM-1 
expression in HAECs, compared to oat β-glucans (Lazaridou et al., 2011). This 
was associated with structural differences - barley β-glucans chains have greater 
levels of 3-O-β-cellobiosyl-D-glucose portions (β-(1 → 3) glycosyl linkages 
compared to oats. Rieder et al. (2011) investigated the effects of commercial, 
cereal-derived β-glucans with different average molecular weights on cytokine 
secretion in IL-1α-stimulated Caco-2 cells and TNF-α-stimulated human intestinal 
epithelial cells (HT-29 cells). In HT29 cells, IL-8 secretion increased in response 
to 40kDa and 359kDa β-glucans, whereas Caco-2 cells were unresponsive. The 
authors speculated that slight differences in structure and composition, outside of 
size, may account for differences in immuno-stimulatory activity observed for the 
different samples. In a more recent study, treatment with a commercially available 
β-glucan-enriched extract (BGEE) in streptozotocin-induced diabetic rats was 
investigated (Uskokovic et al., 2013). BGEE treatment led to the normalization of 
the serum concentrations of the “positive” and “negative” acute-phase proteins, α 
2 -macroglobulin and albumin, respectively. In addition, the expression of anti-
inflammatory cytokines IL-10 and IL-4 was also upregulated. The researchers 
demonstrated that BGEE elicited its effects by impeding the receptor for advanced 
glycation end-products (RAGE)/NF-κB signalling pathway.  
 β-Glucan is known for its ability to attenuate elevated blood glucose, 
triglyceride and cholesterol (Ahmad et al., 2014). However, there is a limited 
amount of evidence suggesting that it plays an important role in reducing 
inflammation and further investigation is warranted.  
 
Arabinoxylans 
AX are non-starch polysaccharides, mainly consisting of xylose and arabinose 
(Bartlomiej et al., 2012; Mendis and Simsek, 2014). Cereal processing practices 
such as milling, gluten-starch separation and brewing result in AX-rich by-
products. AX and its hydrolysis products arabinoxylan oligosaccharides (AXOS) 
have demonstrated different health benefits, including immunomodulatory activity
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in the limited number of published studies (Mendis and Simsek, 2014). Thus, 
utilization of these industrial by-products for the extraction of health-promoting 
dietary fibers holds much promise for these industries (Mendis and Simsek, 
2014). The full impact of AX with respect to human health has yet to be explored. 
 Two water-soluble AX, which were sequentially extracted from wheat bran 
using enzymatic or NaOH extraction were investigated for their complement-
fixing activity using sensitized red blood cells from sheep (Hromadkova et al., 
2013). The complement-fixing activity of the enzyme-extracted fraction was 
lower than that of the NaOH-extracted fraction. Furthermore, the wheat bran 
fraction extracted using NaOH performed better than the positive control, the 
immunogenic polysaccharide PM II. Stimulation with a purified polysaccharide 
subfraction, BLE-P-I, which was isolated from barley leaf using pectinase, led to 
a significant increase in the macrophage-stimulating cytokines TNF-α, IL-6, and 
IL-12 in RAW 264.7 cells (Kim et al., 2016). Purification by column 
chromatography established that glucuronoarabinoxylan (40–45%) and 
rhamnogalacturonan-I mainly branched with a type II arabinogalactan side chain 
(30–35%) were the predominant polysaccharides contained in the extract.  
 The anti-inflammatory effect of water-soluble rice bran polysaccharides and 
sulfated rice bran polysaccharides from defatted rice bran was assessed in mouse 
melanoma cell line B16 and RAW 264.7 macrophages (Wang et al., 2016). It was 
found that the fraction derived from the polysaccharide, RBP2 - an arabingalactan 
consisting mainly of galactose and arabinose, and the sulfated polysaccharide, 
SRBP2 - derived from RBP2, showed immune-enhancing activity in RAW 264.7 
cells by increasing NO and TNF-α secretion. AX also increased the macrophage 
phagocytic activity of chicken red blood cells (CRBC) in S-180 tumor-bearing 
ICR mice and also promoted ConA and LPS-stimulated splenocyte proliferation 
in tumor-bearing mice (Cao et al., 2011). In addition, AX increased the 
effectiveness of natural killer cells from splenocytes in these mice, indicating the 
potential to increase the cytotoxic activity against tumor cells (Cao et al., 2011). 
Similarly, AX from wheat bran, extracted using NaOH, stimulated antibody 
responses in Hubbard chickens (Akhtar et al., 2012). Enzyme-extracted AX and 
alkaline-extracted AX, from de-starched wheat bran, were orally administered to 
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mice and were shown to increase ConA- and LPS-stimulated splenocyte 
proliferation (Zhou et al., 2010).  
 The ability of a granular foodstuff containing hydrolysed rice bran to prevent 
the common cold syndrome in elderly people was investigated by Maeda et al. 
(2004). The hydrolysed rice bran was a water-soluble dietary fibre fraction 
extracted from rice bran and was found to contain AX as the main constituent. 
The rice bran extract reduced the duration of common cold symptoms and 
decreased the severity of symptoms and the requirement for symptomatic therapy, 
showing its value in decreasing physical stress at the acute phase of respiratory 
infection. AX have a complex structure compared to other commonly studied 
dietary fibres and understanding the structure-function relationship between AX 
and immunomodulatory potential needs further research. 
 AX has considerable potential as an anti-inflammatory compound. From a 
functional standpoint, AX is an easily extractable grain component produced 
during cereal processing. It may therefore provide a useful immunomodulatory 
fraction that can be added to functional foods for human consumption.  
 
Anti-inflammatory effects of peptides from cereal grains 
The protein content of cereals ranges from approximately 7% to 11% of dry 
weight and cereals are the primary source of protein for a large part of the world’s 
population. Cereal protein is a good source of essential amino acids, with the 
exception of the limiting amino acids lysine, threonine and methionine, and is also 
a source of bioactive peptides which may be released from the parent protein 
during food processing or during gastro-intestinal digestion by the action of either 
digestive enzymes or colonic bacteria (Korhonen and Pihlanto, 2006). Cereal 
peptides have documented health benefits including angiotensin-converting 
enzyme (ACE) inhibition (Cian et al., 2015), facilitating a reduced glycaemic 
response to carbohydrate intake (Ishikawa et al., 2015) and antioxidant effects 
(Zhu et al., 2006; Chanput et al., 2009; Yin et al., 2015). Peptides derived from 
many foods such as milk, meat, eggs and plant sources, including cereals, have 
also shown anti-inflammatory effects (Chakrabarti et al., 2015).  The mechanisms 
underlying the anti-inflammatory effects of food-derived peptides have not been 
27 
 
fully elucidated and can vary depending of the peptide structure or sequence 
(Majumder et al., 2013). 
 Glutein and prolamin are the major protein classes in cereals. Prolamins have a 
high proline and glutamine content and, in particular, wheat prolamins (gluten) 
have a unique amino acid profile which consists of greater than 40% glutamyl 
residues (Shewry et al., 1986). The prolamin fraction contains the peptide 
sequences responsible for the allergenicity of cereals however, a number of anti-
inflammatory peptides have also been derived from the prolamin fraction (Silano 
et al., 2008; De Vita et al., 2012). The prolamin fraction of rice was identified as 
the fraction with the highest cytokine-mediated anti-leukemic response, in an in 
vitro study, in comparison with the albumin, globulin, and glutelin fractions (Chen 
et al., 2010). 
 Several investigators have demonstrated that peptides derived from cereals 
including wheat and maize can protect against inflammatory bowel disorders such 
as ulcerative colitis and celiac disease (Giordani et al., 2014; Mochizuki et al., 
2010). Celiac disease is characterised by intestinal inflammation resulting from 
exposure to prolamins, particularly the gliadin fraction of wheat. Despite its 
inflammatory effects in celiac disease, wheat gluten has also been shown to 
contain peptide sequences capable of moderating the inflammatory effects of 
gliadin. A decapeptide (QQPQDAVQPF), which had previously been identified in 
durum wheat (De Vincenzi et al., 1997), was synthesised by Silano et al. (2008) 
and was found to ameliorate the wheat gliadin-induced inflammatory response in 
T-cells obtained from celiac patients. The proposed mechanism was a binding of 
the decapeptide to the antigen presenting cells thereby inhibiting presentation of 
the antigen to T-cells and the subsequent inflammatory response. A substitution of 
glycine for aspartic acid at position 5 or alanine at position 6 diminished the anti-
inflammatory activity of the decapeptide indicating the significance of the peptide 
sequence and structure in this anti-inflammatory effect (Silano et al., 2008). An 
analogous peptide sequence (QQPQRPQQPF), also identified in cereals, similarly 
demonstrated protection against inflammation associated with celiac disease (De 
Vita et al., 2012). A more recent study found that both these decapeptides 
hindered the up-regulation of pro-inflammatory cytokines by human dendritic 
cells, which are potent antigen presenting cells, as well as their ability to induce T 
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cell proliferation when dendritic cells were pre-incubated with the peptides prior 
to exposure to gliadin (Giordani et al., 2014). The oral administration of an 
enzymatic hydrolysate of maize gluten (zein) reduced the mucosal levels of 
inflammatory markers, histamine and myeloperoxidase activity, in a rat model of 
inflammatory bowel disease (Mochizuki et al., 2010) and may therefore be 
beneficial in the treatment or prevention of Crohn’s disease and ulcerative colitis.   
 Pryoglutamyl peptides, a product of the heat treatment of glutamine, have been 
identified in wheat gluten and appear to be resistant to gastrointestinal digestion 
(Higaki-Sato et al., 2003). Both free and peptide forms of pyroglutamic acid have 
been detected in the plasma of rats following the intragastric administration of 
wheat gluten hydrolysate indicating that they are bioavailable (Higaki-Sato et al., 
2003). Hirai et al. (2014) investigated the anti-inflammatory effects of 
pyroglutamyl-leucine in an LPS-stimulated mouse macrophage model and 
compared it with the dipeptides pyroglutamyl-leucine, pyroglutamyl-valine, 
pyroglutamyl-methionine and pyroglutamyl-phenylalanine. Each of the dipeptides 
was found to reduce the secretion of pro-inflammatory cytokines in LPS-
stimulated mouse macrophages in a dose-dependent manner. The most marked 
effect was observed for pyroglutamyl-leucine and the authors investigated the 
mechanism involved in the anti-inflammatory effect of this dipeptide. They found 
that the dipeptide did not inhibit binding of LPS to the cell surface of 
macrophages but exerted its anti-inflammatory effect through a suppression of 
IκBκ degradation and MAPK phosphorylation and inhibition of NF-κB activation. 
The authors proposed that the ability of pyroglutamyl-leucine to moderate 
inflammation downstream of LPS-TLR-4 binding would indicate that the 
dipeptide is transported into cells where it directly interacts with inflammatory 
pathways. 
 One of the processes contributing to the progression of multiple sclerosis (MS) 
is the inflammatory demyelination of cells of the nervous system (Lisak and 
Hohlfeld, 2007). A 16 amino acid peptide (AEMIDALAAKMLSEGRG) termed 
RA1, identified as a fragment of cooked Japanese rice, was found to reduce 
inflammation in a mouse model of MS (Shapira et al., 2010). In addition, when 
these animals were orally administered an extract of Japanese cooked rice they 
also demonstrated a significant reduction in neurological symptoms. The authors 
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speculated that the presence of this peptide in rice may contribute to the lower 
incidence of MS in Japan and China. This peptide was also found to be 
synthesised by T regulatory cells in response to incubation with a novel anti-
inflammatory peptide IIIM1, a nonapeptide derived from histone H2A. RA1 also 
reduced the oxidative burst of activated macrophages (Schussheim et al., 2011) 
which is a fundamental activity of many known anti-inflammatory agents. As 
stated by the authors, the fact that RA1 was active following oral administration 
indicates that the peptide is bioavailable and may also be effective against other 
chronic inflammatory disorders (Shapira et al., 2010).  
 Protein hydrolysates derived from BSG have demonstrated anti-inflammatory 
potential by their ability to reduce ConA-stimulated IFN- production in Jurkat T 
cells (McCarthy et al., 2013). BSG incorporated into a variety of foodstuffs and 
subjected to an in vitro digestion procedure has also demonstrated anti-
inflammatory potential in cell culture models (Crowley et al., 2015; McCarthy et 
al., 2015). Montoya-Rodriguez et al. (2014a) showed that extruded amaranth 
hydrolysates significantly reduced TNF- secretion in both LPS-induced THP-1 
and RAW 264.7 cells. This was accompanied by a reduction in PGE2 and COX-2, 
along with a decrease in the expression of p65 NF-κB subunits in the cell nuclei. 
A subsequent study assessed the ability of pepsin-pancreatin hydrolysates from 
unprocessed and extruded amaranth to reduce atherosclerosis markers in LPS-
induced THP-1 human macrophage-like cells (Montoya-Rodriguez et al., 2014b). 
Extruded amaranth hydrolysate demonstrated anti-inflammatory activity by 
reducing the expression of a host of proteins associated with the lectin-type 
oxidized LDL receptor 1 (LOX-1) signalling pathway in LPS-induced THP-1 
human macrophage-like cells. Synthetic, pure peptides derived from amaranth 
proteins also demonstrated anti-inflammatory potential by a reduction in the 
expression of LOX-1, ICAM-1 and matrix metallopeptidase 9 (MMP-9) in LPS-
induced THP-1 human macrophage-like cells (Montoya-Rodriguez et al., 2015).  
 Rice bran protein hydrolysates, extracted by alkaline or enzymatic 
mechanisms, were fed to male Sprague-Dawley rats on a high carbohydrate-high 
fat diet and a decrease in mRNA expression of proinflammatory cytokines, IL-6, 
TNF-α, iNOS and MCP-1 in the intra-abdominal fat cells was observed (Boonloh 
et al., 2015). The authors speculated that the decrease in these cytokines may be 
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related to the upregulation of peroxisome proliferator-activated receptor γ (Ppar-γ) 
which regulates fatty acid uptake and glucose metabolism. Additionally, the 
possibility that components in the extract other than peptides may enhance the 
bioactivity of the hydrolysate fractions was proposed.  
 There is a significant amount of evidence supporting that peptides from cereal 
grains have immunomodulatory activity. Cereal grain peptides may have potential 
as functional food ingredients aimed at reducing inflammation. More research is 
required, particularly with regard to the bioaccessibility and bioavailability of 
cereal grain proteins and peptides. There is also a need for further evaluation of 
the anti-inflammatory effects of cereal grain peptides in human populations to 
validate health claims.  
 
Conclusion 
In cereal crops the edible seed, referred to as the grain, has excellent nutritional 
qualities. Most bioactive compounds in whole-grain cereals are located in the 
bran/germ component (Gani et al., 2012). A number of different cereal grain 
components have shown anti-inflammatory and immunomodulatory activity, as 
demonstrated by the plethora of in vitro and in vivo studies which have been 
performed over the last decade. Many bioactive components have already been 
identified, whereas in some other cases, specific bioactive constituents of cereal 
grains have not yet been isolated. Some bioactive compounds are associated with 
specific cereals, for example γ-ORZ in rice, avenanthramides in oats, 
alkylresorcinols in rye and β-glucans in both oats and barley (Gani et al., 2012). 
Such compounds have the potential to become useful ingredients in ‘functional 
foods’ or foods/dietary components that contribute health benefits beyond basic 
nutrition (Das et al., 2012). Further work is however required to identify fully the 
specific bioactive components of cereal grains that elicit anti-inflammatory and 
immunomodulatory effects. Furthermore, greater numbers of studies using human 
subjects are required to validate fully the bioactivity of such components.  
 Another future challenge in the area of cereal grain research will involve 
detailed investigation of the bioaccessibility and bioavailability of bioactive 
constituents. Bioaccessibility is the first obstacle to a compound’s bioavailability. 
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It relates to the intestinal release of a compound from a food matrix, making it 
available for absorption (Bjorck et al., 2012). This is particularly relevant to 
compounds, such as phenolics which are bound to the grain matrix, therefore 
hindering extraction and bioaccessibility (Dykes and Rooney, 2007). Different 
processing technologies have been created to modulate and increase the 
bioaccessibility of bound compounds such as phenolics in cereal grains (Wang et 
al., 2014). These include reducing particle size and degradation of cereal matrices 
or breakdown of fibre polymers via methods such as mechanical treatment, 
thermal treatment, bioprocessing and extrusion cooking. Such technologies may 
prove useful in the further exploitation of bioactive constituents present in cereal 
grains. 
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Research Objective 
Brewers’ spent grain (BSG) is the insoluble portion of the barley malt leftover at 
the end of the brewing process and is known as a rich source of protein and 
phenolic compounds, with potential functional food applications. Phenolic 
extracts and protein hydrolysates generated using alkaline hydrolysis have 
previously demonstrated bioactive effects in in vitro cell culture models. The 
objective of this thesis was to investigate the bioactivity of phenolic extracts and 
protein hydrolysates generated from BSG using an extraction procedure utilising 
food-grade carbohydrase and proteinase enzymes, in in vitro cell culture models 
and to assess their potential as functional food ingredients. 
Firstly, the anti-inflammatory activity of an alkaline-extracted protein-enriched 
isolate and subsequent fractions produced using membrane fractionation, which 
were added to low-fat milk and subjected to simulated gastrointestinal digestion 
(SGID), was investigated. The anti-inflammatory activity of the resultant 
digestates was assessed using an in vitro cell culture model. 
Next, the antioxidant potential of enzyme-extracted BSG phenolic extracts was 
assessed in in vitro cell culture models. Following on from this, the most active 
phenolic extracts were then added to flavoured water, where the antioxidant 
activity of the drinks was measured before and after SGID.  
Additionally, the anti-inflammatory and antioxidant activity of BSG protein 
hydrolysates was examined. Hydrolysates produced using direct enzymatic 
hydrolysis were assessed for their bioactive effects. Similarly, the bioactivity of 
another set of hydrolysates generated using direct enzymatic hydrolysis procedure 
was investigated and compared with hydrolysates produced using an alkaline-
extraction method, alkaline-extracted hydrolysates subjected to SGID and 
alkaline-extracted hydrolysates generated using ultrafiltration. 
The neuroprotective potential of BSG phenolic extracts was also researched, 
where the impact of extracts on oxidant-induced apoptosis and lipid peroxidation 
was measured. Finally, the antiproliferative effects of BSG phenolic extracts and 
protein hydrolysates in cells of a cancerous origin, was examined, as well as the 
ability of phenolic extracts to induce apoptosis. 
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Chapter 2 
Immunomodulatory potential of a brewers’ spent grain protein 
hydrolysate incorporated into low-fat milk following in vitro 
gastrointestinal digestion.  
 
Published in: International Journal of Food Sciences and Nutrition (2015) 66, 
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Abstract 
A brewers’ spent grain (BSG) protein rich fraction was previously hydrolysed 
using Alcalase (U) and 3 additional fractions were prepared from U by membrane 
fractionation; a 5 kDa retentate (U >5), a 5kDa permeate (U <5) and a 3 kDa 
permeate (U <3). In the present study, these fractions were added to milk and 
subjected to simulated gastrointestinal digestion (SGID) and their anti-
inflammatory potential was investigated. The digestates caused a significant 
reduction (P<0.05) in interleukin-6 (IL-6) production in Concanavalin-A (ConA)-
stimulated Jurkat T cells. The samples did not significantly alter the production of 
IL-6 in lipopolysaccharide (LPS)-stimulated RAW 264.7 cells. IL-2 and 
interferon-γ (IFN-γ) production in stimulated Jurkat T cells and IL-1β and tumor 
necrosis factor- (TNF-) production in stimulated RAW 264.7 cells were also 
not affected in the presence of the digestates. The results show that a SGID milk 
product supplemented with BSG hydrolysate and its associated ultrafiltered 
fractions can confer anti-inflammatory effects in Jurkat T cells.   
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Introduction 
The demand for ‘healthy foods’ has increased significantly over the last number 
of years (Hasler, 2002). This has led to the rapid increase in the development of 
functional foods containing bioactive food-derived ingredients or physiologically 
active nutrients with validated health benefits (Crowe and Francis, 2013). Protein 
hydrolysates from agricultural crops have demonstrated bioactive effects which 
support their potential use as functional food ingredients (McCarthy et al., 2013a; 
Celus et al., 2007).   
One of the challenges to the commercialisation of bioactive protein 
hydrolysates is the limited amount of information available regarding their 
bioavailability which is the amount of an ingested nutrient that is absorbed and 
metabolised (Li-Chan, 2015). It has been estimated, for example, that up to 97% 
of the cereal-derived, anti-inflammatory peptide lunasin is destroyed by 
gastrointestinal digestion (Dia et al., 2009a). In addition, peptides can be released 
from the parent protein during the digestive process. A number of studies have 
reported the release of bioactive peptides following the simulated gastrointestinal 
digestion (SGID) of plant proteins (Lo et al., 2006; Marambe et al., 2011; 
Vermeirssen et al., 2005). SGID is typically used to determine the bioaccessibility 
of a nutrient and may be coupled with the Caco-2 cell model to estimate nutrient 
bioavailability (Ting et al., 2015) however, the in vitro SGID method has also 
been used to assess the stability of protein hydrolysates to gastrointestinal 
enzymes (Raikos and Dassios, 2014).   
Inflammation is an essential process in the body’s reaction to nonlethal injury, 
however, excessive and uncontrolled inflammatory responses can lead to chronic 
diseases (Chakrabarti et al., 2014). Several cereal-derived peptides have 
demonstrated anti-inflammatory effects. Shapira et al. (2010) found that a peptide 
derived from Japanese rice reduced the secretion of the pro-inflammatory 
cytokines interferon gamma (IFN-γ) and interleukin-17 (IL-17) and increased 
production of the anti-inflammatory cytokines IL-4 and IL-10 in splenocytes 
isolated from a mouse model of multiple sclerosis. Hydrolysates prepared from 
the pseudo-cereal amaranth have demonstrated anti-inflammatory effects in both 
lipopolysaccharide (LPS)-induced human THP-1 macrophage cells and RAW 
264.7 cells (Montoya-Rodríguez et al., 2014). The peptide lunasin demonstrated 
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anti-inflammatory activity in LPS-induced RAW 264.7 cells (Dia et al., 2009b). 
Brewers’ spent grain (BSG) which is the insoluble portion of the barley malt 
which remains at the end of the brewing process is a rich source of protein 
(Mussatto et al., 2006). Research from our laboratory has previously 
demonstrated that protein hydrolysates derived from BSG possess anti-
inflammatory activity in human Jurkat T cells (McCarthy et al., 2013b).    
In the present study a BSG protein-enriched isolate hydrolysed using Alcalase 
(U) and 3 fractions prepared from U using membrane fractionation; a 5 kDa 
retentate (U >5), a 5kDa permeate (U <5) and a 3 kDa permeate (U <3), were 
added to low-fat milk. The anti-inflammatory potential of these hydrolysates was 
previously reported in McCarthy et al. (2013b). The supplemented milk samples 
were then subjected to SGID and the anti-inflammatory potential of the resultant 
digestates was investigated in Concanavalin-A (ConA)-stimulated Jurkat T cells 
and LPS-stimulated murine macrophage RAW 264.7 cells. Both T cells and 
macrophages have a critical role in the immune response. T cells develop in the 
thymus and possess a T cell receptor on their surface. Macrophage cells originate 
from monocytes and engulf pathogens in addition to stimulating lymphocytes and 
other immune cells (Hu and Pasare, 2013). Con-A is a mitogenic lectin which 
stimulates the secretion of inflammatory cytokines in Jurkat T cells (Dupis and 
Bastin, 1988). RAW 264.7 cells are known to produce inflammatory cytokines in 
response to LPS and are widely used for the investigating the activity of potential 
anti-inflammatory compounds (Rossol et al., 2011).   
 
Materials and Methods 
Materials 
All chemicals, unless otherwise stated, were purchased from Sigma-Aldrich 
Ireland Limited, Co. Wicklow, Ireland. Jurkat T cells and RAW 264.7 cells were 
obtained from the European Collection of Animal Cell Cultures (ECACC, 
Salisbury, UK).  
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Preparation of protein hydrolysate 
The BSG protein rich isolate was extracted at semi-pilot scale using a method 
previously described (Connolly et al., 2013). The parent hydrolysate (U) was 
prepared using Alcalase 2.4L. During hydrolysis, the pH was maintained by 
addition of NaOH using a pH-Stat system (Metrohm 718 STAT Titrino, Herisau, 
Switzerland) and the temperature was kept constant using a thermostatically 
controlled water bath (IKA® Werke GmbH & Co. KG, Staufen, Germany). The 
resulting hydrolysate was adjusted to pH 7.0, heated at 95°C for 10 minutes to 
inactivate the enzyme and was then freeze-dried (U)  or fractionated using 5 and 3 
kDa molecular cut-off membranes (Minimate™ Tangental Flow Filtration 
Capsules, Pall Corporation, New York, USA) prior to freeze drying (U >5, U <5, 
U <3).  
 
Preparation of fortified food 
The low-fat (1.5%) milk (Dawn Dairies, Co. Cork) was purchased in a local 
supermarket. Before addition to foods, a 1% (w/v) solution of freeze dried 
hydrolysate (U) or ultrafiltration fraction (U >5, U <5, U <3) solution was 
prepared using distilled, deionised water. Each of the hydrolysate samples (1%, 
w/v) were added to low-fat milk aliquots (50 mL) at a concentration of 0.125 % 
(v/v) to yield a milk product with a final concentration of 12.5 ppm sample, 
similar to previously published studies (McCarthy et al., 2015; Nasri et al., 2013; 
Segura-Campos et al., 2013).  
 
Simulated gastrointestinal digestion (SGID) 
A SGID model, as previously described (McCarthy et al., 2015) was utilised to 
simulate human digestion. Briefly, for the gastric digestion 2 mL sample and 1 
mL Pepsin (0.04 g/mL in 0.1M HCl) were added to 12 mL Hank’s balanced salt 
solution (HBSS) and the pH was adjusted to 2 using 0.1M HCl, to simulate the 
physiological conditions of the stomach. Samples were incubated for 1 h in a 
shaking waterbath (Grant OLS 200, Grant Instruments, Cambridge, UK) at 95 
rpm and 37
o
C. To simulate duodenal digestion, 100 µL Pancreatin (0.08 g/mL in 
HBSS) and 200 µL bile salts (0.2 g glycodeoxycholate, 0.125 g taurodeoxycholate 
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and 0.2 g taurocholate in 5 mL HBSS) were added, the pH was adjusted to 7.4 
using 1N NaOH and samples were incubated in a shaking waterbath (95 rpm) at 
37
o
C for 2 h. Samples were centrifuged at 5,525 x g for 1 h and the supernatant 
(digestate) was isolated, aliquoted and stored at -20
o
C. A digestate blank was 
prepared in the same manner but the 2 mL sample was substituted with 2 mL 
HBSS. Prior to addition to cells, all digestates were sterile filtered (0.22 µm 
filters, Fisher Scientific, Dublin, Ireland). 
 
Cell culture 
Jurkat T cells, a human leukemic T cell line, were maintained in antibiotic-free 
RPMI-1640 medium supplemented with 10% (v/v) fetal bovine serum (FBS) and 
plated at a density of 1 x 10
5
 and 2 x 10
5
 cells/mL for cell proliferation and 
ELISA assays, respectively. RAW 264.7 murine macrophages were grown and 
maintained in Dulbecco’s Modified Eagle Medium (DMEM) media supplemented 
with 10% FBS and were seeded at a density of 0.2 x 10
5
 cells/mL for ELISA 
assays. Cells were maintained at 37
o
C in a 5% CO2 atmosphere. Reduced serum 
media (2.5% FBS) was used for all experiments. 
 
Cell proliferation 
The (3-(4, 5-Dimethylthiazol-2-yl)-2, 5-diphenyltetrazolium bromide (MTT) 
assay was used to measure the effect of the digestates on cell proliferation in 
Jurkat T cells and RAW 264.7 cells. Cells were incubated for 24 h at 37
o
C with 0 
- 10 % (v/v) of the supplemented milk digestates in a 96 well plate. The MTT 
assay kit (MTT I proliferation kit, Roche Diagnostics, West Sussex, UK) was then 
used to measure cell proliferation. Absorbance was determined at 570 nm using a 
microplate reader (VarioskanFlash, Thermo Scientific, Massachusetts, USA) and 
cell proliferation was calculated as a percentage of the control, untreated cells. 
Concentrations of 2.5 % (v/v) digestates were selected for analysis of potential 
anti-inflammatory effects based on the results of the MTT assay.  
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Cytokine production 
Jurkat T cells were stimulated using 50 µg/mL Concanavalin-A (ConA) and 
incubated for 24 h at 37
o
C with 2.5% (v/v) digestates. The production of 
cytokines interferon-γ (IFN-γ), interleukin-2 (IL-2) and interleukin-6 (IL-6) were 
measured by ELISA. RAW 264.7 cells were allowed to adhere overnight. Cells 
were incubated for a further 24 h at 37°C with 2.5% (v/v) digestates and 0.1 
µg/mL LPS. The production of cytokines IL-6, interleukin-1 beta (IL-1β) and 
tumor necrosis factor-alpha (TNF-α) was measured by ELISA. Cytokine 
production was determined using eBioscience ELISA kits (Ready-SET-Go kit 
purchased from eBioscience, Hatfield, UK). Absorbance was measured at 450 nm 
on a microplate reader (VarioskanFlash, Thermo Scientific, Massachusetts, USA) 
and cytokine production was expressed as percentage of ConA-stimulated Jurkat 
T cells or LPS-stimulated RAW 264.7 cells.  
 
Statistical analysis 
All data represent the mean ± standard error (SE) of at least three independent 
experiments. Statistical analysis was by one-way analysis of variance (ANOVA) 
followed by Dunnett’s test or Tukey’s test as analysed using GraphPad Prism 4 
(GraphPad software, California, U.S.A.). 
 
Results and Discussion 
Supplementation of low fat milk with BSG hydrolysates 
The BSG Alcalase hydrolysate, U, and its associated membrane fractions were 
added to low-fat milk and subjected to SGID to determine if the supplemented 
milk products possess potential anti-inflammatory activity following digestion. 
The degree of hydrolysis (DH) of U was 12.1%, as measured using the 
trinitrobenzenosulfonic (TNBS) method (Connolly et al., 2015). Gel permeation 
chromatography revealed that the molecular mass distribution profile of U and its 
associated fractions was > 15 kDa (31.35 %), 15 - 5 kDa (~14 %), 5 - 1 kDa 
(~20%) and < 1 kDa (~35%). Ultrafiltration enriches permeates with low 
molecular weight proteins and the retentates contained higher molecular weight 
proteins (Connolly et al., 2015). The majority of peptides with antioxidant activity 
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have a lower molecular weight (500-1800Da) (Samaranayaka et al., 2011) 
whereas higher molecular weight peptides have previously demonstrated greater 
anti-inflammatory activity (McCarthy et al., 2013b).  
Hydrolysates were added to low-fat milk at a concentration of 12.5 ppm which 
is a similar concentration to that used in previous studies (McCarthy et al., 2015). 
Milk and other dairy beverages are common vehicles for functional food 
ingredients including probiotics, omega-3 fatty acids, plant sterols, vitamins and 
minerals and bioactive peptides. Several dairy-based products containing added 
bioactive peptides with health or functional properties have been launched on the 
market (Dziuba and Dziuba, 2014). 
   
Cytotoxicity of digested milk with added BSG hydrolysates 
Jurkat T cells were incubated with BSG protein hydrolysate-supplemented milk 
digestates (1%-10%, v/v) for 24 h and cell proliferation was measured using the 
MTT assay. There was no decrease in cell proliferation observed up to a 
concentration of 2.5% (v/v) digestate for any of the samples investigated (Table 
1). At the 5% and 10% (v/v) concentrations all of the digested milk samples 
caused a significant (P<0.05) decrease in cell viability (Table 1). The digestate 
blank was not cytotoxic at 10% (v/v) indicating that the digestive enzymes were 
not responsible for the cytotoxic effects of the digested milk samples (Table 1). A 
non-toxic concentration of 2.5% (v/v) digestate for all samples was selected for 
further experiments in Jurkat T cells. Digestate at 2.5% (v/v) was also non-toxic 
in RAW 264.7 cells (data not shown). 
 
Immunomodulating effect of digested milk with added BSG hydrolysates 
Two models of inflammation were investigated in the present study, a ConA-
stimulated Jurkat T cell model and an LPS-stimulated mouse macrophage RAW 
264.7 model. IL-6 production was significantly decreased (P<0.05) in stimulated 
Jurkat T cells in the presence of BSG protein hydrolysate-supplemented milk 
digestates (Table 2). Supplementation of milk with U >5 decreased IL-6 
production to 79.4% of the ConA-stimulated control cells followed by U <3, U <5 
and U which reduced IL-6 production to 82.3%, 83.5% and 85.1%, respectively. 
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Table 1: The effect of BSG protein hydrolysate-fortified milk simulated gastrointestinal digestates (1%-10% v/v) on cell proliferation in Jurkat 
T cells. 
 
Cell Viability (% of untreated control cells) 
 1% v/v digestate 2% v/v digestate 2.5% v/v digestate 5% v/v digestate 10% v/v digestate 
Digestate blank 102.5 ± 4.7 120.0 ± 4.2 115.9 ± 9.0 115.2 ± 4.7 122.0 ± 3.9 
Unfortified milk 108.2 ± 5.4 108.0 ± 2.7 104.3 ± 7.9 60.7 ± 15.2* 26.9 ± 21.9* 
Milk + U 101.9 ± 3.9 102.8 ± 5.6 92.0 ± 8.0 62.9 ± 15.5* 15.0 ± 6.8* 
Milk + U<3 95.7 ± 9.9 102.4 ±  11.0 85.9 ± 7.6 58.6 ± 17.3* 18.4 ± 13.2* 
Milk + U<5 107.8 ± 8.4 106.1 ± 4.5 97.0 ± 6.4 63.1 ± 12.7* 20.9 ± 16.7* 
Milk + U>5 95.2 ± 5.3 90.2 ± 6.3 83.4 ± 12.2 25.3 ± 9.1* 3.5 ± 1.2* 
The values are expressed as a percentage relative to untreated Jurkat T cells, mean ± SE of five independent experiments. The digestate blank 
represents a digestion containing HBSS and digestive enzymes only. Unfortified milk represents a digestion of milk with no added BSG protein 
hydrolysate. U represents unfractionated BSG protein hydrolysate; U <3, <5 and >5 indicate fractionated BSG protein hydrolysate. * Denotes 
statistically significant difference in cell viability, relative to untreated Jurkat T cells (P<0.05), ANOVA followed by Dunnett’s Test.
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Table 2: The effect of BSG protein hydrolysate-fortified milk simulated gastrointestinal digestates (2.5 % v/v) on cytokine production in 
Concanavalin-A (ConA) stimulated Jurkat T cells. 
Cytokine Production ( % of control, ConA-stimulated cells) 
 IFN-γ IL-6 IL-2 
Digestate Blank 88.5 ± 12.4 91.5 ± 4.1 (U >5) 98.4 ± 2.4 
Unfortified Milk 108.1 ± 9.7 91.6 ± 1.8 (U>5) 98.2 ± 6.6 
Milk + U 90.1 ± 7.4 85.1 ± 3.4* 96.0 ± 4.4 
Milk + U<3 95.4 ± 4.5 82.3 ± 7.0* 95.1 ± 6.3 
Milk + U<5 111.1 ± 18.8 83.5 ± 0.8* 94.2 ± 3.2 
Milk + U>5 86.9 ± 4.9 79.4 ± 2.4*(DB,UF) 91.9 ± 3.3 
The values are expressed as a percentage relative to Jurkat T cells treated with ConA alone, mean ± SE of three independent experiments. The 
digestate blank represents a digestion containing HBSS and enzymes only. Unfortified milk represents a digestion of milk with no added BSG 
protein hydrolysate. U represents unfractionated BSG protein hydrolysate; U <3, <5 and >5 indicate fractionated BSG protein hydrolysate. * 
denotes statistically significant difference in cytokine production relative to control Jurkat T cells (P<0.05), 
(DB)
 denotes significant difference 
relative to digestate blank (P<0.05), 
(UF)
 denotes significant difference relative to unfortified milk (P<0.05),
 (U>5) 
denotes significant difference 
relative to milk + U>5 (P<0.05), ANOVA followed by Tukey’s Test.
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The secretion of IL-2 and IFN-γ was not altered in ConA-induced Jurkat T cells 
incubated with digested BSG hydrolysate-supplemented milk samples (Table 2). 
The BSG protein hydrolysate, U, and its 5kDa retentate (U >5), previously 
demonstrated anti-inflammatory effects at a concentration of 0.5% (w/v), when 
added directly to cells, by reducing the production of IFN-γ in ConA-stimulated 
Jurkat T cells (McCarthy et al., 2013b). The inability of SGID BSG-supplemented 
milk to reduce the secretion of IFN-γ in Jurkat T cells could result from the lower 
concentration of sample added to the cells as a consequence of their dilution in the 
milk and the simulated digestion fluid, or it could also indicate that the peptides 
responsible for the reduction in IFN-γ production were not stable to 
gastrointestinal enzymes. It has previously been observed that BSG hydrolysate, 
U, is relatively stable to SGID as ACE-inhibitory values were similar before and 
after digestion (Connolly et al., 2015) therefore, it seems likely that in order to 
elicit a reduction in IFN-γ the concentration of hydrolysate incorporated into the 
food will need to be increased. Increasing the hydrolysate content in milk may 
necessitate encapsulation; microencapsulation of whey protein concentrate 
hydrolysates (WPCH) by spray drying reduced the bitter taste and hydroscopicity 
of WPCH without altering the immunoregulatory activity (Ma et al., 2014) and 
may also provide a suitable method for supplementation of foods with BSG 
hydrolysates. 
None of the digested milk samples significantly altered the production of IL-6, 
IL-1β or TNF- in LPS-stimulated RAW 264.7 cells (Table 3) which may be 
indicative of a cell specific effect (Table 3). Hydrolysates from a variety of 
sources including salmon fin and almonds have demonstrated the ability to inhibit 
inflammatory cytokine release in RAW 264.7 cells (Ahn et al., 2015; Udenigwe et 
al., 2013). Again, it is possible that incorporating the hydrolysates into the milk at 
a higher concentration may improve the anti-inflammatory effects in RAW 264.7 
cells. 
The action of digestive enzymes can alter the chemical structure and 
bioactivity of food components including peptides (Wang et al., 2015). Several 
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Table 3: The effect of BSG protein hydrolysate-fortified milk simulated gastrointestinal digestates (2.5 % v/v) on cytokine production in 
lipopolysaccharide (LPS)-stimulated RAW 264.7 cells. 
Cytokine Production ( % of control LPS-stimulated cells) 
 IL-1β IL-6 TNF-α 
Digestate Blank 88.1 ± 9.2 114.7 ± 11.6 108.0 ± 14.8 
Unfortified Milk 133.7 ± 12.4 122.6 ± 5.9 100.3 ± 13.7 
Milk + U 114.1 ± 18.1 125.6 ± 13.6 86.0 ± 11.4 
Milk + U<3 111.7 ± 13.6 108.3 ± 17.6 99.2 ± 1.2 
Milk + U<5 126.3 ± 23.8 112.4 ± 8.5 111.7 ± 15.1 
Milk + U>5 103.6 ± 13.0 110.5 ± 17.8 109.3 ± 10.6 
The values are expressed as a percentage relative to RAW 264.7 cells treated with LPS alone, mean ± SE of three independent experiments. The 
digestate blank represents a digestion containing HBSS and enzymes only. Unfortified milk represents a digestion of milk with no added BSG 
protein hydrolysate. U represents unfractionated BSG protein hydrolysate; U <3, <5 and >5 indicate fractionated BSG protein hydrolysate with 
molecular weight <3, <5 and >5 kDa, respectively. Statistical analysis by ANOVA followed by Tukey’s Test.
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examples of the effect of digestion on the anti-inflammatory effects of food 
constituents may be cited. The anti-inflammatory activity of herbs and a natural 
eggshell membrane were found to be enhanced following in vitro digestion, as 
determined using a TNF--stimulated Caco-2 cell model and a mitogen-
stimulated peripheral blood mononuclear cell model, respectively (Chohan et al., 
2012; Benson et al., 2012). However, the anti-inflammatory activity of a fruit 
juice supplemented with pine bark extract was reduced in a cell model designed to 
replicate in vivo intestinal inflammation, following in vitro digestion (Frontela-
Saseta et al., 2013).  
The anti-inflammatory effects of an in vitro SGID snack-bar, chocolate-drink 
and yogurt with added BSG protein hydrolysates in Jurkat T cells have previously 
been reported (McCarthy et al., 2015). The findings indicated that the 
immunomodulatory effects of BSG protein hydrolysates may be influenced by the 
food vehicle in which they are incorporated. Digested samples containing a BSG 
protein hydrolysate, prepared using Flavourzyme, and its 5kDa retentate, 3kDa or 
5kDa permeate caused a decrease in the production of IFN-γ in ConA-induced 
Jurkat T cells when a snack bar was used as the vehicle but had no effect on IFN-γ 
when incorporated into a sports drink or yogurt. Similarly, two of the fractions 
(<3kDa and <5kDa) enhanced the IL-2 reducing activity of digested yogurt in 
ConA-induced Jurkat T cells but had no effect when delivered in a snack bar or 
sports drink (McCarthy et al., 2015).   
Milk proteins may be hydrolysed to produce bioactive peptides during 
gastrointestinal digestion (De Noni, 2008). However, no change was found in the 
production of cytokines in either the Jurkat T cell or RAW 264.7 cell model in the 
presence of digested, unsupplemented milk samples (Table 2 & 3). 
 
Conclusions 
It is important that nutraceuticals demonstrate an ability to retain their bioactivity 
following digestion. Several factors, such as the food matrix, can influence the 
anti-inflammatory activity of BSG protein hydrolysates following their 
incorporation into a food vehicle and subjection to gastrointestinal digestion. The 
immunomodulatory effects of the digested BSG hydrolysate supplemented milk 
appear to be cell specific and certain cytokines (e.g.: IL-6) may be more 
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susceptible to modulation. The results of our study indicate that BSG hydrolysates 
can confer some anti-inflammatory effects in Jurkat T cells following 
supplementation into milk and SGID. However, further research, including 
additional inflammatory markers, is necessary to optimise the anti-inflammatory 
effect of BSG hydrolysate supplemented food products. 
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Chapter 3 
Aqueous and enzyme-extracted phenolic compounds from 
brewers’ spent grain (BSG): assessment of their antioxidant 
potential. 
 
Published in: Journal of Food Biochemistry (2017) 41, e12370  
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Abstract 
Brewers’ spent grain (BSG) is a major co-product of the brewing industry and a 
potential valuable source of protein, cell wall polysaccharides, lignin, lipid and 
phenolic compounds. The aim of this study was to assess the antioxidant potential 
of phenolic extracts isolated from BSG using cell wall degrading enzymes, Depol 
740L, Shearzyme and Ultraflo Max. The phenolic extracts were prepared from 
black BSG (derived from barley grains roasted at 200°C) and pale BSG (derived 
from malted barley grains). The phenolic extracts protected against hydrogen 
peroxide (H2O2)-induced DNA single strand breaks in U937 cells as assessed 
using the comet assay. The extracts also protected against a H2O2 challenge in 
HepG2 cells, as assessed by measuring the cellular content of glutathione (GSH) 
and the activity of cellular antioxidant enzymes, superoxide dismutase (SOD) and 
catalase (CAT). Enzyme-extracted black and pale BSG phenolic extracts 
protected against oxidant-induced DNA damage and enhanced the cellular 
antioxidant activity in cells. 
 
Introduction 
Brewers’ spent grain (BSG) is a residue from the production of wort for the 
brewing industry and is comprised of the husk, pericarp and seed coat layers of 
barley (McCarthy et al., 2012). Currently, BSG is primarily used as an animal 
feed. However, BSG contains approximately 20g protein and 70g fibre per 100g 
(Mussatto et al., 2006) and is also a potentially valuable source of bioactive 
phytochemicals such as phenolic compounds (Connolly et al., 2013; McCarthy et 
al., 2014; Connolly et al., 2015). BSG derived from the standard brewing process 
is referred to as pale BSG. Black BSG, a product of dark wort production, is 
obtained following the roasting of barley grain at 200°C (Connolly et al., 2013; 
Piggott et al., 2014). The principal category of phenolic compounds identified in 
pale and black BSG are the hydroxycinnamic acids (HCAs) which are primarily 
comprised of p-coumaric acid, caffeic acid, ferulic acid and their derivatives 
(Teixeira et al., 2013). The total HCA content of pale and black BSG was 
previously shown to be 555.29 and 237.70 µg g
−1 
BSG dry weight (DW), 
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respectively (McCarthy et al., 2013) and ferulic acid was the predominant 
phenolic compound. 
Oxidative stress is an imbalance between reactive oxygen species (ROS) 
production and the activity of the cellular antioxidant defences. HCAs have 
demonstrated antioxidant activity and research has shown that HCAs can be used 
as preventive and/or therapeutic agents in several diseases related to oxidative 
stress including atherosclerosis, inflammatory injury, cancer and cardiovascular 
diseases (Teixeira et al., 2013). Previous studies have demonstrated the significant 
antioxidant potential of phenolic extracts prepared from BSG using an alkaline 
extraction method (McCarthy et al., 2012; McCarthy et al., 2014; Piggott et al., 
2014). However, alkaline extraction is a crude procedure which has been shown to 
result in the degradation of phenolic acids and also increases the salt content of 
the extracts (Krygier et al., 1982; Nardini et al., 2002). Enzymatic treatment, 
using carbohydrases, has also been investigated as it has the added benefit of 
facilitating the release of bioactives which may be bound to the cell wall 
(Alrahmany and Tsopmo, 2012). Enzymatic hydrolysis is a potential extraction 
method for BSG components due to the specificity and mild reaction conditions 
required (Forssell et al., 2008).  
The aim of this research was to assess the in vitro antioxidant activity of BSG 
extracts prepared using the carbohydrase Depol 740L or a combination of Depol 
740L, Shearzyme and Ultraflo Max. Depol 740L is a feruloyl esterase which has 
been shown to be effective in the release of bound ferulic and p-coumaric acid 
(Forssell et al., 2008). Shearzyme 500L is a xylanase and Ultraflo Max is a β-
glucanase–xylanase mixture (Hu et al., 2014). Extracts were prepared from wet 
(75% moisture) and dry samples (11% moisture) of both pale and black BSG. The 
DNA protective effects of BSG phenolic extracts were measured by their ability 
to protect against hydrogen peroxide (H2O2)-induced DNA single strand breaks in 
U937 cells using the comet assay. The impact of BSG phenolic extracts on the 
cellular antioxidant status in HepG2 was assessed by measuring the cellular 
content of glutathione (GSH) and the activity of the enzymes superoxide 
dismutase (SOD) and catalase (CAT) following an oxidative challenge. 
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Materials and Methods 
Materials 
All chemicals, unless otherwise stated, were purchased from Sigma-Aldrich 
Ireland Limited, (Co. Wicklow, Ireland). HepG2 cells and U937 cells were 
obtained from the European Collection of Animal Cell Cultures (ECACC, 
Salisbury, UK). Shearzyme 500 L (declared activity 500 Fxu g
-1
) and Ultraflo 
Max (declared activity 470 Fxu g
-1
) were purchased from Novozymes A/S, 
Bagsværd, Denmark. Depol 740L (declared activity 945 u g
-1
) was purchased 
from Biocatalysts Ltd., Cardiff, UK.  
 
Preparation of Phenolic Extracts  
Whole BSG samples were obtained from the same brewery. For dry BSG, 
samples were oven-dried for 18 hours, at 60°C. Both pale and black BSG were 
stored in 1 kg quantities in polyethylene bags which were vacuum-packed and 
maintained at -20°C. To generate phenolic extracts, BSG was sheared in distilled 
H2O (1:10) at 24,000 rpm for 2 minutes using an Ultra Turrax
®
T25 high-
performance disperser (IKA
®
 Werke GmbH & Co. KG, Staufen, Germany). The 
BSG suspension was then incubated with carbohydrases: Shearzyme 500 L, 
Ultraflo Max  and/or Depol 740L for either 240 or 540 minutes, at 50°C and pH 5 
or pH 7 (Table 1). The carbohydrase enzymes were heat deactivated at 80
o
C for 
20 minutes in a waterbath. Following centrifugation at 2,700 g for 20 minutes at 
10°C (Hettich Zentrifugen Universal 320R centrifuge, Andreas Heittich GmbH & 
Co., Tuttlingen, Germany), the supernatant was retained and stored at -20°C prior 
to analysis. Phenolic preparations from black, wet BSG were designated BW1-4; 
from black, dry BSG were designated BD1-2; from pale, wet BSG were 
designated PW1-5 and from pale, dry BSG were designated PD1-3, as detailed in 
Table 1. Samples BW1 and PW1 were obtained by shearing BSG in distilled H2O 
without the addition of carbohydrase enzymes. These samples were used as 
control samples throughout the experiments with BW1 being used as a control for 
all black BSG extracts and PW1 being used as a control for all pale BSG extracts. 
The samples investigated were selected based on a pre-screening process which
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Table 1: Extraction procedure used for the generation of BSG phenolic extracts.  
Sample code BSG type Enzyme Enzyme volume (µL g
-1 
BSGdw) pH Extraction time (minutes) 
BW1 Black Wet  0 7 240 
BW2 Black Wet Depol 740L 40 7 240 
BW3 Black Wet Depol 740L 60 7 240 
BW4 Black Wet Shearzyme/Ultraflo Max/Depol 740L 60 (each) 7 240 
BD1 Black Dry Depol 740L 30 5 240 
BD2 Black Dry Depol 740L 60 5 240 
PW1 Pale Wet  0 7 240 
PW2 Pale Wet Depol 740L 100 5 240 
PW3 Pale Wet Depol 740L 100 7 240 
PW4 Pale Wet Shearzyme/Ultraflo Max 75 (each) 5 240 
PW5 Pale Wet Shearzyme, Ultraflo Max/ Depol 740L 75 (each) 5 240 
PD1 Pale Dry Depol 740L 10 5 240 
PD2 Pale Dry Depol 740L 100 7 240 
PD3 Pale Dry Shearzyme, Ultraflo Max/ Depol 740L 100 (each) 5 540 
Black BSG was derived from barley grains roasted at 200°C and pale BSG was derived from malted barley grains. Wet BSG contains < 75% 
moisture (Connolly et al., 2013). Dry BSG contains <10% moisture (Santos et al., 2003). All samples were treated with enzymes at 50°C.  
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identified the most active fractions as analysed by Ferric reducing antioxidant 
power (FRAP); 2,2-Diphenyl-1-picrylhydrazyl (DPPH•); Oxygen radical 
absorbance capacity (ORAC); 2,2'-azino-bis(3-ethylbenzothiazoline-6-sulphonic 
acid) (ABTS+); Dipeptidyl peptidase-4 (DPP4) and angiotensin-converting-
enzyme (ACE) inhibition.  
 
Total Phenolic Content (TPC) 
The Folin–Ciocalteu assay, as described previously (Singleton and Rossi, 1965), 
was used to measure the TPC of BSG phenolic extracts. This assay is based on the 
capacity of a compound to reduce the Folin–Ciocalteu reagent (FCR), and thus the 
TPC method is non-specific to phenols and measures the presence of any reducing 
agent. Following reaction of the samples with FCR, the absorbance was measured 
at 765 nm relative to a distilled H2O blank. The phenolic content, expressed as 
gallic acid equivalents (GAE), was determined using gallic acid as a standard. 
Results were expressed as milligram gallic acid equivalents per mL phenolic 
extract (mg GAE mL
-1
). 
 
DPPH• Assay 
The DPPH• radical scavenging potential of the extracts was performed according 
to the method described previously (Brand-Williams et al., 1995). The assay 
allows a measure of antioxidant potential, based on the ability of a compound to 
scavenge the DPPH radical by hydrogen donation. Trolox (6-hydroxy-2,5,7,8-
tetramethylchroman-2- carboxylic acid), ranging from 0.04 to 0.40 µM was used 
to prepare a standard curve. Absorbance values were determined at 515 nm, 
following a 30 min incubation with the DPPH reagent (0.0238 µg/ml). Results 
were expressed as %DPPH• inhibition: %DPPH• inhibition = [(AbsBlank – 
AbsSample)/AbsBlank] x 100. 
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FRAP Assay 
The FRAP assay (Benzie and Strain, 1996), was used to determine to ability of 
extracts to reduce ferric (Fe
3+
) to ferrous (Fe
2+
). The reducing power of extracts 
was measured spectrophotometrically at 593 nm. Ferrous sulphate heptahydrate 
(0–100 µM) was used to prepare a standard curve and results were expressed as 
µM FRAP. 
 
Cell Culture 
HepG2 cells, a human liver carcinoma cell line, were grown and maintained in 
Dulbecco’s Modified Eagle’s Medium (DMEM) supplemented with 10% fetal 
bovine serum (FBS) and plated at a density of 0.5 x 10⁵ and 2 x 10⁵ cells mL-1 for 
cell viability and cellular antioxidant assays, respectively. U937 cells, a human 
leukemic monocytic lymphoma cell line, were maintained in antibiotic-free 
RPMI-1640 medium supplemented with 10% (v/v) FBS and plated at a density of 
2 x 10⁵ cells mL-1 and 1 x 105 cells mL-1 for cell viability and comet assays 
respectively. Cells were maintained at 37°C in a 5% CO₂ atmosphere. Reduced 
serum media (2.5% FBS) was used for all experiments.  
 
Cell Viability 
The (3-(4, 5-Dimethylthiazol-2-yl)-2, 5-diphenyltetrazolium bromide (MTT) 
assay was used to measure the effect of the extracts on cell viability in HepG2 
cells and U937 cells. Cells were incubated for 24 hours at 37°C with BSG extracts 
at concentrations of 0 to 20% v/v of the extracts. The MTT assay kit (MTT I 
proliferation kit, Roche Diagnostics, West Sussex, UK) was then used to measure 
cell viability. Absorbance was determined at 570 nm using a microplate reader 
(VarioskanFlash, Thermo Scientific, Waltham, MA) and cell viability was 
calculated as a percentage of the control, untreated cells. An inhibitory 
concentration-50 (IC50) value, the concentration of a compound that reduces cell 
viability to 50% of the untreated control cells, was determined for each of the 
phenolic extracts.  
71 
 
Comet Assay 
U937 cells were seeded in a 12-well plate at a density 1 x 10
5
 cells mL
-1
  in 
RPMI-1640 medium with 2.5% FBS. Cells were incubated for 24 hours with 
either BSG phenolic extracts BW1-4 and BD1-2 (0.1% v/v) or PW1-5 and PD1-3 
(4% v/v) or ferulic acid (1 μg mL-1). Cells were subsequently treated with H2O2 
(75 μM for 30 minutes). Oxidative DNA damage to the U937 cells was then 
assessed using the comet assay adapted from Tice et al. (1991). Fifty cells were 
scored for each slide using a fluorescence microscope (Optiphot-2, Nikon) and the 
Komet 5.5 image analysis software. Data were expressed as percent tail DNA. 
 
Cellular Antioxidant Assays: Glutathione, Superoxide Dismutase and Catalase 
HepG2 cells (2 x 10
5
 cells mL
-1
) were incubated with BSG phenolic extracts 
BW1-4 and BD1-2 (0.5% v/v) or PW1-5 and PD1-3 (4% v/v) for 24 hours at 
37°C. Following incubation, cells were exposed to 2 mM H2O2 for 120 minutes. 
Cells were harvested, sonicated and centrifuged (800 rpm, 10 minutes) and the 
supernatant was collected for the determination of antioxidant enzyme activity.  
The glutathione (GSH) content of the cells was measured according to the 
method described previously (Hissin and Hilf, 1976). The GSH content was 
measured in cells as an indicator of intracellular non-enzymatic antioxidant 
defences. Briefly, 100 μL supernatant was mixed with sodium phosphate–
ethylenediaminetetraacetic acid buffer (1.8 mL) and σ-phthaldialdehyde (0.1 mg). 
The fluorescence intensity of the samples was determined (Thermo Scientific 
Varioskan Flash microplate reader) at wavelengths of 360 nm (absorption) and 
430 nm (emission). The GSH content of the samples was determined from a 
standard curve (0–2.5 nmol mL−1 GSH).  
The activity of cellular superoxide dismutase (SOD) was determined using the 
method previously described by Misra and Fridovich, (1977). Briefly, the cell 
supernatant was diluted in 0.05 M potassium phosphate buffer (pH 7) and 
xanthine, xanthine oxidase and cytochrome c were added. The xanthine oxidase 
system generates superoxide anion which reduces cytochrome c and this reaction 
is inhibited by SOD. The reduction in cytochrome c was used to determine the 
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activity of SOD present in the samples from a standard curve (0-1µg SOD mL
-1
). 
Samples were read at 550 nm at 20 minute intervals for at least 5 readings.  
Catalase (CAT) activity was determined using a modification of the method of 
Baudhuin et al. (1964). H2O2 was added to the cell supernatants and following 
incubation any remaining H2O2 was determined spectrophotometrically at 465 
nm. One unit of catalase activity was defined as the amount of catalase required to 
decompose 1 µmol H2O2 per min at pH 7.5 and 25°C. 
GSH content and SOD and CAT activity were quantified relative to the protein 
content as nmol mL
-1
 GSH mg
-1
 protein in cell homogenate and SOD and CAT 
units
 
mg
-1
 protein, respectively. The protein content of the samples was quantified 
by the bicinchoninic acid (BCA) protein assay as previously described (Smith et 
al., 1985). Data were expressed as a percentage of untreated control cells. 
 
Statistical Analysis  
All data represent the mean ± standard error (SE) of at least three independent 
experiments. Statistical analysis was done by one-way analysis of variance 
(ANOVA) followed by Dunnett’s test as analysed using GraphPad Prism 4 
(GraphPad software, La Jolla, CA). 
 
Results and discussion 
Alkaline extracts derived from BSG have been shown to protect against oxidant-
induced DNA damage and oxidant-induced depletion of cellular antioxidant 
markers (McCarthy et al., 2012; McCarthy et al., 2014). Acid and alkaline 
hydrolysis are the most common extraction methods for phenolic compounds but 
may cause degradation of these compounds. The use of enzymatic hydrolysis is an 
alternative method, whereby enzymes are used to degrade carbohydrate linkages 
and release bound phenolics (Stalikas, 2007). The aim of the present research was 
to assess the DNA protective effects and cellular antioxidant potential of 
phenolic-rich extracts obtained from BSG using an enzyme-aided extraction 
procedure. BSG may be subjected to various drying techniques such as oven 
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drying and freeze-drying, to increase its use and marketability (Santos et al., 
2003). The antioxidant activity of extracts prepared from both wet and dry (75% 
and 11% moisture, respectively) black and pale BSG were compared.  
 
Antioxidant Power of BSG Phenolic Extracts  
The TPC content of the BSG extracts prepared using different carbohydrase 
combinations ranged from 0.015 to 0.056 mg GAE mL
-1
 (Table 2) and in general, 
the average TPC was lower in the pale BSG extracts in comparison to the black 
BSG extracts. Similarly, in a study of alkaline-extracted BSG phenolic extracts, 
the black phenolic extracts also had a higher average TPC compared with pale 
phenolic extracts (McCarthy et al., 2012). It has previously been shown that 
roasting barley grain increases the TPC, proportionate to roasting time, owing to 
the formation of Maillard browning reaction products (MRP) (Omwamba and Hu, 
2010; Dabina-Bicka et al., 2011), also resulting in the simultaneous formation of 
compounds with antioxidant properties (Piggott et al., 2014). The TPC method is 
not specific to phenolic compounds as it measures any compound which is 
capable of reducing Folin–Ciocalteu reagent including MRP (Huang et al., 2005).  
The BSG extracts prepared using alkaline extraction (McCarthy et al., 2012) 
had higher TPC than the carbohydrase extracts (Table 2). Chemical extractions 
achieve high quantities of released products (Tang et al., 2016), however, these 
procedures involve high temperature and harsh acidic and alkaline conditions 
which could destroy other components. Enzymatic fractionation methods on the 
other hand take advantage of enzymes’ high selectivity and thus allow more 
targeted and effective fractionation processes. Therefore, it is not surprising that 
values obtained from our earlier studies (McCarthy et al., 2012) using alkaline 
extraction were higher than reported in the present study. There were no 
statistically significant differences across any of the values for TPC (Table 2). 
Therefore, neither increasing enzyme concentration, the drying of the samples or 
alteration of the pH during extraction had a significant effect on the quantity of 
phenolics released from the samples.  
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Table 2: Total phenolic content (TPC), 2,2-diphenyl-1-picrylhydrazyl (DPPH•) radical scavenging activity and ferric reducing antioxidant 
power (FRAP) of BSG phenolic extracts. 
Sample Code TPC (mg GAE mL
-1
) DPPH• scavenging (%) FRAP (µM) 
BW1 0.048 ± 0.006 57.29 ± 12.43 148.62 ± 5.16 
BW2 0.043 ± 0.003 42.47 ± 5.46 136.27 ± 0.90 
BW3 0.032 ± 0.002 42.12 ± 13.44 140.80 ± 1.64 
BW4 0.056 ± 0.002 59.23 ± 12.63 146.68 ± 7.02 
BD1 0.023 ± 0.003 22.64 ± 13.64 126.22 ± 9.66 
BD2 0.052 ± 0.012 54.86 ± 16.68 135.06 ± 10.01 
PW1 0.015 ± 0.001 37.99 ± 14.21 114.59 ± 0.57 
PW2 0.037 ± 0.008 24.18 ± 8.95 117.10 ± 7.13 
PW3 0.016 ± 0.006 12.89 ± 1.93 114.39 ± 5.77 
PW4 0.030 ± 0.01 23.62 ± 5.48 116.25 ± 6.73 
PW5 0.037 ± 0.009 28.82 ± 7.78 117.51 ± 5.90 
PD1 0.024 ± 0.006 25.80 ± 4.15 114.15 ± 5.65 
PD2 0.024 ± 0.005 18.71 ± 2.76 114.91 ± 6.60 
PD3 0.032 ± 0.007 20.24 ± 5.76 115.66 ± 6.40 
Values are mean ± SE of three independent experiments. BW1-4 represent extracts from black, wet BSG; BD1-2 represents extracts from black, 
dry BSG; PW1-5 represents extracts from pale, wet BSG and PD1-3 represents extracts from pale, dry BSG.
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The radical scavenging ability (DPPH•) of BSG extracts (Table 2) ranged from 
12.89-59.23%. DPPH• scavenging activity of black BSG extracts showed a 
similar trend to the TPC values. With the exception of BD1, black BSG extracts 
demonstrated higher DPPH• scavenging activities compared with pale BSG 
extracts. Similarly, McCarthy et al. (2013) showed that alkaline-extracted black 
BSG extracts had a higher average DPPH• radical scavenging ability compared 
with their pale counterparts. Papetti et al. (2006) showed that roasted barley had a 
higher DPPH• scavenging ability compared with natural barley. There was no 
significant difference in the DPPH• activity of any of the samples tested 
regardless of the extraction procedure used.  
Black BSG extracts had a higher average ferric reducing power compared to 
pale BSG extracts. A similar trend was noted by McCarthy et al. (2012), where 
alkaline-extracted black BSG extracts showed a higher average FRAP activity 
compared to pale extracts. Similarly, Piggott et al. (2014) showed that alkaline 
extracted black BSG phenolics demonstrated higher FRAP activity compared with 
the corresponding pale BSG phenolic extracts. In the present study, there was no 
statistically significant differences across the FRAP values between all the 
samples. 
Overall however, there was a reasonable correlation between TPC and the 
other two antioxidant measurements, DPPH• and FRAP. 
 
Cell Viability 
Phenolic extracts from black BSG had a greater cytotoxic effect in the U937 cell 
line, compared to pale BSG extracts, as demonstrated by the lower IC50 values. 
IC50 values in U937 cells ranged from 0.7 to 9.6% (v/v) for black phenolic 
extracts and 19.1 to 45.0% (v/v) for pale phenolic extracts (Table 3). Most 
phenolic extracts from black BSG (BW1-4, BD2) demonstrated significant levels 
of cytotoxicity at concentrations above 1% (v/v) (Table 3), while some phenolic 
extracts from pale BSG (PW1 and PW4) did not demonstrate any significant 
cytotoxic effects within the concentration range tested (0-20% v/v) (Table 3).   
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Table 3: Effects of brewers spent grain (BSG) phenolic extracts (0-20% (v/v)) on cell viability in U937 cells. 
 0.5% 1% 2% 2.5% 4% 6% 8% 10% 15% 20% IC50 (% 
v/v) 
BW1 58.6±4.1* 54.8±5.8* 49.8±6.9* 46.9±7.0* 40.8±6.5* 35.1±12.0* 32.0±7.1* 14.4±6.6* 10.6±5.5* 7.2±5.7* 1.5 
BW2 84.8±9.9 66.2±2.7* 68.8±5.9* 57.1±4.8* 47.4±5.6* 48.6±7.5* 38.4±10.2* 28.7±4.8* 9.3±6.0* 1.6±1.6* 3.7 
BW3 51.8±4.1* 46.1±3.5* 44.9±6.1* 42.6±4.5* 42.3±11.0* 36.4±5.9* 36.2±10.8* 21.0±4.1* 19.3±3.5* 18.0±4.9* 0.7 
BW4 59.2±3.8* 53.0±4.9* 52.9±4.8* 53.9±7.7* 42.4±7.6* 56.3±9.2* 45.2±7.1* 23.7±6.3* 20.8±1.7* 0.0±0.0* 2.2 
BD1 71.9±8.6 72.4±7.4 70.8±6.3 57.0±14.3* 69.2±12.2 68.8±12.3 64.3±14.7 43.8±5.8* 25.2±14.7* 23.6±12.9* 9.6 
BD2 80.1±10.5 64.6±4.7* 65.7±5.6* 66.7±3.8* 66.5±3.6* 53.1±7.0* 51.5±11.7* 45.6±8.8* 41.1±8.6* 28.8±4.5* 7.8 
PW1 105.7±10.4 114.9±9.7 105.2±9.0 109.5±11.9 103.6±12.9 100.5±16.0 99.3±11.1 94.7±12.4 90.2±9.5 73.0±6.7 26.0 
PW2 122.9±5.2 115.5±8.6 117.5±3.9 123.6±9.6 107.7±0.5 113.2±3.7 98.8±1.9 101.8±8.2 75.6±2.5* 61.1±7.2* 21.8 
PW3 107.1±1.9 105.6±3.2 94.4±4.1 99.8±3.8 91.5±6.2 86.4±1.6 73.6±4.6* 69.4±0.8* 60.7±1.2* 53.8±8.2* 20.3 
PW4 120.9±12.5 124.3±13.0 110.3±9.1 111.5±14.5 99.1±15.1 91.8±14.2 90.4±13.8 89.1±13.7 79.6±12.2 56.1±6.0 22.7 
PW5 107.1±7.8 115.1±4.0 111.5±11.1 105.1±17.0 104.8±15.8 88.0±17.0 94.6±13.1 80.5±6.6 64.7±0.3 48.1±2.5* 19.1 
PD1 105.5±5.2 100.7±5.4 97.2±7.4 90.8±3.8 92.0±10.7 80.9±14.6 74.5±11.4 64.9±12.2 68.4±7.1 56.1±7.5* 23.9 
PD2 108.2±3.7 101.3±2.8 94.8±3.0 90.5±4.5 89.9±3.4 79.9±0.8* 73.6±3.5* 64.2±2.5* 57.7±4.6* 53.3±2.1* 19.6 
PD3 93.7±8.7 85.2±7.9 90.9±9.0 91.6±6.6 86.1±7.7 88.8±8.9 82.8±8.8 73.9±6.0 70.6±2.9 60.7±2.8* 45.0 
Values are mean ± SE of three independent experiments, expressed as a percentage relative to untreated U937 cells. BW1-4 represent extracts 
from black, wet BSG; BD1-2 represents extracts from black, dry BSG; PW1-5 represents extracts from pale, wet BSG and PD1-3 represents 
extracts from pale, dry BSG. Statistical analysis by ANOVA followed by Dunnett’s Test. * Denotes statistically significant difference in cell 
viability, relative to untreated U937 cells (P<0.05).
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Previous research on alkaline-extracted BSG phenolic extracts found that black 
BSG extracts were more cytotoxic than their pale equivalents in U937 cells 
(McCarthy et al., 2014), which may be owing to the presence of MRPs generated 
during the roasting of barley. With the exception of extract BW3, BW1 had the 
lowest IC50 value, therefore it does not appear that the use of enzymes in the 
extraction procedure increases the cytotoxicity of the black BSG phenolic extracts 
(Table 3). 
BSG phenolic extracts were less cytotoxic in HepG2 cells compared with U937 
cells (Table 4). In HepG2 cells, black phenolic extracts, with the exception of 
extracts BW4 and BD2, demonstrated cytotoxic effects at concentrations 
exceeding 4% (v/v). The IC50 values of enzyme-treated black phenolic extracts 
was higher than that of BW1, suggesting that the carbohydrases were not toxic to 
HepG2 cells. Pale phenolic extracts, apart from extract PW3, did not demonstrate 
any significant toxic effects in HepG2 cells (Table 4). HepG2 cells possess a 
number of metabolising enzymes which facilitate the inactivation/detoxification 
of harmful substances (Knasmuller et al., 1998) and may therefore possess greater 
resistance to the cytotoxic effect of the BSG extracts in comparison to the U937 
cells. Based on these results, non-toxic concentrations of 0.1% (v/v) for black 
extracts and 4% (v/v) for pale extracts were chosen for further analysis in U937 
cells and concentrations of 0.5% (v/v) and 4% (v/v) for black and pale extracts 
respectively were selected for cellular antioxidant assays in HepG2 cells. This 
experimental approach was similar to that used by Karnjanapratum et al. (2016) to 
assess the antioxidant potential of gelatin hydrolysates from unicorn leatherjacket 
skin, utilising U937 cells to assess DNA protective effects and HepG2 cells to 
assess cellular antioxidant potential. Since U937 cells are suspension cells, the 
background DNA damage in control cells will be significantly lower than in 
adherent cells (HepG2 cells) which require scraping for analysis.   
 
Comet Assay 
To assess the DNA protective effects of the phenolic extracts from black and pale 
BSG, U937 cells were pre-incubated with the extracts for 24 hours prior to 
treating the cells with 75 μM H₂O₂ for 30 minutes. Exposure to H₂O₂ increased
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Table 4: Effects of brewers’ spent grain (BSG) phenolic extracts (0-20% (v/v)) on cell viability in the HepG2 cell line. 
 0.5 1 2 2.5 4 6 8 10 15 20 IC50 (% 
v/v) 
BW1 79.3±7.5 72.6±12.7 63.0±8.2 64.9±9.0 52.5±10.2* 57.5±10.2* 56.3±12.3* 56.5±7.7* 57.2±14.1* 52.0±6.7* 19.8 
BW2 68.0±7.9* 61.7±1.7* 66.0±2.5* 58.3±7.1* 61.9±3.2* 56.4±5.0* 58.9±4.2* 50.8±7.0* 51.3±7.3* 47.0±6.9* 21.1 
BW3 71.2±10.9 64.8±10.3 47.8±9.6* 67.3±9.1 57.3±4.8* 59.3±11.6* 46.9±8.2* 57.0±13.1* 46.1±9.9* 53.5±6.5* 39.0 
BW4 72.0±11.7 79.5±23.2 61.9±8.7 61.3±15.1 57.8±14.2 52.1±14.2 56.1±16.2 56.4±16.9 55.2±15.7 54.0±10.8 22.0 
BD1 83.5±6.4 85.6±4.5 78.8±4.4* 76.3±6.2* 78.9±7.1* 73.0±2.8* 70.9±1.7* 68.7±6.3* 66.1±3.3* 51.6±4.0* 37.6 
BD2 93.7±12.3 92.6±18.0 87.4±7.3 77.2±11.6 84.9±13.3 74.7±9.8 77.8±7.8 70.4±10.1 70.1±10.7 67.6±14.4 78.4 
PW1 103.1±3.2 94.5±4.7 98.1±3.3 100.6±5.4 109.6±8.2 109.2±12.1 103.8±9.2 99.0±5.6 105.5±10.7 97.6±8.7 n/d 
PW2 114.3±2.5 115.8±9.8 109.6±3.7 119.8±13.1 109.0±14.2 120.5±19.8 122.0±17.5 127.1±20.5 127.8±18.2 115.8±17.3 n/d 
PW3 63.7±2.5* 79.9±8.5 61.4±3.4* 58.6±3.2* 61.7±7.7* 62.1±5.5* 59.3±6.7* 59.7±3.4* 51.6±5.5* 39.1±15.9* 17.9 
PW4 109.5±5.2 102.8±8.0 97.1±8.1 115.9±2.3 114.7±4.5 118.0±2.5 116.9±7.2 115.2±4.2 115.3±19.1 126.8±10.5 n/d 
PW5 110.2±2.9 108.1±1.7 108.0±6.3 103.3±7.8 109.8±5.9 103.9±14.3 116.5±4.2 107.2±6.6 129.7±13.1 114.4±3.9 n/d 
PD1 92.5±9.4 87.0±6.0 82.5±8.9 89.2±4.0 80.5±6.7 86.9±3.3 87.5±4.4 88.8±5.1 95.5±11.3 96.0±2.6 n/d 
PD2 118.0±15.2 105.9±15.2 89.3±8.8 103.0±14.0 103.3±10.4 104.7±12.2 103.0±6.4 108.8±8.0 102.4±2.2 111.7±9.6 n/d 
PD3 114.1±17.2 114.7±15.1 104.8±16.3 104.4±14.3 100.3±13.6 112.5±16.9 100.2±8.2 100.5±18.7 111.5±13.2 107.8±11.2 n/d 
Values are mean ± SE of three independent experiments, expressed as a percentage relative to untreated HepG2 cells. BW1-4 represent extracts 
from black, wet BSG; BD1-2 represents extracts from black, dry BSG; PW1-5 represents extracts from pale, wet BSG and PD1-3 represents 
extracts from pale, dry BSG. Statistical analysis by ANOVA followed by Dunnett’s Test. * Denotes statistically significant difference in cell 
viability, relative to untreated HepG2 cells (P<0.05). n/d: IC50 value could not be determined in the range of concentrations tested. 
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DNA damage from 6.1% to 62.5% tail DNA (Figure 1). Both black (0.1% v/v) 
and pale (4% v/v) BSG phenolic extracts (except PW3) significantly reduced 
H2O2-induced DNA damage in U937 cells (Figure 1). Extract BW4 significantly 
reduced tail DNA to 24.7% which was similar to the level of protection afforded 
by the positive control, 1 μg mL-1 ferulic acid which reduced DNA damage to 
27.9% (Figure 1). In the pale BSG extracts, PW2 demonstrated the greatest 
protective effect and reduced DNA damage in H2O2 exposed U937 cells to 28.5% 
(Figure 1). No clear correlation was found between the TPC content and the DNA 
protective effects of the extracts however, extract PW3 had the least DNA 
protective effect and also the lowest TPC content (0.016 mg GAE mL
-1
) and the 
highest DNA protective effect was observed for sample BW4 which had the 
highest TPC content (0.056 mg GAE mL
-1
). The extracts produced without the 
use of enzymes (BW1 and PW1) were also effective in the protection against 
DNA damage (Figure 1). 
H2O2 forms a hydroxyl radical in the presence of transition metal ions 
(Aruoma, 1998) which reacts with DNA bases or the deoxyribosyl backbone of 
DNA causing base damage and strand breaks (Valko et al., 2006). The direct 
quenching of reactive oxygen species (ROS), chelation of metal ions and 
regeneration of membrane-bound antioxidants by phenolic compounds have been 
proposed as mechanisms for their antioxidant action (Ji et al., 2015). Ferulic acid 
has previously demonstrated an ability to reduce H2O2-induced DNA breakage in 
HT-29 cells; (Ferguson et al., 2005) and ferulic, sinapic and caffeic acids have 
also shown a protective effect against 2,2'-azobis(2-amidinopropane 
dihydrochloride) (AAPH)-initiated oxidative damage in plasmid DNA (Shang et 
al., 2015). Similarly, Li et al. (2015) demonstrated that caffeic acid decreased 
H2O2-induced DNA double strand breaks in human embryo liver (L-02) cells. 
Evidence of the presence of both ferulic acid and caffeic acid in BSG has 
previously been shown (McCarthy et al., 2013). 
Black BSG phenolic extracts at 0.1% (v/v) demonstrated a similar DNA 
protective effect to pale BSG phenolic extracts which were assessed at the higher 
concentration of 4% (v/v). Previous research on the DNA protective effects of 
alkaline-extracted BSG phenolic extracts noted that black extracts demonstrated 
greater antioxidant activity compared to pale extracts in H2O2-treated U937 cells
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Figure 1: DNA damage in U937 cells treated with 75 μM H₂O₂ for 30 minutes following 24 hour incubation with black BSG extracts (0.1% 
v/v), pale BSG extracts (4% v/v) or ferulic acid (1 μg mL-1). BW1-4 represent extracts from black, wet BSG; BD1-2 represents extracts from 
black, dry BSG; PW1-5 represents extracts from pale, wet BSG and PD1-3 represents extracts from pale, dry BSG. Values are mean ± SE of at 
least three independent experiments. Statistical analysis was by ANOVA followed by Dunnett’s test. * Denotes significant difference (P<0.05) 
in DNA damage relative to H₂O₂ control. 
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(McCarthy et al., 2012). The higher total phenolic content in black BSG could be 
responsible for greater antioxidant activity of these extracts however; other non-
phenolic compounds such as MRPs may also contribute to the antioxidant effects 
of the black BSG extracts. Wijewickreme and Kitts (1998) showed that direct 
incubation of PM2 bacteriophage DNA with brewed, boiled, or instant coffee 
MRPs, together with Fe
2+
, protected against DNA breakage. It should also be 
noted however that certain individual compounds such as acrylamide produced 
during the heat treatment of foods may have genotoxic effects (Somoza, 2005). 
Therefore it would seem prudent to further characterise black BSG extracts to 
fully elucidate their effects. 
 
Cellular Antioxidant Assays 
Alkaline-extracted BSG phenolic extracts have previously demonstrated 
antioxidant effects in U937 cells by preventing H2O2-induced decreases in 
antioxidant enzyme activity (McCarthy et al., 2014). In the present study, the 
cellular antioxidant assays GSH, SOD and CAT were performed in oxidant-
challenged HepG2 cells which were pre-incubated with BSG extracts. HepG2 
cells were then challenged with 2mM H2O2 for 2 hours. A similar oxidant 
concentration and exposure time was used by Karnjanapratum et al. (2016); this is 
the standard experimental procedure adopted in our research group following 
previous investigation. HepG2 contain a large quantity of metabolising enzymes 
which are involved in the inactivation and detoxification of harmful substances 
(Knasmuller et al., 1998). Therefore higher concentrations of H2O2 were used in 
the HepG2 cell model (compared with the U937 model) in order to elicit an effect. 
With the exception of extract BW1 all of the extracts demonstrated significant 
(P<0.05) antioxidant activity in at least one cellular antioxidant enzyme assay. 
Treatment of HepG2 cells with H2O2 led to a significant reduction in GSH content 
(66.9%) compared to the untreated control (Figure 2A). Black BSG extracts BW2, 
BW3, BD1 and BD2 at a concentration of 0.5% (v/v) significantly (P<0.05) 
protected against a H2O2-induced decrease in GSH content, BW1 (extracted in the 
absence of enzymes) as well as BW4 did not significantly protect against GSH 
depletion. Pale phenolic extracts PD1, PD2, PD3, PW1, PW2, PW4 and PW5 at 
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Figure 2A: Antioxidant potential of BSG black [0.5% (v/v)] and pale [4% (v/v)] phenolic extracts as assessed by their ability to protect cellular 
glutathione (GSH) content against H2O2-induced oxidative stress in HepG2 cells. BW1-4 represent extracts from black, wet BSG; BD1-2 
represents extracts from black, dry BSG; PW1-5 represents extracts from pale, wet BSG and PD1-3 represents extracts from pale, dry BSG. 
Values represent the mean ± SE of at least three independent experiments. Statistical analysis by ANOVA followed by Dunnett’s test. * 
Statistically significant difference between sample and H2O2 control (P<0.05). 
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4% (v/v) demonstrated an antioxidant effect by protecting against H2O2-induced 
GSH depletion. In cells exposed to the pale extracts, the highest GSH content was 
found in the HepG2 cells treated with PW1 (extracted in the absence of enzymes) 
therefore, the use of enzymes in the extraction procedure does not appear to 
enhance the ability of the resulting pale BSG extracts to protect against oxidant-
induced GSH depletion. 
The black phenolic extract BW2, BD1 and BD2 (0.5% v/v) and pale phenolic 
extracts PD1-3, PW2 and PW3 (4% v/v) protected against an oxidant-induced 
decrease in SOD activity (Figure 2B). Extracts BW1 and PW1, which were not 
treated with enzyme, did not protect against the H2O2 induced depletion in SOD 
activity. This would indicate that the extraction conditions used may have 
enhanced the ability of extracts to augment the antioxidant enzyme activity of the 
cells. The antioxidant effects of cereal extracts have previously been investigated 
by Qingming et al. (2010) and Giriwono et al. (2010). Qingming et al. (2010) 
found that the administration of a malt extract from barley to D-galactose-treated 
mice increased the activities of SOD and glutathione peroxidase in brain and liver 
tissue. Giriwono et al. (2010) found that an extract of fermented barley improved 
the expression and enzyme activity of glutathione peroxidase 1 and CAT in the 
livers of chronic ethanol-fed female Wistar rats but there was no significant effect 
on hepatic SOD activity. The activity of catalase in HepG2 cells was reduced to 
approximately 40% of the control following exposure to H2O2 (Figure 2C). 
Similar to the results of the SOD activity, neither BW1 nor PW1 (prepared in the 
absence of enzymes) protected against the H2O2-induced reduction in catalase 
activity. This again suggests that carbohydrase enzymes may be required to 
release active phenolic compounds found in BSG. Extracts BW2, BW4 and PW3 
significantly (P<0.05) protected against the oxidant induced decrease in catalase 
activity.
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Figure 2B: Antioxidant potential of BSG black [0.5% (v/v)] and pale [4% (v/v)] phenolic extracts as assessed by their ability to protect 
superoxide dismutase (SOD) activity against H2O2-induced oxidative stress in HepG2 cells. BW1-4 represent extracts from black, wet BSG; 
BD1-2 represents extracts from black, dry BSG; PW1-5 represents extracts from pale, wet BSG and PD1-3 represents extracts from pale, dry 
BSG. Values represent the mean ± SE of at least three independent experiments. Statistical analysis by ANOVA followed by Dunnett’s test. * 
Statistically significant difference between sample and H2O2 control (P<0.05).
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Figure 2C: Antioxidant potential of BSG black [0.5% (v/v)] and pale [4% (v/v)] phenolic extracts as assessed by their ability to protect catalase 
(CAT) activity against H2O2-induced oxidative stress in HepG2 cells. BW1-4 represent extracts from black, wet BSG; BD1-2 represents extracts 
from black, dry BSG; PW1-5 represents extracts from pale, wet BSG and PD1-3 represents extracts from pale, dry BSG. Values represent the 
mean ± SE of at least three independent experiments. Statistical analysis by ANOVA followed by Dunnett’s test. * Statistically significant 
difference between sample and H2O2 control (P<0.05).  
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Conclusions  
The DNA protective and cellular antioxidant potential of a series of novel BSG 
extracts, prepared using carbohydrases, were investigated. BSG extracts protected 
against DNA damage however, the use of enzymes in the extraction procedure did 
not enhance the DNA protective effects of the extracts. In general, BSG extracts 
prepared in the presence of enzymes were more effective in protecting against a 
depletion of cellular antioxidant GSH content and SOD and CAT activity in 
oxidant-challenged HepG2 cells than the extracts prepared in the absence of the 
enzymes. Further research is required in order to fully characterise the bioactive 
constituents of the extracts however, the findings of this study indicate that 
enzyme-extraction could be used in the production of novel, natural, plant-derived 
bioactive components for use in the food industry as an alternative to conventional 
solvent extraction. 
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Chapter 4 
In vitro antioxidant potential of water drinks fortified with 
brewers’ spent grain phenolic extract before and after in vitro 
digestion. 
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Abstract 
Brewers’ spent grain (BSG) is the residual solid fraction left after the brewing 
process. Owing to its phenolic content, extracts from BSG have demonstrated 
antioxidant effects in a number of different in vitro experimental models. Here, 
the ability of enzyme-extracted BSG phenolic extracts to enhance the antioxidant 
potential of flavoured water drinks before and after in vitro digestion was 
investigated. The antioxidant activities of BSG phenolic extracts was measured by 
total phenolic content (TPC), 2,2-Diphenyl-1-picrylhydrazyl (DPPH) assay and 
Ferric reducing antioxidant power (FRAP). The antioxidant potential of water 
drinks fortified with BSG phenolic extracts was assessed by DPPH, FRAP and 
Oxygen Radical Absorbance Capacity (ORAC). Results demonstrated that 
addition of phenolic extracts did not significantly increase antioxidant activity of 
commercially available antioxidant-containing flavoured water drinks.   
 
Introduction 
With a heightened understanding of the benefits of antioxidant compounds, there 
is a greater demand from consumers to increase the development of beverages 
rich in antioxidants (Loizzo et al., 2012). Water is the most consumed beverage in 
the world. Flavoured water has become a prominent product on the marketplace. 
It typically contains flavours, juices, bioactive compounds, preservatives and/or 
sweeteners that give singular tastes and smells accepted by consumers (Fatima 
Barroso et al., 2009). These drinks are supplemented with antioxidant substances 
capable of providing protection against oxidative stress (Loizzo et al., 2012). 
The most common by-products of the brewing industry are spent grain, spent 
hops and yeast (Mussatto et al., 2006). Brewers’ spent grain (BSG) includes the 
seed coat–pericarp–husk fractions of the original barley grain. As a by-product, 
BSG represents a useful source of compounds that have potential uses as 
functional, bioactive ingredients in human nutrition (Lynch et al., 2016). BSG has 
been shown to be a source of valuable phenolic compounds, hydroxycinnamic 
acids (McCarthy et al., 2013a), which have demonstrated antioxidant activity in 
relation to several diseases where oxidative stress is a prominent feature, 
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including inflammatory injury, cancer, and cardiovascular diseases (Teixeira et 
al., 2013). Phenolic-enriched extracts of BSG have previously demonstrated 
cellular antioxidant activities (McCarthy et al., 2012; McCarthy et al., 2014; 
Crowley et al., 2017). 
It is important that phenolic extracts from BSG demonstrate an ability to retain 
their bioactivity during digestion (McCarthy et al., 2013b). In vitro digestion 
models can be used to quickly evaluate the stability of food ingredients during 
digestion, as an alternative to animal and human trials (Hur et al., 2011). This 
provides a truer reflection of the health benefits of bioactive compounds, 
revealing the amount of a compound available for absorption. Bioaccessibility 
entails the amount of compound that is released from a food matrix into the gut. 
Phenolic compounds released via enzymatic digestion in the gastrointestinal tract 
are potentially available for absorption (Chandrasekara and Shahidi, 2012). 
The aim of this particular research was to assess the antioxidant potential of 
flavoured waters fortified with select phenolic extracts of BSG and secondly, to 
assess the stability of the BSG extracts during simulated gastrointestinal digestion. 
The selected BSG phenolic extracts had previously demonstrated cellular 
antioxidant potential, reducing hydrogen peroxide (H2O2)-induced DNA damage 
in U937 cells and protecting against H2O2-induced decreases in glutathione 
content, superoxide dismutase and catalase activity (Crowley et al., 2017).  
 
Materials and Methods 
Materials 
All chemicals, unless otherwise stated, were purchased from Sigma-Aldrich 
Ireland Limited, Co. Wicklow, Ireland.  
 
Preparation of phenolic extracts  
Pale BSG was the residual solid fraction retained following the removal of wort 
during beer production in the brewing process. BSG was stored in 1 kg quantities 
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in polyethylene bags which were vacuum packed and maintained at −20°C. To 
generate phenolic extracts, BSG was sheared in distilled H2O (1:10) at 24,000 rpm 
for 2 minutes. The supernatant was then incubated with carbohydrases 
(Shearzyme, Ultraflo Max and/or Depol 740L) for either 240 or 540 minutes, at 
50°C and pH5 or pH7 (Table 1). Phenolic preparations from pale BSG were 
designated PD1, PD2, PD3 and PW3. 
 
Total phenolic content (TPC) 
The Folin–Ciocalteu assay as described previously (Singleton and Ross, 1965) 
was used to measure the antioxidant capacity of BSG phenolic extracts. This 
assay is based on the capacity of a compound to reduce the Folin–Ciocalteau 
reagent (FCR), generating a yellow to blue/green colour change that is measured 
spectrophotometrically at 765 nm. The TPC method is non-specific to phenols and 
measures any reducing agent. Results were expressed as milligram gallic acid 
equivalents per ml phenolic extract (mg GAE mL
-1
). 
 
2,2-Diphenyl-1-picrylhydrazyl (DPPH) assay 
The DPPH assay was performed according to the method illustrated by Brand-
Williams et al. (1995). Trolox (6-hydroxy-2,5,7,8-tetramethylchroman-2-
carboxylic acid) concentrations from 0.04 to 0.40 μM were used to prepare a 
standard curve for calibration. To allow for coloured samples, colour blanks were 
used consisting of 100 μl sample and 3.9 ml methanol (MetOH). Absorbance at 
515 nm of all samples was measured following 30 min incubation with the DPPH 
reagent (0.0238 μg mL-1). The assay measures antioxidant potential based on a 
compound’s ability to scavenge the DPPH radical by hydrogen donation. Results 
were expressed as %DPPH inhibition. 
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Table 1: Extraction procedure used for the generation of BSG phenolic extracts 
Sample code BSG type Enzyme Enzyme volume (µL g
-1
 BSGdw) Temperature (°C) pH Extraction time (minutes) 
PD1 Pale Dry Depol 740L 10 50 5 240 
PD2 Pale Dry Depol 740L 100 50 7 240 
PD3 Pale Dry Shearzyme, 
Ultraflo Max & 
Depol 740L 
100 (each) 50 5 540 
PW3 Pale Wet Depol 740L 100 50 7 240 
Pale BSG was the residual solid fraction retained following the removal of wort during beer production in the brewing process. Wet BSG 
contains approximately 70-80% water. Dry BSG contains <10% moisture.
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Ferric reducing antioxidant power (FRAP) 
The FRAP assay (Benzie and Strain, 1996), was used to determine the reducing 
power of the samples. The assay is based on the reduction of ferric (Fe
3+
) to 
ferrous (Fe
2+
), which can be measured spectrophotometrically at 593 nm. To 
account for sample colour, colour blanks were prepared with 100 μl sample and 
2.9 ml distilled H2O where appropriate. For calibration, 0–100 μM ferrous 
sulphate heptahydrate (FeSO4·7H2O) was used and results were expressed as μM 
FRAP. 
 
Oxygen Radical Absorbance Capacity (ORAC)  
The ORAC assay was performed as described by Kittiphattanabawon et al. (2012) 
with some modifications. The samples were diluted 1:10 in 75 mM phosphate 
buffer (pH 7.0). The prepared sample (25 µL) was loaded onto white polystyrene, 
nontreated 96-well microplate (Costar Corning Inc., Corning, NY, USA). Only 
the internal wells of the microplate were used. Then 50 µL of 0.04 µM fluorescein 
dissolved in 75 mM phosphate buffer (pH 7.0) was added to the sample. The 
loaded microplate was allowed to equilibrate at 37°C for 20 min in a microplate 
reader (Thermo Scientific Varioskan
®
 Flash Multimode Reader, Fisher Scientific 
UK Ltd., Leicestershire, UK). The reaction was started by the addition of 100 µL 
of 221 mM AAPH. The reaction was performed at 37°C. The fluorescence 
intensity was measured every 5 min for 25 cycles with excitation and emission 
filters of 485 and 535 nm, respectively. The control was prepared in the same 
manner, except that 75 mM phosphate buffer (pH 7.0) was used instead of the 
sample. The kinetic curve (AUC) of the samples was plotted between relative 
fluorescence intensity and time. Trolox (0–100 µM) was used as the standard. The 
ORAC was expressed as µmol Trolox equivalents (TE). 
 
Preparation of fortified drinks 
Five commercially available water drinks were purchased from a local 
supermarket; Ballygowan Still Natural Mineral Water (Britvic Soft Drinks Ltd., 
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UK), Tesco Lemon And Lime Still Flavoured Water (Tesco, UK), Volvic Touch 
Of Fruit Lemon and Lime (Danone Waters (UK and Ireland) Ltd., UK), Sobe V 
Water Pomegranate And Blueberry (Britvic Soft Drinks Ltd., UK) and Glaceau 
Vitaminwater XXX Triple Berry Acai-Blueberry-Pomegranate (Coca-Cola 
Enterprises Ltd., UK) (Table 2). Owing to the presence of known antioxidant 
compounds in both products, the Sobe and Glaceau water drinks were used as 
positive controls for the purpose of this research. Samples were aliquoted into 
15 ml centrifuge tubes and stored at −20°C until analysis. For fortified samples, 
BSG phenolic extracts, PD1-3 and PW3, were added at 10% (v/v) to a final 
volume of 5 ml prior to freezing. The selection of these extracts was based on 
their pale colour (therefore being unable to influence the colour of the water 
drinks) and their antioxidant potential demonstrated in cell culture models 
(Crowley et al., 2017). Previous research has been carried out using BSG phenolic 
extracts at concentration of 10% v/v (McCarthy et al., 2013b). The antioxidant 
activities of all samples were analysed before and after in vitro digestion. 
 
In vitro digestion 
A SGID model, as previously described (McCarthy et al., 2015) was utilised to 
simulate human digestion. Briefly, for the gastric digestion 2 mL sample and 1 
mL Pepsin (0.04 g mL
-1
 in 0.1M HCl) were added to 12 mL Hank’s balanced salt 
solution (HBSS) and the pH was adjusted to 2 using 0.1M HCl, to simulate the 
physiological conditions of the stomach. Samples were incubated for 1 h in a 
shaking waterbath (Grant OLS 200, Grant Instruments, Cambridge, UK) at 95 
rpm and 37
o
C. To simulate duodenal digestion, 100 µL Pancreatin (0.08 g mL
-1
 in 
HBSS) and 200 µL bile salts (0.2 g glycodeoxycholate, 0.125 g taurodeoxycholate 
and 0.2 g taurocholate in 5 mL HBSS) were added, the pH was adjusted to 7.4 
using 1N NaOH and samples were incubated in a shaking waterbath (95 rpm) at 
37
o
C for 2 h. Samples were centrifuged at 5,525 x g for 1 h and the supernatant 
(digestate) was isolated, aliquoted, blown with N2 gas and stored at -20
o
C. 
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Table 2: Water drinks ingredients list 
Water drink Ingredients list (as per label) 
Ballygowan Still Natural Mineral 
Water 
Natural mineral water 
Tesco Lemon And Lime Still 
Flavoured Water 
Mineral Water, Acid (Citric Acid), Flavourings, Preservatives (Potassium Sorbate, Dimethyl Dicarbonate), 
Sweetener (Sucralose) 
Volvic Touch Of Fruit Lemon 
And Lime 
Volvic Natural Mineral Water (92%), Sugar (5.4%), Acid (Citric Acid), Natural Lemon and Lime 
Flavouring, Preservative (Potassium Benzoate) 
Sobe V Water Pomegranate And 
Blueberry 
Spring Water, Natural Blueberry Flavouring with Other Natural Flavourings, Acid (Citric Acid), 
Vitamins: C, E, Carrot and Hibiscus Concentrates, Sweetener (Steviol Glycosides), Minerals: Zinc 
Sulphate, Sodium Selenite, Burdock Root Extract 
Glaceau Vitaminwater XXX 
Triple Berry Acai-Blueberry-
Pomegranate 
Spring Water, Fructose, Sugar, Citric Acid, Vitamins (C, Niacin, E, Pantothenic Acid, B6), Fruit and 
Vegetable Concentrates (Blueberry, Carrot), Fruit Extracts (Apple, Blueberry, Pomegranate, Acai), 
Natural Flavourings, Sweetener (Steviol Glycosides), Mineral Salt (Zinc Gluconate) 
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Analysis of the antioxidant potential of flavoured waters 
The antioxidant activities of fortified flavour water were determined before and 
after digestion by DPPH, FRAP and ORAC. 
 
Statistical Analysis  
All data represent the mean ± standard error (SE) of at least three independent 
experiments. Statistical analysis was done by one-way analysis of variance 
(ANOVA) followed by Tukey’s multiple comparison test as analysed using 
GraphPad Prism 4 (GraphPad software, La Jolla, CA). 
 
Results 
TPC, DPPH and FRAP measurements of BSG phenolic extracts 
Table 3 shows the antioxidant potential of BSG phenolic extracts as measured by 
TPC, DPPH and FRAP. There were no statistically significant differences 
between the extracts. The BSG phenolic extract PD3 demonstrated the highest 
phenolic acid content as measured by the TPC assay (0.03 mg GAE mL
-1
), 
whereas extract PW3 had the lowest TPC measurement (0.01 mg GAE mL
-1
) 
(Table 3). Additionally, extract PW3 elicited the lowest antioxidant effect when 
assessed by the DPPH assay. The highest DPPH inhibition was identified with 
extract PD1 (25.80%). Similar to the TPC measurement, BSG extract PD3 
produced the highest FRAP value (115.66 µM). Correlation statistics suggest 
positive correlations between the TPC and FRAP assays (R
2
=0.62). The 
correlation between the TPC and DPPH assays (R
2
=0.30) and DPPH and FRAP 
assays was considerably lower (R
2
=0.01). 
 
Antioxidant activity of fortified drinks before in vitro digestion 
The ability of phenolic extracts to enhance the antioxidant potential of flavoured 
water drinks was investigated. % DPPH inhibition of between 15.76-25.98% was 
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Table 3: Total phenolic content (TPC), DPPH radical inhibition and Ferric 
reducing antioxidant power (FRAP) of brewers’ spent grain (BSG) phenolic 
extracts. 
Sample TPC (mg GAE mL
-1
) 
 
DPPH inhibition 
(%) 
FRAP (µM) 
PD1 0.02 ± 0.01 25.80 ± 4.15 114.15 ± 5.65 
PD2 0.02 ± 0.01 18.71 ± 2.76 114.91 ± 6.60 
PD3 0.03 ± 0.01 20.24 ± 5.76 115.66 ± 6.40 
PW3 0.01 ± 0.01 12.89 ± 1.93 114.39 ± 5.77 
Data represents mean ± SE of at least three independent experiments.
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achieved by unfortified control waters (Table 4). Addition of BSG phenolic 
extracts increased the % DPPH inhibitory activity of all the water drinks assessed. 
However, none of these increases were statistically significant. Statistically 
significant increases in % DPPH inhibition were noted with the positive controls, 
Sobe V Water and Glaceau Vitaminwater. The water drinks were used as positive 
controls owing to their added antioxidant content (Table 2). Addition of the BSG 
phenolic extracts led to no change in the FRAP activity of the water drinks. 
    Similar to the strong DPPH inhibitory activity, Sobe V Water and Glaceau 
Vitaminwater demonstrated significantly higher FRAP activity compared to 
control waters. Phenolic extract fortification of both Ballygowan and Volvic 
waters led to non-significant increases in ORAC values. A non-significant 
decrease in ORAC values was noted with the addition of phenolic extracts to 
Tesco water. 
 
Antioxidant activity of fortified drinks after in vitro digestion 
The impact of simulated gastrointestinal in vitro digestion (SGID) on the 
antioxidant activity of BSG phenolic extract-fortified water drinks can be seen in 
Table 5. Non-significant decreases in % DPPH inhibitory activity was noted with 
all phenolic extract fortified-water drinks assessed. The antioxidant containing-
water drinks Sobe V Water and Glaceau Vitaminwater showed statistically 
significantly lower % DPPH inhibitory activity following SGID. There was quite 
a lot of variation in the FRAP values of water drinks subjected to SGID. For 
example, SGID led to non-significant increases in the FRAP values of Volvic 
waters supplemented with BSG phenolic extracts PD1-PD3 and PW3, whereas 
Tesco waters supplemented with extracts PD1, PD2 and PW3 demonstrated non-
significantly lower FRAP values. Significant decreases in the FRAP values of 
Sobe V Water and Glaceau Vitaminwater were noted after SGID. Of all the water 
drinks assessed, no significant changes in ORAC values, as a result of SGID, were 
noted.
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Table 4: Antioxidant activity of flavoured mineral waters supplemented with BSG phenolic extracts.  
Water sample  DPPH inhibition (%) FRAP (μM) ORAC (µM TE) 
Ballygowan Control 18.35 ± 9.31 84.18 ± 2.62 218.59 ± 151.28 
 10% (v/v) PD1 24.66 ± 5.93 79.69 ± 2.69 451.67 ± 57.23 
 10% (v/v) PD2 30.24 ± 7.73 80.31 ± 1.59 563.37 ± 94.63 
 10% (v/v) PD3 25.33 ± 5.35 83.36 ± 2.53 530.77 ± 67.67 
 10% (v/v) PW3 24.28 ± 8.59 81.18 ± 2.45 532.95 ± 89.77 
Tesco Control 15.76 ± 4.36 84.51 ± 2.11 489.14 ± 70.78 
 10% (v/v) PD1 31.89 ± 4.41 77.77 ± 2.04 321.64 ± 85.55 
 10% (v/v) PD2 33.27 ± 5.69 84.09 ±  1.86 418.25 ± 124.66 
 10% (v/v) PD3 34.69 ± 5.29 79.18 ± 2.08 280.38 ± 109.95 
 10% (v/v) PW3 29.68 ± 5.37 81.70 ± 2.34 487.56 ± 66.14 
Volvic Control 25.98 ± 5.91 82.03 ± 2.66 345.47 ± 121.34 
 10% (v/v) PD1 30.23 ± 3.93 78.13 ± 1.39 543.11 ± 91.90 
 10% (v/v) PD2 32.33 ± 6.61 80.49 ± 3.40 449.75 ± 117.43 
 10% (v/v) PD3 33.84 ± 6.25 80.54 ± 2.60 465.16 ± 95.55 
 10% (v/v) PW3 28.15 ± 6.24 81.72 ± 1.72 521.90 ± 117.57 
 Glaceau 87.77 ± 1.19* 107.58 ± 4.06* 499.93 ± 40.92 
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 Sobe 90.01 ± 3.46* 102.23 ± 1.93* 442.89 ± 40.46 
Data represents mean ± SE of at least three independent experiments. Statistical analysis by ANOVA followed by Tukey’s multiple comparison 
test. * Denotes statistically significant difference (P<0.05) within a column between control water and supplemented/unsupplemented water.
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Table 5: Antioxidant activity of flavoured mineral waters supplemented with BSG phenolic extracts, following in vitro digestion. 
Water sample  DPPH inhibition (%) FRAP (μM) ORAC (µM TE) 
Ballygowan Control 3.73 ± 2.37 79.66 ± 1.97 407.51 ± 78.63 
 10% (v/v) PD1 9.10 ± 5.40 79.93 ± 3.43 521.15 ± 46.38 
 10% (v/v) PD2 9.43 ± 6.99 77.93 ± 1.54 589.18 ± 54.65 
 10% (v/v) PD3 10.51 ± 5.58 78.40 ± 0.59 538.73 ± 33.52 
 10% (v/v) PW3 9.62 ± 6.28 78.69 ± 0.94 496.67 ± 30.42 
Tesco Control 3.62 ± 2.19 76.78 ± 1.15 459.42 ± 51.90 
 10% (v/v) PD1 11.52 ± 6.10 77.59 ± 0.92 374.65 ± 44.44 
 10% (v/v) PD2 9.84 ± 6.03 77.96 ± 1.42 507.73 ± 97.32 
 10% (v/v) PD3 10.79 ± 5.80 82.21 ± 2.13 365.74 ± 78.03 
 10% (v/v) PW3 6.16 ± 4.73 79.39 ± 1.47 533.15 ± 99.85 
Volvic Control 2.61 ± 1.35 78.40 ± 1.07 352.97 ± 31.55 
 10% (v/v) PD1 11.30 ± 6.60 86.63 ± 7.24 515.66 ± 75.39 
 10% (v/v) PD2 9.76 ± 5.61 82.88 ± 3.15 552.59 ± 96.71 
 10% (v/v) PD3 8.16 ± 5.10 84.90 ± 5.07 484.14 ± 57.24 
 10% (v/v) PW3 11.21 ± 6.27 86.42 ± 8.23 548.18 ± 91.53 
 Glaceau 23.63 ± 16.23
a 
79.63 ± 1.47
a 
495.99 ± 26.70 
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 Sobe 8.31 ± 6.78
a 
79.09 ± 1.05
a 
518.54 ± 16.15 
Data represents mean ± SE of at least three independent experiments. Statistical analysis by ANOVA followed by Tukey’s multiple comparison 
test.  
a 
Denotes statistically significant difference (P<0.05) within a column between undigested (Table 4) and digested values.
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Discussion 
A functional beverage is described as a drink product that is ready to drink and 
which contains non-traditional ingredients. Popular ingredients include herbs, 
vitamins, minerals, amino acids or additional raw fruit or vegetable ingredients. 
Such drink products can provide specific health benefits that go beyond general 
nutrition (Loizzo et al., 2012). 
The potential of polyphenols to protect against chronic disease development 
has encouraged food companies to create drinks containing antioxidants that 
appeal to consumers. Such drinks include vitamin enhanced waters (VEWs), as 
well as fruit and berry juices. A large number of VEWs exist on the market with 
some products claiming to contain high antioxidant levels and therefore high 
antioxidant capacity (Donnelly et al., 2010). BSG is a co-product of the brewing 
industry which has been added as an ingredient to certain foods (Ktenioudaki et 
al., 2012; Guo et al., 2014). It has also demonstrated promising effects as a 
potential functional ingredient of foods such as cranberry juice, yoghurt, snack 
bars and milk (McCarthy et al., 2013a; McCarthy et al., 2015; Crowley et al., 
2015). Recently, BSG phenolic compounds generated using a carbohydrase-
extraction method, demonstrated antioxidant potential in cell culture models 
(Crowley et al., 2017). The aim of this research was to assess the ability of select 
enzyme-extracted BSG phenolic extracts to enhance the antioxidant activity of 
water drinks.   
The initial assessment of the antioxidant potential of the BSG phenolic extracts 
involved the use of the in vitro antioxidant assays; TPC, DPPH and FRAP. The 
extracts were derived from pale BSG which is known as a source of 
hydroxycinnamic acids (McCarthy et al., 2013a). Here extract PD3 demonstrated 
the highest TPC and FRAP measurements, while extract PD1 was the most 
effective extract at inhibiting DPPH. The TPC and FRAP assays showed good 
correlation (R
2
=0.62), suggesting that the ability to reduce ferric ions to the 
ferrous form is related to the antioxidant content of the extracts. Similar positive 
correlations between the methods have been also highlighted in other studies 
(Hashim et al., 2013; Ku et al., 2014). The ability of antioxidants to reduce ferric 
tripyridyltriazine to ferrous tripyridyltriazine can be measured using the FRAP 
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assay (Loizzo et al., 2012). The TPC method is of course, not specific to phenolic 
compounds as it measures any compound which is capable of reducing Folin–
Ciocalteu reagent (Huang et al., 2005). Previous research on the in vitro 
antioxidant potential of alkaline-extracted BSG phenolic extracts demonstrated 
higher average TPC measurements compared with extracts analysed here 
(McCarthy et al., 2012; McCarthy et al., 2013a). In contrast to this, the DPPH 
inhibitory activity of enzyme-extracted BSG phenolic extracts was on average 
higher than that of alkaline-extracted BSG phenolic extracts. This may highlight 
the effectiveness of carbohydrase enzymes at releasing antioxidant components in 
the BSG. DPPH is a radical which has a UV-vis absorption maximum of 515 nm 
and can be reduced, leading to a colour change which can be recorded by 
spectrophotometry. Many antioxidants may be non-reactive or may react slowly 
with DPPH, yet react quickly with peroxyl radicals (Huang et al., 2005).  
The ability of phenolic extracts to enhance the antioxidant potential of 
flavoured water drinks was investigated. Similar research in the past has assessed 
the ability of both BSG phenolic and protein extracts to increase the antioxidant 
and anti-inflammatory potential of different food formulations (McCarthy et al., 
2013a; McCarthy et al., 2015; Crowley et al., 2015). Results presented here 
demonstrated that addition of phenolic extracts to water drinks did not 
significantly increase antioxidant activity. Increases in both DPPH scavenging and 
FRAP activity were noted with Glaceau and Sobe drinks. Glaceau Vitaminwater 
contains among other vitamins and minerals, vitamin C and E as well as zinc 
which are all known as antioxidants (Padayatty et al., 2003; Traber and Atkinson, 
2007; and Prasad, 2014). Similarly, Sobe V Water contains these nutrients as well 
as selenium which is also known to play a role as an antioxidant (Tinggi, 2008). 
Both drinks contain concentrates of carrot, which is a rich source of antioxidant 
carotenoids such as β-carotene (Sharma et al., 2012). Sobe V Water contains a 
concentrate of Hibiscus, the leaves of which are consumed in many countries and 
have been found to contain high levels of polyphenols, such as chlorogenic acid, 
quercetin and kaempferol glycosides (Zhen et al., 2016). The drink also contains a 
root extract from the perennial herb, burdock, which has demonstrated in vitro 
antioxidant activity and contains tannin, caffeic acid and chlorogenic acid (Predes 
et al., 2011; Chan et al., 2011). The Glaceau Vitaminwater also contains extracts 
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from apple, pomegranate, blueberry and acai. Zhang et al. (2016) found that the 
flavonoids phloridzin and phloretin were the principal components responsible for 
the antioxidant properties of an apple extract. Pomegranate extracts have also 
been shown to have very high antioxidant activity (Salgado et al., 2012; 
Kalaycioglu and Erim, 2017). Both blueberries and acai are rich in anthocyanins 
(Wang et al., 2017; Santos et al., 2014). The ORAC and PSC assays were used to 
show the high antioxidant activity of blueberry extracts in vitro and in cellular 
systems (Wang et al., 2017). The açaí fruit is derived from Euterpe oleracea and 
Santos et al. (2014) showed that an açaí extract protected astrocytes against 
manganese neurotoxicity. The antioxidant capability of Vitaminwater brand 
beverages has previously been reported by Donnelly et al. (2010) and Hong et al., 
(2016). Also of note here are the antioxidant effects of the unfortified (control) 
water drinks. These drinks contain mineral water and, in the case of the Tesco and 
Volvic drinks, flavourings and preservatives. A possible reason for the antioxidant 
effect is that the mineral content of these waters is contributing to the antioxidant 
effect. Nappi et al. (2011) demonstrated the positive antioxidant role of hydric 
supplementation with a “Lete“mineral water in human subjects. A possible reason 
for the lack of an enhancement effect with fortification of the drinks may be 
connected to the low concentration (10% v/v) added to the water drinks. The 
antioxidant effects of the phenolic extracts are likely to have been diluted. The 
10% (v/v) concentration was selected based on previous research (McCarthy et 
al., 2013a), where addition of phenolic extracts to cranberry juice increased the 
FRAP activity of the drink.  
As can be seen in Table 5, digestion did not significantly impact on the 
antioxidant activity of the fortified drinks. However significant decreases in the 
DPPH scavenging and FRAP activity of both Glaceau and Sobe after digestion 
were noted. Other studies which have employed SGID to assess the 
bioaccessibility of phenolic compounds found similar results. Schulz et al. (2017) 
assessed the minerals and phenolic contents, as well as antioxidant capacity of 
juçara fruit (Euterpe edulis Martius) before and after the in vitro gastrointestinal 
digestion and noted a decrease in DPPH scavenging capacity and FRAP after 
SGID (Schulz et al., 2017). Similarly, Celep et al. (2015) noted decreases in the 
H2O2-scavenging activities and total antioxidant capacities of wine samples after 
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in vitro gastrointestinal digestion. The authors speculated that lower 
concentrations of phenolic compounds compared to undigested samples and pH 
variations during digestion were responsible for the lower antioxidant activity of 
digested samples. In contrast to this, Chandrasekara and Shahidi (2012) found that 
the TPC, total flavonoid content and trolox equivalent antioxidant capacity values 
of millet grains increased following in vitro digestion. It was suggested that a 
likely reason for this was the transformation of compounds present in the raw 
grain during the digestive process. Previous research on BSG extract-fortified 
foods has demonstrated positive results with regards to their ability to retain 
bioactivity following in vitro digestion. McCarthy et al. (2015) demonstrated that 
digestates of foods supplemented with BSG phenolic extracts significantly 
reduced oxidant-induced DNA damage in Caco-2 cells, as well as attenuating IL-
4, IL-10 and IFN-γ production in stimulated Jurkat T cells. Similarly, milk 
fortified with BSG protein hydrolysates decreased IL-6 production in stimulated 
Jurkat T cells, following in vitro digestion (Crowley et al., 2015). 
 
Conclusions 
In conclusion, the addition of BSG phenolic extract does not significantly enhance 
the antioxidant potential of water drinks, either prior to or after in vitro digestion.  
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Chapter 5 
Effects of varying the carbohydrase enzymes on the production of 
anti-inflammatory and antioxidant hydrolysates from brewers’ 
spent grain (BSG).  
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Abstract 
Brewers’ spent grain (BSG) is the residual fraction left over from the brewing 
process and is an excellent source of bioactive compounds. Enzyme extraction 
methods may be favoured over solvent extraction procedures due to their 
specificity and mild reaction conditions. Here the potential of using carbohydrase 
(Shearzyme, Ultraflo Max, and Depol 740 L) and proteinase (Alcalase, Brewers 
Clarex and Flavourzyme) enzymes to extract BSG protein hydrolysates with anti-
inflammatory and antioxidant activities was investigated. The impact of BSG 
protein hydrolysates on cytokine production in both concanavalin A (ConA)-
treated Jurkat T cells and lipopolysaccharide (LPS)-stimulated RAW 264.7 cells, 
DNA damage in H2O2-treated U937 cells and GSH content, SOD and CAT 
activity of H2O2-treated HepG2 cells was assessed. The most effective enzyme 
treatment yielding bioactive BSG hydrolysates was seen with the carbohydrase 
combination of Shearzyme and Ultraflo Max and proteinase combination of 
Alcalase, Brewers Clarex and Flavourzyme. The unhydrolysed fraction also 
demonstrated both anti-inflammatory and antioxidant activity, suggesting that 
other components present in the BSG may be responsible for its bioactivity.  
 
Introduction 
It is now well established that food or food waste materials may contain 
components that have biological activities above the basic nutritional value. This 
has led to increased interest from the food industry, particularly concerning the 
development of so-called nutraceuticals (Cheli and Baldi, 2011). In this regard, 
food or food waste-derived biologically active peptides (bioactive peptides) offer 
potential as functional food components that can be used to treat a variety of 
medical conditions including inflammation, hypertension, diabetes and 
cardiovascular disease. The inclusion of bioactive peptides through food is an 
appealing alternative to delivering synthetic drugs. In developing countries, these 
naturally-occurring bioactive peptides are often more cost-effective and more 
widely available than synthetic drugs (Maestri et al., 2016). Hydrolysates have 
been described as mixtures consisting of peptides and amino acids which are 
generated by enzyme, acid or alkali treatment of proteins or by fermentation of 
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proteins (Sarmadi and Ismail, 2010). Bioactive peptides differ, in that they are 
several linked amino acids purified from hydrolysates (Sarmadi and Ismail, 2010). 
Hydrolysates are generally easier to obtain than purified peptides (Maestri et al., 
2016). 
The immune system serves as the first line of defence against pathogens and 
aids in protecting the body against potential infections. Proper immune 
functioning is important for the prevention and elimination of infections 
(Santiago-Lopez et al., 2016). Peptides obtained from soybeans and milk have 
demonstrated anti-inflammatory effects on intestinal inflammation, with the 
inhibition of pro-inflammatory cytokines and chemokine expression (Cicero et al., 
2017). Oxidative stress is an imbalance between oxidants and antioxidants (Cheli 
and Baldi, 2011). Reactive oxygen species (ROS), produced from the 
mitochondrial respiratory chain, are the predominant contributors to oxidative 
damage. Antioxidants are molecules with an ability to stabilise or deactivate the 
harmful effects of free radicals, such as ROS (Cheli and Baldi, 2011). 
Antioxidative peptides are capable of reducing the damage caused by ROS, 
resulting in the decrease of essential fatty acid peroxidation (Maestri et al., 2016). 
Brewers’ spent grain (BSG) is the insoluble part of the barley grain, 
constituting the seed coat–pericarp–husk layers that encased the original cereal 
grain, which is left over from the brewing process (Lynch et al., 2016). BSG is the 
residual fraction following the mashing step and because of the large amount 
produced annually and current commercial value, there is a lot of interest in 
exploiting this nutritionally valuable co-product (Lynch et al., 2016). BSG has 
proven to be an excellent source of bioactive compounds obtained by different 
extraction methods, such as solid–liquid extraction, microwave-assisted 
extraction, alkaline extraction and enzymatic extraction (Mussatto, 2014). With 
the presence of different substituted groups and various bond linkage types of the 
BSG polymers, such as the hemicellulose fraction, enzymes with diverse activities 
are required for complete polymer hydrolysis (Lynch et al., 2016). Enzyme 
extraction methods may be favoured over solvent extraction procedures due to 
their specificity and mild reaction conditions (Forssell et al., 2008). BSG (15–
25% w/w protein) is currently being researched as a source of protein concentrate 
or hydrolysates with techno-functional applications and/or health benefits (Lynch 
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et al., 2016). Recent studies on alkaline-extracted protein hydrolysates generated 
from BSG suggest that it is a source of anti-inflammatory and antioxidant peptides 
(McCarthy et al., 2013a; McCarthy et al., 2013b). The purpose of this research 
was to investigate the potential of using carbohydrase (Shearzyme, Ultraflo Max 
and Depol 740L) and proteinase (Alcalase, Brewers Clarex and Flavourzyme) 
enzymes to extract BSG protein hydrolysates with anti-inflammatory and 
antioxidant activities.  
 
Materials and Methods 
Materials 
BSG was obtained from a single batch which was brewed in November 2009, 
vacuum-packed and stored at -20
o
C in polypropylene bags until use. Shearzyme 
500 L (declared activity 500 Fxu g21) and Ultraflo Max (declared activity 470 
Fxu g21) were sourced from Novozymes A/S, Bagsværd, Denmark. Depol 740L 
(declared activity 945 u g21) was purchased from Biocatalysts Ltd., Cardiff, UK. 
Alcalase 2.4L and Flavourzyme
® 
500L were purchased from Sigma Chemical Co. 
(Dorset, UK). Brewer’s Clarex™ (Aspergillus niger prolyl endoproteinase) was 
received from Dutch State Mines (DSM, Heerlen, Netherlands). Jurkat T cells, 
RAW 264.7 murine macrophages, U937 cells and HepG2 cells were obtained 
from the European Collection of Animal Cell Cultures (ECACC, Salisbury, UK). 
All other chemicals were purchased from Sigma, unless otherwise stated. 
 
Generation of the enzyme-extracted hydrolysates 
The enzyme-extracted hydrolysates were prepared by shearing BSG in distilled 
H2O (1:10) at 24000 rpm for 2 minutes using an Ultra Turrax
®
T25 high-
performance disperser (IKA
®
 Werke GmbH & Co. KG, Staufen, Germany). The 
BSG suspension was then incubated with carbohydrases: Shearzyme 500 L, 
Ultraflo Max and/or Depol 740L for either 240 or 540 minutes, at 50°C (Table 1). 
Samples were centrifuged at 2700 g for 20 minutes at 10°C (Hettich Zentrifugen 
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Table 1: Summary of methods used to prepare brewers’ spent grain (BSG) protein hydrolysates A-J.  
Sample Description Carbohydrase enzyme Protease enzymes pH 
A Unhydrolysed BSG protein No enzyme No enzyme _ 
B BSG protein hydrolysate Shearzyme, Ultraflo Max, Depol 740L Brewers Clarex, Flavourzyme 5,7 
C BSG protein hydrolysate Depol 740L Brewers Clarex, Flavourzyme 5,7 
D BSG protein hydrolysate Shearzyme, Ultraflo Max Brewers Clarex, Flavourzyme 5,7 
E BSG protein hydrolysate Shearzyme, Ultraflo Max, Depol 740L Alcalase, Flavourzyme 5,9,7 
F BSG protein hydrolysate Depol 740L Alcalase, Flavourzyme 5,9,7 
G BSG protein hydrolysate Shearzyme, Ultraflo Max Alcalase, Flavourzyme 5,9,7 
H BSG protein hydrolysate Shearzyme, Ultraflo Max, Depol 740L Alcalase, Brewers Clarex, Flavourzyme 5,9,7 
I BSG protein hydrolysate Depol 740L Alcalase, Brewers Clarex, Flavourzyme 5,9,7 
J BSG protein hydrolysate Shearzyme, Ultraflo Max Alcalase, Brewers Clarex, Flavourzyme 5,9,7 
BSG was incubated with carbohydrases for 4 h at pH5, at 50°C followed by incubation at 50°C with proteases for 4 h. Hydrolysis with Alcalase 
was carried out a pH9. Hydrolysis with Brewers Clarex and Flavourzyme was carried out at pH7.
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Universal 320R centrifuge, Andreas Heittich GmbH & Co., Tuttlingen, Germany) 
and the resulting supernatant (phenolic-enriched extract) being retained and stored 
at -20°C prior to analysis. The remaining sediment was incubated at 50°C with 
Alcalase for 2 h at pH 9 and/or Brewers Clarex/Flavourzyme for 2 h at pH 7. 
Sediment was then filtered and washed with deionised water at 50°C for 30 
minutes. The fibre-enriched sediment was collected and stored at -20°C, while the 
remaining supernatants were labelled A-J, freeze-dried and stored at -20°C until 
further analysis. 
 
Cell culture 
Jurkat T cells, a human leukemic cell line, were maintained in antibiotic-free 
Roswell Park Memorial Institute (RPMI)-1640 medium supplemented with 10% 
(v/v) fetal bovine serum (FBS) and plated at a density of 1 x 10
5
 and 2 x 10
5
 cells 
mL
-1
 for cell viability and ELISA assays, respectively. RAW 264.7 cells, a murine 
macrophage cell line were grown in Dulbecco’s Modified Eagle Medium 
(DMEM) media supplemented with 10% FBS. Cells were seeded at a density of 
0.2 x 10
5
 cells mL
-1
 for cell viability and ELISA assays. U937 cells, a human 
leukemic monocytic lymphoma cell line were grown in antibiotic-free RPMI-
1640 medium supplemented with 10% (v/v) FBS and plated at a density of 1 x 10
5
 
cells mL
-1
 for the comet assay. HepG2 cells, a human liver carcinoma cell line, 
were maintained in DMEM supplemented with 10% FBS and plated at a density 
of 2 x 10⁵ cells mL-1 for cellular antioxidant assays. Cells were maintained at 
37°C in a 5% CO2 atmosphere. Reduced serum media (2.5% FBS) was used for 
all experiments. 
 
Cell Viability 
The (3-(4, 5-Dimethylthiazol-2-yl)-2, 5-diphenyltetrazolium bromide (MTT) 
assay was used to measure the effect of the extracts on cell viability in Jurkat T 
cells and RAW 264.7 cells. Cells were incubated for 24 h at 37°C with BSG 
hydrolysates at concentrations of 0 to 0.2% (w/v). The MTT assay kit
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(MTT I proliferation kit, Roche Diagnostics, West Sussex, UK) was then used to 
measure cell viability. Absorbance was determined at 570 nm using a microplate 
reader (VarioskanFlash, Thermo Scientific, Waltham, MA) and cell viability was 
calculated as a percentage of the control, untreated cells. An inhibitory 
concentration-50 (IC50) value, the concentration of a compound that reduces cell 
viability to 50% of the untreated control cells, was determined for each of the 
BSG hydrolysates.  
 
Cytokine production 
Jurkat T cells were stimulated using 50 mg mL
-1
 concanavalin A (ConA) and 
incubated for 24 h at 37°C with 0.005% (w/v) BSG hydrolysates. The production 
of cytokines interleukin-6 (IL-6) and interferon gamma (IFN-γ) was measured by 
ELISA. RAW 264.7 cells were allowed to adhere overnight. Cells were incubated 
for a further 24 h at 37°C with 0.001% (w/v) BSG hydrolysates and 0.1 mg mL
-1
 
lipopolysaccharide (LPS). The production of cytokines IL-6 and tumor necrosis 
factor-alpha (TNF-α) was measured by ELISA. Cytokine production was 
determined using eBioscience ELISA kits (Ready-SET-Go kit purchased from 
eBioscience, Hatfield, UK). Absorbance was measured at 450 nm on a microplate 
reader (VarioskanFlash, Thermo Scientific, Waltham, MA) and cytokine 
production was expressed as percentage of ConA-stimulated Jurkat T cells or 
LPS-stimulated RAW 264.7 cells. 
 
Comet Assay 
U937 cells were seeded in a 12-well plate at a density 1 x 10
5
 cells mL
-1
  in 
RPMI-1640 medium with 2.5% FBS. Cells were incubated for 24 h at 37°C with 
either BSG hydrolysates (0.2% w/v) or ferulic acid (1 μg mL-1). Previous 
cytotoxicity studies suggested that 0.2% (w/v) was a safe, non-toxic concentration 
to use in U937 cells (see Chapter 8). 1 μg mL-1 ferulic acid has previously been 
used in the U937 cell line as a safe and effective antioxidant compound (Crowley 
et al., 2017) and was used a positive control here. Cells were subsequently treated 
with H2O2 (75 μM for 30 minutes). Oxidative DNA damage to the U937 cells was
122 
 
then assessed using the comet assay adapted from Tice et al. (1991). Fifty cells 
were scored for each slide using a fluorescence microscope (Optiphot-2, Nikon) 
and the Komet 5.5 image analysis software. Data were expressed as percent tail 
DNA. 
 
Cellular Antioxidant Assays: Glutathione, Superoxide Dismutase and Catalase 
HepG2 cells (2 x 10
5
 cells mL
-1
) were incubated with BSG protein hydrolysates 
(0.08% w/v) for 24 h at 37°C. Previous cytotoxicity data suggested that 0.08% 
(w/v) was a safe, non-toxic concentration to use in HepG2 cells (see Chapter 8).  
Following incubation, cells were exposed to 2 mM H2O2 for 120 minutes. Cells 
were harvested, sonicated and centrifuged (800 rpm, 10 minutes) and the 
supernatant was collected for the determination of antioxidant enzyme activity.  
The glutathione (GSH) content of the cells was measured as described 
previously (Hissin and Hilf, 1976). The GSH content was measured in cells as an 
indicator of intracellular non-enzymatic antioxidant defences. Briefly, 100 μL 
supernatant was mixed with sodium phosphate–ethylenediaminetetraacetic acid 
buffer (1.8 mL) and σ-phthaldialdehyde (0.1 mg). The fluorescence intensity of 
the samples was determined (Thermo Scientific Varioskan Flash microplate 
reader) at wavelengths of 360 nm (absorption) and 430 nm (emission). The GSH 
content of the samples was determined from a standard curve (0–2.5 nmol mL−1 
GSH).  
Cellular superoxide dismutase (SOD) activity was measured using the method 
previously described by Misra and Fridovich, (1977). Briefly, the cell supernatant 
was diluted in 0.05 M potassium phosphate buffer (pH 7) and xanthine, xanthine 
oxidase and cytochrome c were added. The xanthine oxidase system generates 
superoxide anion which reduces cytochrome c and this reaction is inhibited by 
SOD. The reduction in cytochrome c was used to determine the activity of SOD 
present in the samples from a standard curve (0-1µg SOD mL
-1
). Samples were 
read at 550 nm at 20 minute intervals for at least 5 readings.  
Catalase (CAT) activity was assessed using a modification of the method of 
Baudhuin et al. (1964). H2O2 was added to the cell supernatants and following 
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incubation any remaining H2O2 was determined spectrophotometrically at 465 
nm. One unit of catalase activity was defined as the amount of catalase required to 
decompose 1 µmol H2O2 per min at pH 7.5 and 25°C. 
GSH content and SOD and CAT activities were quantified relative to the 
protein content as nmol mL
-1
 GSH mg
-1
 protein in cell homogenate and SOD and 
CAT units
 
mg
-1
 protein, respectively. The protein content of the samples was 
quantified by the bicinchoninic acid (BCA) protein assay as previously described 
(Smith et al., 1985). Data were expressed as a percentage of untreated control 
cells. 
 
Statistical Analysis  
All data represent the mean ± standard error (SE) of at least three independent 
experiments. Statistical analysis was done by one-way analysis of variance 
(ANOVA) followed by Dunnett’s test or Tukey’s multiple comparison test as 
analysed using GraphPad Prism 4 (GraphPad software, La Jolla, CA). 
 
Results 
Cell viability  
The cytotoxic assessment of the BSG protein hydrolysates was carried out in 
Jurkat T cells and RAW 264.7 cells (Tables 2 and 3). In Jurkat T cells, the 
hydrolysates were assessed in the concentration range of 0-0.2% (w/v). Samples 
A and B reduced cell viability to 0% at concentrations greater than 0.025% and 
0.04% (w/v), respectively. Similarly, hydrolysate D demonstrated a toxic effect in 
Jurkat T cells, reducing cell viability to 0% at concentrations greater than 0.08% 
(w/v). Hydrolysate I was the least cytotoxic of hydrolysates A-J, with no 
significant reduction in cell viability. Following these results, BSG protein 
hydrolysates (A-J) were used at 0.005% (w/v) for immunomodulatory assays in 
Jurkat T cell.
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Table 2: Effect of BSG protein hydrolysates A-J (0-0.2% (w/v)) on cell viability in Jurkat T cells 
Cell proliferation (% of control) 
 A B C D E F G H I J 
0.005% 76.9 ± 4.6* 67.0 ± 13.6* 92.9 ± 15.4 88.3 ± 11.0 83.6 ± 11.7 75.2 ± 16.5 83.5 ± 8.0 87.2 ± 12.0 79.6 ± 3.9 67.1 ± 7.2 
0.01% 48.5 ± 4.1* 49.1 ± 7.4* 82.5 ± 14.4 71.6 ± 10.6 66.0 ± 11.6 68.9 ± 9.8 62.7 ± 6.8* 51.8 ± 7.4* 80.5 ± 7.1 80.7 ± 11.6 
0.02% 5.1 ± 4.4* 27.8 ± 11.8* 79.9 ± 13.6 55.1 ± 13.0* 89.4 ± 12.2 75.9 ± 8.0 68.0 ± 7.0* 47.1 ± 4.8* 95.8 ± 5.1 67.3 ± 6.4 
0.025% 7.7 ± 4.4* 18.8 ± 6.4* 85.3 ± 13.8 58.2 ± 11.3* 83.7 ± 10.7 66.2 ± 11.4 64.1 ± 4.6* 38.4 ± 8.3* 39.1 ± 14.3 34.1 ± 7.2* 
0.04% 0.0 ± 0.0* 24.7 ± 10.0* 94.2 ± 13.7 23.8 ± 12.8* 117.1 ± 1.3 79.5 ± 9.8 67.5 ± 7.6* 24.2 ± 6.3* 69.1 ± 11.2 52.7 ± 14.0 
0.06% 0.0 ± 0.0* 0.0 ± 0.0* 89.4 ± 15.1 9.0 ± 6.2* 77.7 ± 5.6 63.2 ± 9.3 51.9 ± 8.7* 37.7 ± 6.6* 93.2 ± 12.7 74.5 ± 18.2 
0.08% 0.0 ± 0.0* 0.0 ± 0.0* 77.0 ± 15.9 2.4 ± 2.4* 88.7 ± 4.2 65.1 ± 0.6 51.8 ± 4.4* 40.3 ± 9.1* 49.1 ± 23.0 31.4 ± 15.7* 
0.1% 0.0 ± 0.0* 0.0 ± 0.0* 86.5 ± 13.8 0.0 ± 0.0* 48.9 ± 6.7* 56.0 ± 15.2* 45.9 ± 6.5* 36.2 ± 5.0* 45.4 ± 20.5 20.4 ± 10.6* 
0.15% 0.0 ± 0.0* 0.0 ± 0.0* 58.7 ± 14.9 0.0 ± 0.0* 47.3 ± 7.4* 42.6 ± 7.2* 45.6 ± 5.7* 25.2 ± 7.8* 99.0 ± 18.7 45.5 ± 23.3 
0.2% 0.0 ± 0.0* 0.0 ± 0.0* 19.3 ± 19.0* 0.0 ± 0.0* 15.3 ± 8.2* 38.6 ± 3.5* 14.7 ± 13.3* 33.2 ± 4.6* 65.9 ± 34.1 58.6 ± 19.9 
IC50 0.01 0.01 0.15 0.02 0.12 0.15 0.07 0.02 n/d 0.06 
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Values are mean ± SE of at least three independent experiments. Statistical analysis was by ANOVA followed by Dunnett’s test. * Denotes 
significant difference (P<0.05) in cell viability relative to untreated control Jurkat T cells. n/d: IC50 was not determinable for the range of 
concentrations tested. A is unhydrolysed BSG protein. B is BSG protein treated with Shearzyme, Ultraflo Max, Depol 740L, Brewers Clarex and 
Flavourzyme. C is BSG protein treated with Depol 740L, Brewers Clarex and Flavourzyme. D is BSG protein treated with Shearzyme, Ultraflo 
Max, Brewers Clarex and Flavourzyme. E is BSG protein treated with Shearzyme, Ultraflo Max, Depol 740L, Alcalase and Flavourzyme. F is 
BSG protein treated with Depol 740L, Alcalase and Flavourzyme. G is BSG protein treated with Shearzyme, Ultraflo Max, Alcalase and 
Flavourzyme. H is BSG protein treated with Shearzyme, Ultraflo Max, Depol 740L, Alcalase, Brewers Clarex and Flavourzyme. I is BSG 
protein treated with Depol 740L, Alcalase, Brewers Clarex and Flavourzyme. J is BSG protein treated with Shearzyme, Ultraflo Max, Alcalase, 
Brewers Clarex and Flavourzyme.
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Table 3: Effect of BSG protein hydrolysates A-J (0-0.02% (w/v)) on cell viability in RAW 264.7 cells 
Cell proliferation (% of control) 
 
A B C D E F G H I J 
0.0005% 62.4 ± 4.7 74.6 ± 5.5 81.6 ± 6.5 80.2 ± 7.4 81.3 ± 12.1 76.0 ± 18.4 74.5 ± 19.0 97.5 ± 6.0 81.5 ± 12.1 81.9 ± 5.1 
0.001% 59.0 ± 4.0* 80.3 ± 4.8 77.6 ± 4.3 68.7 ± 5.6 85.8 ± 16.2 82.2 ± 14.6 75.1 ± 8.0 80.1 ± 8.8 68.8 ± 9.5 70.2 ± 5.0* 
0.002% 44.5 ± 7.2* 50.1 ± 14.5* 59.3 ± 10.6* 59.2 ± 6.8* 76.3 ± 25.9 65.7 ± 21.7 58.9 ± 14.8* 71.0 ± 9.8* 65.3 ± 6.7 52.8 ± 7.4* 
0.0025% 48.0 ± 1.6* 62.4 ± 3.9* 65.7 ± 5.3* 42.3 ± 11.4* 73.3 ± 21.5 71.8 ± 7.3 63.5 ± 6.5 69.1 ± 4.2* 65.3 ± 4.9 50.5 ± 6.7* 
0.004% 74.6 ± 14.0 56.5 ± 5.3* 47.9 ± 6.5* 53.1 ± 9.3* 78.5 ± 18.3 65.9 ± 6.7 60.4 ± 5.3 49.5 ± 4.6* 62.6 ± 3.5* 40.5 ± 1.6* 
0.006% 47.6 ± 1.4* 48.6 ± 3.4* 55.0 ± 7.8* 50.6 ± 8.1* 74.0 ± 12.6 62.7 ± 8.8 56.6 ± 4.0* 56.9 ± 1.9* 67.7 ± 18.9 48.0 ± 4.4* 
0.008% 72.0 ± 20.2 53.7 ± 9.0* 52.6 ± 6.8* 49.6 ± 7.5* 65.0 ± 18.9 52.1 ± 11.2 49.9 ± 7.8* 50.0 ± 4.6* 61.6 ± 4.8* 48.8 ± 2.9* 
0.01% 52.1 ± 1.4* 47.3 ± 3.6* 43.4 ± 7.1* 49.4 ± 7.2* 68.9 ± 9.9 61.1 ± 0.5 55.7 ± 5.1* 53.2 ± 4.5* 52.0 ± 3.3* 47.1 ± 4.3* 
0.015% 60.0 ± 16.6 40.7 ± 8.4* 43.6 ± 13.5* 41.6 ± 9.0* 56.8 ± 13.5 47.6 ± 11.0* 45.5 ± 10.7* 46.8 ± 7.1* 56.6 ± 5.6* 47.2 ± 6.5* 
0.02% 58.1 ± 8.4* 52.3 ± 3.9* 49.2 ± 5.6* 50.4 ± 7.7* 60.1 ± 3.1 54.9 ± 2.0 56.9 ± 8.8* 49.2 ± 3.2* 51.3 ± 8.7* 28.2 ± 3.4* 
IC50 n/d 0.009 0.009 0.007 0.06 0.02 0.02 0.01 0.03 0.005 
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Values are mean ± SE of at least three independent experiments. Statistical analysis was by ANOVA followed by Dunnett’s test. * Denotes 
significant difference (P<0.05) in cell viability relative to untreated control RAW 264.7 cells. n/d: IC50 was not determinable for the range of 
concentrations tested. A is unhydrolysed BSG protein. B is BSG protein treated with Shearzyme, Ultraflo Max, Depol 740L, Brewers Clarex and 
Flavourzyme. C is BSG protein treated with Depol 740L, Brewers Clarex and Flavourzyme. D is BSG protein treated with Shearzyme, Ultraflo 
Max, Brewers Clarex and Flavourzyme. E is BSG protein treated with Shearzyme, Ultraflo Max, Depol 740L, Alcalase and Flavourzyme. F is 
BSG protein treated with Depol 740L, Alcalase and Flavourzyme. G is BSG protein treated with Shearzyme, Ultraflo Max, Alcalase and 
Flavourzyme. H is BSG protein treated with Shearzyme, Ultraflo Max, Depol 740L, Alcalase, Brewers Clarex and Flavourzyme. I is BSG 
protein treated with Depol 740L, Alcalase, Brewers Clarex and Flavourzyme. J is BSG protein treated with Shearzyme, Ultraflo Max, Alcalase, 
Brewers Clarex and Flavourzyme.
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The effects of BSG protein hydrolysates A-J on RAW 264.7 cell viability were 
assessed in the concentration range of 0-0.02% (w/v) (Table 3). The lower IC50 
values in RAW 264.7 cells, compared with Jurkat T cells, demonstrated the 
greater degree of cytotoxicity of the enzyme-extracted hydrolysates. Hydrolysate J 
was the most cytotoxic extract, showing a significant reduction in cell viability at 
concentrations above 0.0005% (w/v). The least cytotoxic fraction was hydrolysate 
E, with no significant reduction in cell viability across the concentration range 
tested. Following on from these results BSG protein hydrolysates were used at 
0.001% (w/v) (A-J) for immunomodulatory assays in RAW 264.7 cells. 
 
Immunomodulatory potential 
ELISA was used to assess the impact of BSG protein hydrolysates on cytokine 
production in both Jurkat T cells and RAW 264.7 cells (Figures 1-4). 
Hydrolysates A-J were assessed in ConA-stimulated Jurkat T cells at 0.005% 
(w/v). Hydrolysate J significantly reduced ConA-stimulated IL-6 production to 
66.6% of control. ConA-stimulated IFN-γ production in Jurkat T cells decreased 
in the presence of both hydrolysate F and J, however these reductions were not 
significant. In RAW 264.7 cells, LPS was used to stimulate cytokine production. 
Hydrolysates A-J were assessed at a concentration of 0.001% (w/v). Hydrolysates 
H and J (58.4% and 61.4%) significantly reduced IL-6 production in RAW 264.7 
cells. Also of note was the anti-inflammatory effect of the unhydrolysed fraction, 
A, which reduced IL-6 production to 66.1%. LPS-stimulated TNF-α was also 
significantly reduced by extract A to 68.4%. 
 
Antioxidant activity 
BSG protein hydrolysates demonstrating anti-inflammatory activity were then 
selected for analysis for their antioxidant potential in U937 cells using the comet 
assay and in HepG2 cells using the GSH, SOD and CAT assays (Figures 5-8). 
Hydrolysates A, I and J protected against H2O2-induced DNA damage in U937 
cells. None of the hydrolysates assessed had a significant effect on GSH content 
in H2O2-treated HepG2 cells. The SOD activity in H2O2-treated HepG2 cells 
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Figure 1: The effect of enzyme-extracted BSG protein hydrolysates A-J (0.005% 
w/v) on IL-6 production in concanavalin A (ConA)-stimulated Jurkat T cells. 
Values are a mean ± SE of three independent experiments, expressed as a 
percentage relative to cells treated with ConA alone. Statistical analysis by 
ANOVA followed by Tukey’s test. * Denotes statistically significant difference in 
IL-6 production between control and cells treated with protein hydrolysate 
(P<0.05). A is unhydrolysed BSG protein. B is BSG protein treated with 
Shearzyme, Ultraflo Max, Depol 740L, Brewers Clarex and Flavourzyme. C is 
BSG protein treated with Depol 740L, Brewers Clarex and Flavourzyme. D is 
BSG protein treated with Shearzyme, Ultraflo Max, Brewers Clarex and 
Flavourzyme. E is BSG protein treated with Shearzyme, Ultraflo Max, Depol 
740L, Alcalase and Flavourzyme. F is BSG protein treated with Depol 740L, 
Alcalase and Flavourzyme. G is BSG protein treated with Shearzyme, Ultraflo 
Max, Alcalase and Flavourzyme. H is BSG protein treated with Shearzyme, 
Ultraflo Max, Depol 740L, Alcalase, Brewers Clarex and Flavourzyme. I is BSG 
protein treated with Depol 740L, Alcalase, Brewers Clarex and Flavourzyme. J is 
BSG protein treated with Shearzyme, Ultraflo Max, Alcalase, Brewers Clarex and 
Flavourzyme. 
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Figure 2: The effect of enzyme-extracted BSG protein hydrolysates A-J (0.005% 
w/v) on IFN-γ production in concanavalin A (ConA)-stimulated Jurkat T cells. 
Values are a mean ± SE of three independent experiments, expressed as a 
percentage relative to cells treated with ConA alone. Statistical analysis by 
ANOVA followed by Tukey’s test. A is unhydrolysed BSG protein. B is BSG 
protein treated with Shearzyme, Ultraflo Max, Depol 740L, Brewers Clarex and 
Flavourzyme. C is BSG protein treated with Depol 740L, Brewers Clarex and 
Flavourzyme. D is BSG protein treated with Shearzyme, Ultraflo Max, Brewers 
Clarex and Flavourzyme. E is BSG protein treated with Shearzyme, Ultraflo Max, 
Depol 740L, Alcalase and Flavourzyme. F is BSG protein treated with Depol 
740L, Alcalase and Flavourzyme. G is BSG protein treated with Shearzyme, 
Ultraflo Max, Alcalase and Flavourzyme. H is BSG protein treated with 
Shearzyme, Ultraflo Max, Depol 740L, Alcalase, Brewers Clarex and 
Flavourzyme. I is BSG protein treated with Depol 740L, Alcalase, Brewers Clarex 
and Flavourzyme. J is BSG protein treated with Shearzyme, Ultraflo Max, 
Alcalase, Brewers Clarex and Flavourzyme. 
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Figure 3: The effect of enzyme-extracted BSG protein hydrolysates A-J (0.001% 
w/v) on IL-6 production in lipopolysaccharide (LPS)-stimulated RAW 264.7 
cells. Values are a mean ± SE of three independent experiments, expressed as a 
percentage relative to cells treated with LPS alone. Statistical analysis by 
ANOVA followed by Tukey’s test. * Denotes statistically significant difference in 
IL-6 production between control and cells treated with protein hydrolysate 
(P<0.05). A is unhydrolysed BSG protein. B is BSG protein treated with 
Shearzyme, Ultraflo Max, Depol 740L, Brewers Clarex and Flavourzyme. C is 
BSG protein treated with Depol 740L, Brewers Clarex and Flavourzyme. D is 
BSG protein treated with Shearzyme, Ultraflo Max, Brewers Clarex and 
Flavourzyme. E is BSG protein treated with Shearzyme, Ultraflo Max, Depol 
740L, Alcalase and Flavourzyme. F is BSG protein treated with Depol 740L, 
Alcalase and Flavourzyme. G is BSG protein treated with Shearzyme, Ultraflo 
Max, Alcalase and Flavourzyme. H is BSG protein treated with Shearzyme, 
Ultraflo Max, Depol 740L, Alcalase, Brewers Clarex and Flavourzyme. I is BSG 
protein treated with Depol 740L, Alcalase, Brewers Clarex and Flavourzyme. J is 
BSG protein treated with Shearzyme, Ultraflo Max, Alcalase, Brewers Clarex and 
Flavourzyme. 
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Figure 4: The effect of enzyme-extracted BSG protein hydrolysates A-J (0.001% 
w/v) on TNF-α production in lipopolysaccharide (LPS)-stimulated RAW 264.7 
cells. Values are a mean ± SE of three independent experiments, expressed as a 
percentage relative to cells treated with LPS alone. Statistical analysis by 
ANOVA followed by Tukey’s test. * Denotes statistically significant difference in 
TNF-α production between control and cells treated with protein hydrolysate 
(P<0.05). A is unhydrolysed BSG protein. B is BSG protein treated with 
Shearzyme, Ultraflo Max, Depol 740L, Brewers Clarex and Flavourzyme. C is 
BSG protein treated with Depol 740L, Brewers Clarex and Flavourzyme. D is 
BSG protein treated with Shearzyme, Ultraflo Max, Brewers Clarex and 
Flavourzyme. E is BSG protein treated with Shearzyme, Ultraflo Max, Depol 
740L, Alcalase and Flavourzyme. F is BSG protein treated with Depol 740L, 
Alcalase and Flavourzyme. G is BSG protein treated with Shearzyme, Ultraflo 
Max, Alcalase and Flavourzyme. H is BSG protein treated with Shearzyme, 
Ultraflo Max, Depol 740L, Alcalase, Brewers Clarex and Flavourzyme. I is BSG 
protein treated with Depol 740L, Alcalase, Brewers Clarex and Flavourzyme. J is 
BSG protein treated with Shearzyme, Ultraflo Max, Alcalase, Brewers Clarex and 
Flavourzyme. 
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Figure 5: DNA damage in U937 cells treated with 75 μM H₂O₂ for 30 minutes 
following 24 hour incubation with BSG protein hydrolysates (0.2% w/v) or ferulic 
acid (1 μg mL-1). Values are mean ± SE of at least three independent experiments. 
Statistical analysis was by ANOVA followed by Dunnett’s test. * Denotes 
significant difference (P<0.05) in DNA damage relative to H₂O₂ control. A is 
unhydrolysed BSG protein. H is BSG protein treated with Shearzyme, Ultraflo 
Max, Depol 740L, Alcalase, Brewers Clarex and Flavourzyme. I is BSG protein 
treated with Depol 740L, Alcalase, Brewers Clarex and Flavourzyme. J is BSG 
protein treated with Shearzyme, Ultraflo Max, Alcalase, Brewers Clarex and 
Flavourzyme. 
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Figure 6: Antioxidant potential of BSG protein hydrolysates (0.08% w/v), 
measured by their ability to protect against oxidative stress induced by H2O2 in 
the HepG2 cell line, using the glutathione (GSH) assay. Values represent the 
mean ± SE of at least three independent experiments. Statistical analysis by 
ANOVA followed by Dunnett’s test. * Statistically significant difference in GSH 
content between control and H2O2 control (P<0.05). A is unhydrolysed BSG 
protein. H is BSG protein treated with Shearzyme, Ultraflo Max, Depol 740L, 
Alcalase, Brewers Clarex and Flavourzyme. I is BSG protein treated with Depol 
740L, Alcalase, Brewers Clarex and Flavourzyme. J is BSG protein treated with 
Shearzyme, Ultraflo Max, Alcalase, Brewers Clarex and Flavourzyme. 
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Figure 7: Antioxidant potential of BSG protein hydrolysates (0.08% w/v), 
measured by their ability to protect against oxidative stress induced by H2O2 in 
the HepG2 cell line, using the superoxide dismutase (SOD) assay. Values 
represent the mean ± SE of at least three independent experiments. Statistical 
analysis by ANOVA followed by Dunnett’s test. * Statistically significant 
difference in SOD activity between control and H2O2 control (P<0.05). 
# 
Statistically significant difference in SOD activity between sample and H2O2 
control (P<0.05). A is unhydrolysed BSG protein. H is BSG protein treated with 
Shearzyme, Ultraflo Max, Depol 740L, Alcalase, Brewers Clarex and 
Flavourzyme. I is BSG protein treated with Depol 740L, Alcalase, Brewers Clarex 
and Flavourzyme. J is BSG protein treated with Shearzyme, Ultraflo Max, 
Alcalase, Brewers Clarex and Flavourzyme. 
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Figure 8: Antioxidant potential of BSG protein extracts (0.08% w/v), measured 
by their ability to protect against oxidative stress induced by H2O2 in the HepG2 
cell line, using the catalase (CAT) assay. Values represent the mean ± SE of at 
least three independent experiments. Statistical analysis by ANOVA followed by 
Dunnett’s test. * Statistically significant difference in CAT activity between 
control and H2O2 control (P<0.05). 
# 
Statistically significant difference in CAT 
activity between sample and H2O2 control (P<0.05). A is unhydrolysed BSG 
protein. H is BSG protein treated with Shearzyme, Ultraflo Max, Depol 740L, 
Alcalase, Brewers Clarex and Flavourzyme. I is BSG protein treated with Depol 
740L, Alcalase, Brewers Clarex and Flavourzyme. J is BSG protein treated with 
Shearzyme, Ultraflo Max, Alcalase, Brewers Clarex and Flavourzyme.
* 
# 
# 
0
20
40
60
80
100
120
140
Control H₂O₂ A H I J
C
A
T
 a
ct
iv
it
y
 (
%
 o
f 
co
n
tr
o
l)
 
137 
 
was significantly increased when cells were incubated with all BSG protein 
hydrolysates, including the unhydrolysed fraction, A. Hydrolysate J also exhibited 
an ability to protect against H2O2-induced oxidative stress in HepG2 cells by 
significantly increasing CAT activity. The unhydrolysed fraction, A also 
demonstrated cellular antioxidant ability by significantly increasing CAT activity. 
 
Discussion 
Research has been conducted on milk proteins as a source of bioactive peptides. 
However, animal and plant-derived proteins have also shown promise as sources 
of bioactive peptides (Santiago-Lopez et al., 2016). In particular, BSG, a co-
product of the brewing industry, has been identified as a source of bioactive 
peptides. The protein content of BSG is approximately 20% per dry weight basis 
(Lynch et al., 2016). Protein hydrolysates generated from BSG, using an alkaline 
extraction protocol, have demonstrated anti-inflammatory and antioxidant effects 
in cell culture models (McCarthy et al., 2013a; McCarthy et al., 2013b). 
Enzymatic hydrolysis is an efficient method used for the production of bioactive 
peptides (Saadi et al., 2015). Commercial enzymes such as Alcalase and 
Flavourzyme have been commonly used for protein hydrolysis (Vieri et al., 2017). 
However, owing to the hemicellulose nature of BSG, enzymes such as xylanase 
and feruloyl esterases are often required to breakdown this fibrous fraction (Lynch 
et al., 2016). The rigid structure of this material can affect enzyme activity and 
therefore physical pre-treatment (e.g. shearing) or chemical pre-treatment is often 
required to allow the polysaccharide structure more open to enzymatic hydrolysis 
(Lynch et al., 2016). The milder conditions used with enzyme hydrolysis means 
that less damage occurs to the protein substrate, making it a suitable method for 
the generation of food-grade protein hydrolysates (Power et al., 2013). The 
purpose of this research was to assess the anti-inflammatory and antioxidant 
effects of BSG protein hydrolysates using an enzyme extraction method. 
Nine protein hydrolysates (B-J) were produced from a BSG protein-rich isolate 
(A), using a combination of carbohydrase (Shearzyme, Ultraflo Max and Depol 
740L) and proteinase (Alcalase, Brewers Clarex and Flavourzyme) enzymes. The
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protein-rich isolate and associated hydrolysates were assessed with regard to their 
effects on Jurkat T cell and RAW 264.7 cell viability, cytokine production in 
Jurkat T cells and RAW 264.7 cells, DNA-protective effects in U937 cells and 
cellular antioxidant content/enzyme activity in HepG2 cells. 
The MTT assay was used to assess cell viability. The assay is a sensitive and 
cost-effective assay allowing for the high throughput screening of substances that 
can be carried out in multi-well plates (Cheli and Baldi, 2011). Cell viability can 
be assessed by exposing cells to a compound of interest, followed by the addition 
of the MTT (3-(4, 5-dimethylthiazoyl-2-yl)-2, 5- diphenyltetrazolium bromide) 
substrate. The formation of a formazan product allows for the measure of the 
number of viable cells and the effect on viability can be quantified in terms of 
differences in the optical density between treated versus untreated cells (Maestri et 
al., 2016). The BSG samples (A-J) were assessed in Jurkat T cells at 
concentrations between 0-0.2% (w/v) and in RAW 264.7 cells at concentrations 
between 0-0.02% (w/v). In Jurkat T cells, samples A and B demonstrated the 
greatest degree of cytotoxicity, reducing cell viability to 0% of untreated, control 
cells, at concentrations above 0.025% (w/v) and 0.04% (w/v) respectively (Table 
2). Previously, unhydrolysed BSG protein had demonstrated dose-dependent 
cytotoxic effects in the U937 cell line (McCarthy et al., 2013a; McCarthy et al., 
2013b). The use of the carbohydrase Depol 740L alone to produce hydrolysates C, 
F and I, demonstrated the least cytotoxic effect as evidenced by the IC50 values of 
these hydrolysates. In RAW 264.7 cells, IC50 values were lower indicating that 
this cell line is more sensitive to the BSG hydrolysates, than Jurkat T cells.  
Bioactive compounds often demonstrate an affinity and a specificity for a 
given receptor typically found in cell membranes, the cytosol or within the 
nucleus (Serrano et al., 2015). Cell culture models can be developed accordingly, 
allowing for the identification of specific cell subtypes and specific 
pathophysiological conditions necessary for the bioactive to take effect. This is an 
important assessment parameter in functional food development (Serrano et al., 
2015). The immunomodulatory activities of peptides can be assessed by assays 
measuring the production of cytokines and inflammatory mediators, which are 
released early in the immune response. Quantifying these signalling molecules 
can demonstrate the immunostimulatory or immunosuppressive effects of 
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peptides, firstly, by exposing cells or animals to inflammatory stimuli, treating 
with peptides and determining the inflammatory response (Maestri et al., 2016). 
Regarding anti-inflammatory activity of bioactive peptides, the modulation of 
transcription factors, kinases (NF-κB and MAPK) and/or cytosolic compounds are 
thought to be the primary mechanisms of action (Cicero et al., 2017). In the 
present study, the anti-inflammatory effects of BSG samples were evaluated in 
ConA-stimulated Jurkat T cells and LPS-stimulated RAW 264.7 cells. In Jurkat T 
cells, the BSG hydrolysate J, produced using the carbohydrase combination of 
Shearzyme and Ultraflo Max and the protease combination of Alcalase, Brewers’ 
Clarex and Flavourzyme, significantly reduced ConA-stimulated IL-6 production 
(Figure 1). Alcalase is a protease from Bacillus licheniformis, which has proven to 
be a very effective with BSG protein solubilisation (Lynch et al., 2016). Alkaline-
extracted BSG protein hydrolysates produced using Alcalase and Flavourzyme 
have previously demonstrated an ability to reduce ConA-induced IFN-γ 
production in Jurkat T cells (McCarthy et al., 2013a; McCarthy et al., 2013b). 
Enzyme-extracted BSG samples did not significantly impact on ConA-induced 
IFN-γ production in Jurkat T cells. Hydrolysates produced using Alcalase, 
Brewers Clarex and Flavourzyme did demonstrate further anti-inflammatory 
activity, reducing LPS-stimulated IL-6 production in RAW 264.7 cells (Figure 3). 
Hydrolysates H and J significantly reduced IL-6 production to 58.4% and 61.4% 
of the LPS control, respectively. Shearzyme, Ultraflo Max and Depol 740L were 
the carbohydrases used to produce hydrolysate H. Interestingly, the unhydrolysed 
fraction A exhibited anti-inflammatory effects in RAW 264.7 cells, significantly 
decreasing LPS-stimulated IL-6 and TNF-α production in RAW 264.7 cells. 
McCarthy et al. (2013a; 2013b) previously showed that unhydrolysed BSG 
protein isolates demonstrated an ability to decrease ConA-stimulated IFN-γ 
production in Jurkat T cells. This suggests that other BSG components may be 
responsible for the anti-inflammatory activity. However, the individual 
components of the peptide-rich fractions need to be characterised to find out their 
mechanisms of action including the specific receptors and signalling pathways 
involved (Cicero et al., 2017). This can help clarify the specific amino acid 
sequences providing bioactive effects.  
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Following on from the assessment of the anti-inflammatory activity of BSG 
protein samples, the cellular antioxidant potential of selected samples was 
ascertained. The unhydrolysed fraction, A and the hydrolysates produced using 
Alcalase, Brewers Clarex and Flavourzyme (H-J), were assessed in U937 cells 
using the comet assay and in HepG2 cells using the GSH, SOD and CAT assays. 
This approach was recently used to evaluate the antioxidant potential of phenolic 
compounds from BSG (Crowley et al., 2017). Antioxidants can perform at the cell 
membrane, disrupting peroxyl radical chain reactions, or can react intracellularly 
with ROS following cellular uptake (Cheli and Baldi, 2011). There is growing 
evidence from in vitro studies of the antioxidant activity of peptides derived from 
food protein hydrolysates (Power et al., 2013). Biomarkers such as cellular 
antioxidant enzymes and nonenzymatic antioxidants may offer a greater 
understanding of the specific mechanisms involved in the biological activity of 
food-derived antioxidant compounds (Cheli and Baldi, 2011). The protective 
effects of the hydrolysates against oxidant-induced DNA damage was assessed in 
U937 cells using the comet assay. The protein-rich isolate A and the associated 
hydrolysates, I and J, demonstrated antioxidant effects, protecting U937 cells 
against H2O2-induced DNA damage (Figure 5). McCarthy et al. (2013a; 2013b) 
showed that alkaline-extracted BSG protein hydrolysates generated using Alcalase 
and Flavourzyme protected against H2O2-induced DNA damage in U937 cells. 
Recently published results from Vieri et al. (2017), showed that three <10kDa 
BSG protein hydrolysates prepared from brewers’ spent yeast proteases, Neutrase 
and Alcalase, protected against free-radical induced cytotoxicity in both Caco-2 
and HepG2 cells. The liver is the principal target for absorbed antioxidant 
compounds and is also central to xenobiotic metabolism. Accordingly, studies 
using cultured cells from hepatic origin are widely used to assess the effect of 
dietary compounds (Cheli and Baldi, 2011). Here, the effect of BSG samples on 
the GSH content, SOD and CAT activity of HepG2 cells were also investigated. 
Results showed that all samples had an antioxidant effect protecting against the 
H2O2-induced decrease in SOD activity (Figure 7). The unhydrolysed fraction A 
and associated hydrolysate J, also protected against H2O2-induced decrease in 
CAT activity (Figure 8).  
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BSG has been demonstrated as potential source of bioactive peptides. The 
findings from the present study suggest that use of carbohydrase and proteinase 
enzymes is an effective way of generating hydrolysates with anti-inflammatory 
and antioxidant activity. Enzyme hydrolysis procedures are more specific and use 
milder reaction conditions compared with solvent extraction procedures. The most 
effective enzyme treatment was seen with the carbohydrase combination of 
Shearzyme and Ultraflo Max and proteinase combination of Alcalase, Brewers 
Clarex and Flavourzyme, yielding the BSG hydrolysate J. It is worth noting 
however, that the enzyme extraction procedure did not enhance the bioactivity of 
BSG protein, considering that the unhydrolysed fraction A, demonstrated both 
anti-inflammatory and antioxidant activity. This may indicate that other BSG 
components may be responsible for the noted bioactivity. More research is 
required to fully elucidate the molecular mechanisms involved and the specific 
amino acid sequences that are responsible for the biological activity. There is also 
a need for animal studies and clinical trials to be conducted in order to uncover 
any potentially negative effects associated with bioactive peptides (Santiago-
Lopez et al., 2016). This can lead to the development of more effective functional 
food products targeting specific health issues. 
 
Conclusions 
Both the unhydrolysed fraction and hydrolysate produced using the carbohydrase 
combination of Shearzyme and Ultraflo Max and proteinase combination of 
Alcalase, Brewers Clarex and Flavourzyme, demonstrated anti-inflammatory and 
antioxidant activity. The former suggests that other components present in the 
BSG may be responsible for the demonstrated bioactivity. 
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Chapter 6 
Comparison of alkaline and direct enzyme extraction procedures 
on the generation of brewers’ spent grain (BSG) protein 
hydrolysates with anti-inflammatory and antioxidant potential. 
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Abstract 
Brewers’ spent grain (BSG), a cereal grain by-product, is the residual solid 
fraction left over from brewing, comprising of the husk-pericarp-seed coat 
portions of the original barley grain. It has been reported to be a potential source 
of bioactive protein hydrolysates. The cytotoxicity, anti-inflammatory activity and 
antioxidant potential of BSG protein hydrolysates generated using different 
extraction procedures were assessed. The extraction methods included alkaline-
extraction, a direct enzymatic hydrolysis procedure, alkaline-extracted 
hydrolysates subjected to simulated gastrointestinal digestion (SGID) and 
alkaline-extracted hydrolysates prepared using ultrafiltration. The cytotoxicity of 
BSG protein hydrolysates was determined using the (3-(4, 5-Dimethylthiazol-2-
yl)-2, 5-diphenyltetrazolium bromide (MTT) assay. The anti-inflammatory 
activity of the hydrolysates was assessed in lipopolysaccharide (LPS)-stimulated 
RAW 264.7 cells. The impact of the hydrolysates on the glutathione (GSH) 
content, superoxide dismutase (SOD) and catalase (CAT) activity in hydrogen 
peroxide (H2O2)-treated HepG2 cells was also assessed. Alkaline-extracted BSG 
protein hydrolysates produced using Prolyve 1000/Protease P and Corolase 
PP/Flavourzyme, as well as a 10kDa permeate produced using 
Alcalase/Flavourzyme were effective in reducing LPS-stimulated IL-6 secretion 
in RAW 264.7 cells. These same protein hydrolysates also displayed antioxidant 
effects, protecting against H2O2-induced decrease in glutathione (GSH) content 
and H2O2-generated decrease in catalase (CAT) activity. All other hydrolysates 
were not active in any of the bioassays assessed. 
 
Introduction 
Cereal grains are considered a staple food in the human diet, contributing an 
important source of energy. Cereal grains are high in carbohydrates but also 
contain considerable amounts of protein (Cavazos and Gonzalez de Mejia, 2013). 
Between 10-15% of the dry grain of cereals constitutes protein (Gangopadhyay et 
al., 2015). Bioactive peptides from cereal grain proteins including from wheat and 
barley have been reported to display anticancer, antioxidant, antithrombotic, 
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ACE-inhibitor, DPP-IV inhibitor, and PEP-inhibitor activities (Cavazos and 
Gonzalez de Mejia, 2013).  
Brewers’ spent grain (BSG) is an example of a cereal grain by-product and is 
the residual solid fraction left over from brewing, comprising of the husk-
pericarp-seed coat portions of the original barley grain (Mussato et al., 2006). It 
has been reported to be a source of bioactive protein hydrolysates (McCarthy et 
al., 2013a; McCarthy et al., 2013b). A hydrolysate is described as a mixture 
consisting of peptides and amino acids generated through enzyme, acid or alkali 
treatment or fermentation of the protein (Sarmadi and Ismail, 2010).  
Enzyme hydrolysis is a more favourable technique for production of food-
grade protein hydrolysates as it utilises milder conditions, resulting in less damage 
to the protein substrate (Power et al., 2013). Most reported biologically active 
peptides are generated using in vitro enzymatic hydrolysis or fermentation 
(Udenigwe and Aluko, 2012). The simulated gastrointestinal digestion (SGID) 
procedure mimics the physiological digestion of proteins and allows the 
assessment of the potential release of biologically active peptides (Udenigwe and 
Aluko, 2012). Ultrafiltration is a membrane fractionation procedure, involving the 
separation of proteins/peptides based on molecular weight differences (Power et 
al., 2013). Essentially, a number of factors can impact on the biological activity of 
peptides including the hydrolytic enzymes employed, processing conditions and 
peptide size (Udenigwe and Aluko, 2012). 
The primary aim of the research was to compare an alkaline extraction method 
with a direct enzyme extraction procedure, with regard to the generation of BSG 
protein hydrolysates with anti-inflammatory and antioxidant potential. In addition, 
the alkaline-extracted BSG protein hydrolysates were subjected to SGID and 
additionally, alkaline-extracted BSG protein hydrolysates were fractionated using 
ultrafiltration and all samples were assessed for anti-inflammatory potential.  
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Materials and Methods 
Materials 
BSG was obtained from a single batch which was brewed in November 2009, 
vacuum-packed and stored at -20
o
C in polypropylene bags until use. Alcalase 
2.4L and Flavourzyme
® 
500L were purchased from Sigma Chemical Co. (Dorset, 
UK), Corolase
® 
PP was supplied by AB Enzymes (Darmstadt, Germany) and 
Prolyve 1000 (Pro1k) was kindly provided by Lyven Enzymes Industrielles 
(Caen, France). RAW 264.7 murine macrophages and HepG2 cells were obtained 
from the European Collection of Animal Cell Cultures (ECACC, Salisbury, UK). 
All other chemicals were purchased from Sigma, unless otherwise stated. 
 
Generation of the alkaline-extracted hydrolysates 
The alkaline extracted hydrolysates (44% w/w protein) were prepared as 
previously described (Connolly et al., 2013). The samples was then subjected to 
hydrolysis using combinations of Alcalase (Alc), Corolase PP (CorPP), 
Flavourzyme (Flav), Prolyve 1000 (Pro) and/or Protease P (Pro) producing the 
hydrolysates AlcFla, AlcPro, CorPPFla, and ProPro. Alkaline-extracted BSG 
protein hydrolysates were labelled A1-A4 (Table 1).  
 
Simulated gastrointestinal digestion (SGID) of alkaline-extracted hydrolysates 
SGID of BSG alkaline-extracted hydrolysates was performed according to Walsh 
et al. (2004). Briefly, samples were incubated for 90 min at 37
o
C, pH 2.0 with 
pepsin at an E:S of 2.5% (w/w) and then at pH 7.5 with Corolase PP at an E:S of 
1.0% (w/w) for a further 150 min. Enzyme inactivation was performed by heating 
at 80
o
C for 20 minutes and the samples were subsequently freeze-dried and stored 
at -20
o
C. SGID-treated alkaline extracted BSG protein hydrolysates were labelled 
S1-S4 (Table 1).  
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Table 1: Summary of methods used to prepare brewers’ spent grain (BSG) 
protein hydrolysates A1-E4. 
Sample Hydrolysis method Protease enzymes 
A1 Alkaline hydrolysis Prolyve 1000, Protease P 
S1 Alkaline hydrolysis  followed by SGID Prolyve 1000, Protease P 
E1 Direct enzyme hydrolysis Prolyve 1000, Protease P 
A2 Alkaline hydrolysis Corolase PP, Flavourzyme 
S2 Alkaline hydrolysis  followed by SGID Corolase PP, Flavourzyme 
E2 Direct enzyme hydrolysis Corolase PP, Flavourzyme 
A3 Alkaline hydrolysis Alcalase, Protease P 
S3 Alkaline hydrolysis  followed by SGID Alcalase, Protease P 
E3 Direct enzyme hydrolysis Alcalase, Protease P 
A4 Alkaline hydrolysis Alcalase, Flavourzyme 
S4 Alkaline hydrolysis  followed by SGID Alcalase, Flavourzyme 
E4 Direct enzyme hydrolysis Alcalase, Flavourzyme 
The alkaline extracted extracts were obtained as previously described (Connolly et 
al., 2013). SGID of alkaline-extracted hydrolysates was carried out according to 
Walsh et al. (2004). Enzyme-extracted hydrolysates were generated as outlined in 
methodology. Extracts were then hydrolysed using combinations of Alcalase, 
Corolase PP, Flavourzyme, Prolyve 1000 and/or Protease P. 
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Generation of the enzyme-extracted hydrolysates 
The enzyme-extracted hydrolysates were prepared by shearing BSG in distilled 
H2O (1:10) at 24,000 rpm for 2 minutes using an Ultra Turrax
®
T25 high-
performance disperser (IKA
®
 Werke GmbH & Co. KG, Staufen, Germany). The 
BSG suspension was then incubated with carbohydrases: Shearzyme 500 L and 
Ultraflo Max for 4 h at 50°C. Samples were centrifuged at 2,700 g for 20 minutes 
at 10°C (Hettich Zentrifugen Universal 320R centrifuge, Andreas Heittich GmbH 
& Co., Tuttlingen, Germany) and the resulting supernatant (phenolic-enriched 
extract) being retained and stored at -20°C prior to analysis. The remaining 
sediment was incubated at 50°C for 4 h with proteases (Alcalase (Alc), Corolase 
PP (CorPP), Flavourzyme (Flav), Prolyve 1000 (Pro) and/or Protease P (Pro)) 
producing the hydrolysates AlcFla, AlcPro, CorPPFla, and ProPro. Sediment was 
then filtered and washed with deionised water at 50°C for 30 minutes. The fibre-
enriched sediment was collected and stored at -20°C, while the remaining 
supernatant were labelled E1-E4, freeze-dried and stored at -20°C until further 
analysis (Table 1).  
 
Membrane fractionation of alkaline-extracted hydrolysates 
Hydrolysates were fractionated using Minimate™ Tangential Flow Filtration 
Capsules (Pall Corporation, Port Washington, New York, USA). Fractionation 
was performed using membranes with 30 and 10 kDa nominal molecular mass 
cut-off values. The three subsequent fractions (30 and 10 kDa permeates and 30 
kDa retentate) were freeze-dried and stored at -20
o
C. Fractionated BSG protein 
hydrolysates were labelled U1-U6 (Table 2).  
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Table 2: Summary of methods used to prepare brewers’ spent grain (BSG) 
protein hydrolysates U1-U6. 
Sample Description Protease enzymes 
U1 30kDa Retentate Corolase PP, Flavourzyme 
U2 30kDa Retentate Alcalase, Flavourzyme 
U3 30kDa Permeate Corolase PP, Flavourzyme 
U4 30kDa Permeate Alcalase, Flavourzyme 
U5 10kDa Permeate Corolase PP, Flavourzyme 
U6 10kDa Permeate Alcalase, Flavourzyme 
Extracts were generated using an alkaline hydrolysis method as previously 
described (Connolly et al., 2013). Extracts were then hydrolysed using 
combinations of Alcalase, Corolase PP and/or Flavourzyme. Fractionation was 
performed using membranes with 30 and 10 kDa nominal molecular mass cut-off 
values. 
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Cell culture 
RAW 264.7 cells, a murine macrophage cell line, were grown in Dulbecco’s 
Modified Eagle Medium (DMEM) media supplemented with 10% FBS. Cells 
were seeded at a density of 0.2 x 10
5
 cells mL
-1
 for cell viability and ELISA 
assays. HepG2 cells, a human liver carcinoma cell line, were maintained in 
DMEM supplemented with 10% FBS and plated at a density of 2 x 10⁵ cells mL-1 
for cellular antioxidant assays. Cells were maintained at 37°C in a 5% CO2 
atmosphere. Reduced serum media (2.5% FBS) was used for all experiments. 
 
Cell Viability 
The (3-(4, 5-Dimethylthiazol-2-yl)-2, 5-diphenyltetrazolium bromide (MTT) 
assay was used to measure the effect of the extracts on cell viability in RAW 
264.7 cells.  Cells were incubated for 24 h at 37°C with BSG protein hydrolysates 
at concentrations of 0 to 0.02% (w/v). The MTT assay kit (MTT I proliferation 
kit, Roche Diagnostics, West Sussex, UK) was then used to measure cell viability. 
Absorbance was determined at 570 nm using a microplate reader 
(VarioskanFlash, Thermo Scientific, Waltham, MA) and cell viability was 
calculated as a percentage of the control, untreated cells. An inhibitory 
concentration-50 (IC50) value, the concentration of a compound that reduces cell 
viability to 50% of the untreated control cells, was determined for each of the 
BSG protein hydrolysates.  
 
Cytokine production 
RAW 264.7 cells were allowed to adhere overnight. Cells were incubated for a 
further 24 h at 37°C with 0.01% (w/v) BSG hydrolysates and 0.1 mg mL
-1
 LPS. 
The production of cytokines interleukin 6 (IL-6) and tumor necrosis factor-alpha 
(TNF-α) was measured by ELISA. Cytokine production was determined using 
eBioscience ELISA kits (Ready-SET-Go kit purchased from eBioscience, 
Hatfield, UK). Absorbance was measured at 450 nm on a microplate reader 
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(VarioskanFlash, Thermo Scientific, Waltham, MA) and cytokine production was 
expressed as percentage of LPS-stimulated RAW 264.7 cells. 
 
Cellular Antioxidant Assays: Glutathione, Superoxide Dismutase and Catalase 
HepG2 cells (2 x 10
5
 cells mL
-1
) were incubated with BSG protein hydrolysates 
(0.08% w/v) for 24 h at 37°C. This concentration was chosen following on from 
preliminary cytotoxicity data, which noted that 0.08% (w/v) was a safe, non-toxic 
hydrolysate concentration to use in HepG2 cells (see Table 9, Chapter 8). 
Following incubation, cells were exposed to 2 mM H2O2 for 120 minutes. Cells 
were harvested, sonicated and centrifuged (800 rpm, 10 minutes) and the 
supernatant was collected for the determination of antioxidant enzyme activity.  
The glutathione (GSH) content of the cells was measured as described 
previously (Hissin and Hilf, 1976). The GSH content was measured in cells as an 
indicator of intracellular non-enzymatic antioxidant defences. Briefly, 100 μL 
supernatant was mixed with sodium phosphate–ethylenediaminetetraacetic acid 
buffer (1.8 mL) and σ-phthaldialdehyde (0.1 mg). The fluorescence intensity of 
the samples was determined (Thermo Scientific Varioskan Flash microplate 
reader) at wavelengths of 360 nm (absorption) and 430 nm (emission). The GSH 
content of the samples was determined from a standard curve (0–2.5 nmol mL−1 
GSH).  
Cellular superoxide dismutase (SOD) activity was measured using the method 
previously described by Misra and Fridovich, (1977). Briefly, the cell supernatant 
was diluted in 0.05 M potassium phosphate buffer (pH 7) and xanthine, xanthine 
oxidase and cytochrome c were added. The xanthine oxidase system generates 
superoxide anion which reduces cytochrome c and this reaction is inhibited by 
SOD. The reduction in cytochrome c was used to determine the activity of SOD 
present in the samples from a standard curve (0-1µg SOD mL
-1
). Samples were 
read at 550 nm at 20 minute intervals for at least 5 readings.  
Catalase (CAT) activity was assessed using a modification of the method of 
Baudhuin et al. (1964). H2O2 was added to the cell supernatants and following 
incubation any remaining H2O2 was determined spectrophotometrically at 465 
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nm. One unit of catalase activity was defined as the amount of catalase required to 
decompose 1 µmol H2O2 per min at pH 7.5 and 25°C. 
GSH content and SOD and CAT activities were quantified relative to the 
protein content as nmol mL
-1
 GSH mg
-1
 protein in cell homogenate and SOD and 
CAT units
 
mg
-1
 protein, respectively. The protein content of the samples was 
quantified by the bicinchoninic acid (BCA) protein assay as previously described 
(Smith et al., 1985). Data were expressed as a percentage of untreated control 
cells. 
 
Statistical Analysis  
All data represent the mean ± standard error (SE) of at least three independent 
experiments. Statistical analysis was done by one-way analysis of variance 
(ANOVA) followed by Dunnett’s test or Tukey’s multiple comparison test as 
analysed using GraphPad Prism 4 (GraphPad software, La Jolla, CA). 
 
Results 
Cell viability  
The BSG protein hydrolysates were assessed at a concentration range of 0-0.02% 
(w/v). The alkaline-extracted BSG protein hydrolysates A2 (CorPPFla) and A4 
(AlcFla) as well as the alkaline-extracted BSG protein hydrolysates subjected to 
SGID, S2 (CorPPFla) demonstrated significant levels of cytotoxicity in RAW 
264.7 cells (Table 3). The incubation of BSG protein hydrolysate A2 led to a 
dose-dependent effect. Amongst the fractionated hydrolysates, only U1 and U2 
showed a significant reduction in cell viability (Table 4). Following on from these 
results BSG protein hydrolysates were used at 0.01% (w/v) for 
immunomodulatory assays in RAW 264.7 cells. 
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Table 3: Effect of BSG protein hydrolysates (0-0.02% (w/v)) on cell viability in RAW 264.7 cells 
Cell proliferation (% of control) 
 A1 S1 E1 A2 S2 E2 A3 S3 E3 A4 S4 E4 
0 99.9 ± 0.0 100.0 ± 0.0 100.0 ± 0.0 99.9 ± 0.0 100.0 ± 0.0 99.9 ± 0.0 100.0 ± 0.0 100.0 ± 0.0 99.9 ± 0.0 100.0 ± 0.0 100.0 ± 0.0 99.9 ± 0.0 
0.0005 78.6 ± 14.5 79.8 ± 14.2 102.2 ± 6.6 77.2 ± 11.1 69.1 ± 2.7* 66.8 ± 10.9 79.0 ± 12.7 74.0 ± 9.8 88.6 ± 1.8 67.0 ± 5.5* 78.5 ± 3.6 86.0 ± 8.9 
0.001 82.2 ± 3.2 80.6 ± 9.8 98.4 ± 7.5 73.0 ± 7.3* 61.8 ± 4.2* 84.7 ± 4.3 76.5 ± 14.8 67.7 ± 10.8 61.4 ± 17.5 59.4 ± 6.7* 73.3 ± 18.3 81.2 ± 11.7 
0.002 87.6 ± 9.5 71.5 ± 10.2 78.0 ± 7.8 68.8 ± 6.4* 77.2 ± 9.0 75.1 ± 7.4 72.5 ± 12.3 78.0 ± 18.8 78.3 ± 14.5 58.9 ± 8.0* 66.6 ± 8.3 70.5 ± 12.3 
0.0025 78.0 ± 5.9 78.4 ± 9.4 86.5 ± 16.9 64.5 ± 1.9* 66.0 ± 9.0* 82.7 ± 15.7 70.1 ± 12.9 79.6 ± 18.6 85.4 ± 17.5 57.7 ± 5.7* 81.2 ± 25.7 75.2 ± 14.6 
0.004 82.8 ± 5.7 87.3 ± 11.1 68.0 ± 6.2 68.1 ± 6.9* 83.5 ± 8.4 70.9 ± 11.5 83.7 ± 18.6 87.4 ± 20.4 72.7 ± 9.0 68.4 ± 11.8* 74.9 ± 11.4 72.8 ± 12.1 
0.006 82.2 ± 4.4 85.9 ± 7.4 65.6 ± 16.0 68.9 ± 4.8* 76.7 ± 1.1 74.1 ± 15.0 77.2 ± 13.3 81.6 ± 15.4 72.1 ± 6.4 67.9 ± 8.8* 74.5 ± 18.8 79.3 ± 9.5 
0.008 82.4 ± 4.5 78.9 ± 5.8 64.8 ± 13.0 75.7 ± 4.4 76.4 ± 6.5 76.8 ± 14.7 83.2 ± 12.7 80.2 ± 16.5 75.9 ± 9.7 71.0 ± 5.8* 67.2 ± 14.1 81.9 ± 10.8 
0.01 81.1 ± 6.9 85.8 ± 7.2 74.5 ± 18.7 68.4 ± 6.0* 72.1 ± 1.7* 81.9 ± 18.5 80.9 ± 11.3 69.9 ± 13.6 74.6 ± 9.4 70.4 ± 4.9* 68.1 ± 17.0 80.8 ± 10.2 
0.015 83.3 ± 8.3 78.2 ± 2.3 68.3 ± 18.3 71.6 ± 6.1* 72.6 ± 5.5* 76.0 ± 13.0 83.8 ± 15.6 69.1 ± 11.7 76.0 ± 11.0 64.5± 6.6* 64.2 ± 17.1 80.4 ± 12.4 
0.02 78.6 ± 8.5 79.0 ± 5.5 65. 1± 17.6 60.7 ± 3.2* 72.6 ± 6.9* 72.6 ± 16.2 69.0 ± 10.7 64.7 ± 11.8 69.0 ± 12.7 61.0 ± 5.9* 60.0 ± 16.0 79.4 ± 15.3 
IC50 n/d n/d 0.04 n/d n/d n/d n/d n/d n/d n/d 0.32 n/d 
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Values are mean ± SE of at least three independent experiments. Statistical analysis was by ANOVA followed by Dunnett’s test. * Denotes 
significant difference (P<0.05) in cell viability relative to untreated control RAW 264.7 cells. A1 is a BSG protein hydrolysate prepared via 
alkaline hydrolysis and subjected to further hydrolysis by ProPro. S1 is A1 subjected to SGID. E1 is prepared via direct enzyme hydrolysis by 
ProPro. A2 is a BSG protein hydrolysate prepared via alkaline hydrolysis and subjected to further hydrolysis by CorPPFla. S2 is A2 subjected to 
SGID. E2 is prepared via direct enzyme hydrolysis by CorPPFla. A3 is a BSG protein hydrolysate prepared via alkaline hydrolysis and subjected 
to further hydrolysis by AlcPro. S3 is A3 subjected to SGID. E3 is prepared via direct enzyme hydrolysis by AlcPro. A4 is a BSG protein 
hydrolysate prepared via alkaline hydrolysis and subjected to further hydrolysis by AlcFla. S4 is A4 subjected to SGID. E4 is prepared via direct 
enzyme hydrolysis by AlcFla.
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Table 4: Effect of BSG protein hydrolysates (0-0.02% (w/v)) on cell viability in RAW 264.7 cells 
Cell proliferation (% of control) 
 U1 U2 U3 U4 U5 U6 
0 99.9 ± 0.0 99.9 ± 0.0 100.0 ± 0.0 100.0 ± 0.0 99.9 ± 0.0 99.9 ± 0.0 
0.0005 92.6 ± 6.3 92.7 ± 5.4 110.6 ± 10.4 99.0 ± 5.9 84.0 ± 3.5 77.5 ± 6.9 
0.001 73.3 ± 4.7* 79.8 ± 4.5 100.6 ± 3.0 102.4 ± 6.4 84.8 ± 2.5 89.3 ± 4.8 
0.002 73.4 ± 1.5* 69.7 ± 7.4* 87.9 ± 5.2 101.8 ± 6.5 89.1 ± 5.3 81.4 ± 0.7 
0.0025 76.4 ± 3.5* 77.8 ± 4.4 94.1 ± 3.8 99.4 ± 4.5 75.5 ± 7.2 85.0 ± 6.9 
0.004 76.4 ± 6.0* 75.7 ± 2.8 93.8 ± 7.9 93.6 ± 9.7 84.7 ± 13.8 84.5 ± 14.4 
0.006 83.1 ± 5.2 83.2 ± 5.1 107.4 ± 8.9 105.8 ± 17.2 93.4 ± 29.9 89.7 ± 15.6 
0.008 77.5 ± 3.1 83.3 ± 2.6 97.5 ± 9.2 116.9 ± 21.4 101.8 ± 34.5 101.6 ± 27.2 
0.01 82.1 ± 1.5 81.1 ± 3.8 104.4 ± 7.9 129.8 ± 28.0 55.1 ± 15.5 65.7 ± 12.5 
0.015 82.3 ± 3.7 85.9 ± 0.6 95.4 ± 8.1 87.5 ± 28.1 42.1 ± 18.0 49.0 ± 19.9 
0.02 77.1 ± 12.9* 75.0 ± 16.2 91.7 ± 13.3 82.7 ± 31.5 59.6 ± 28.2 73.1 ± 35.6 
IC50 n/d n/d 0.03 n/d 0.03 n/d 
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Values are mean ± SE of at least three independent experiments. Statistical analysis was by ANOVA followed by Dunnett’s test. * Denotes 
significant difference (P<0.05) in cell viability relative to untreated control RAW 264.7 cells. n/d: IC50 was not determinable for the range of 
concentrations tested. U1 is a 30kDa Retentate prepared via alkaline hydrolysis and subjected to further hydrolysis by CorPPFla. U2 is a 30kDa 
Retentate prepared via alkaline hydrolysis and subjected to further hydrolysis by AlcFla. U3 is a 30kDa Permeate prepared via alkaline 
hydrolysis and subjected to further hydrolysis by CorPPFla. U4 is a 30kDa Permeate prepared via alkaline hydrolysis and subjected to further 
hydrolysis by AlcFla. U5 is a 10kDa Permeate prepared via alkaline hydrolysis and subjected to further hydrolysis by CorPPFla. U6 is a 10kDa 
Permeate prepared via alkaline hydrolysis and subjected to further hydrolysis by AlcFla. 
158 
 
Immunomodulatory potential 
ELISA was used to assess the impact of BSG protein hydrolysates on cytokine 
production in RAW 264.7 cells (Figures 1-2). LPS was used to stimulate cytokine 
production. All hydrolysates were evaluated at 0.01% (w/v). Alkaline-extracted 
hydrolysates A1 and A2 produced using ProPro and CorPPFla respectively, 
significantly reduced LPS-stimulated IL-6 production in RAW 264.7 cells. The 
10kDa permeate, U6, produced using a combination of Alcalase and 
Flavourzyme, also displayed significant anti-inflammatory activity, reducing LPS-
stimulated IL-6 production. These hydrolysates also displayed an ability to reduce 
LPS-stimulated TNF-α production, although this was not statistically significant. 
 
Antioxidant activity 
BSG protein hydrolysates demonstrating anti-inflammatory activity were then 
selected for analysis for their antioxidant potential in HepG2 cells using the GSH, 
SOD and CAT assays (Figures 3-5). All BSG protein hydrolysates protected 
against the H2O2-induced decrease in GSH content. None of the hydrolysates 
assessed had a significant effect on SOD activity in H2O2-treated HepG2 cells. 
The fractionated hydrolysate, U6, significantly restored CAT activity following an 
oxidative challenge. 
 
Discussion 
Including protein hydrolysates in the development of foods has become 
increasingly popular in the food industry (Saadi et al., 2015). Bioactive peptides 
present in cereals add to their food protein quality value and increase 
“functionality” of the food as part of the diet (Malaguti et al., 2014). Although not 
as effective as synthetic peptidomimetics and drugs against molecular targets of 
disease, food-derived peptides are useful owing to their safety, low cost and their 
advantage of being a source of beneficial and essential amino acids (Udenigwe 
and Aluko, 2012).
159 
 
 
Figure 1: The effect of BSG protein hydrolysates (0.01% w/v) on IL-6 production in lipopolysaccharide (LPS)-stimulated RAW 264.7 cells. 
A1-A4 are alkaline-extracted hydrolysates, S1-S4 are alkaline-extracted hydrolysates subjected to SGID, E1-E4 are hydrolysates produced using 
direct enzyme hydrolysis, U1-U6 are alkaline-extracted hydrolysates produced using ultrafiltration. Values are a mean ± SE of three independent 
experiments, expressed as a percentage relative to cells treated with LPS alone. Statistical analysis by ANOVA followed by Tukey’s test. * 
Denotes statistically significant difference in IL-6 production between control and cells treated with protein hydrolysate (P<0.05).
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Figure 2: The effect of BSG protein hydrolysates (0.01% w/v) on TNF-α production in lipopolysaccharide (LPS)-stimulated RAW 264.7 cells. 
A1-A4 are alkaline-extracted hydrolysates, S1-S4 are alkaline-extracted hydrolysates subjected to SGID, E1-E4 are hydrolysates produced using 
direct enzyme hydrolysis, U1-U6 are alkaline-extracted hydrolysates produced using ultrafiltration. Values are a mean ± SE of three independent 
experiments, expressed as a percentage relative to cells treated with LPS alone. Statistical analysis by ANOVA followed by Tukey’s test. 
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Figure 3: Antioxidant potential of BSG protein hydrolysates (0.08% w/v), 
measured by their ability to protect against oxidative stress induced by H2O2 in 
the HepG2 cell line, using the glutathione (GSH) assay. Values represent the 
mean ± SE of at least three independent experiments. Statistical analysis by 
ANOVA followed by Dunnett’s test. * Statistically significant difference in GSH 
content between control and H2O2 control (P<0.05).
 # 
Statistically significant 
difference in CAT activity between sample and H2O2 control (P<0.05). 
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Figure 4: Antioxidant potential of BSG protein hydrolysates (0-0.8% w/v), 
measured by their ability to protect against oxidative stress induced by H2O2 in 
the HepG2 cell line, using the superoxide dismutase (SOD) assay. Values 
represent the mean ± SE of at least three independent experiments. Statistical 
analysis by ANOVA followed by Dunnett’s test. * Statistically significant 
difference in SOD activity between control and H2O2 control (P<0.05). 
# 
Statistically significant difference in SOD activity between sample and H2O2 
control (P<0.05). 
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Figure 5: Antioxidant potential of BSG protein extracts (0.08% w/v), measured 
by their ability to protect against oxidative stress induced by H2O2 in the HepG2 
cell line, using the catalase (CAT) assay. Values represent the mean ± SE of at 
least three independent experiments. Statistical analysis by ANOVA followed by 
Dunnett’s test. * Statistically significant difference in CAT activity between 
control and H2O2 control (P<0.05). 
# 
Statistically significant difference in CAT 
activity between sample and H2O2 control (P<0.05). 
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Different processing techniques such as enzyme hydrolysis, alkaline hydrolysis 
and ultrafiltration have been used to extract the bioactive components of food 
proteins. Optimization of extraction techniques is necessary for the high yield 
production of targeted compounds (Saadi et al., 2015). Enzymatic hydrolysis is a 
more favourable process due to its high yield, efficiency and the ability to easily 
scale it in the laboratory (Saadi et al., 2015). Here combinations of Alcalase, 
Corolase PP, Flavourzyme, Prolyve 1000 and/or Protease P were utilised to 
generate BSG protein hydrolysates AlcFla, AlcPro, CorPPFla and ProPro. The 
cytotoxicity, anti-inflammatory activity and antioxidant potential of hydrolysates 
generated using this direct enzymatic hydrolysis procedure was assessed along 
with hydrolysates produced using an alkaline-extraction method, alkaline-
extracted hydrolysates subjected to SGID and alkaline-extracted hydrolysates 
generated using ultrafiltration. This work builds on previous research which 
assessed the bioactivity of BSG protein hydrolysates generated using an alkaline 
extraction procedure (McCarthy et al., 2013a; McCarthy et al., 2013b). 
The cytotoxicity of BSG protein hydrolysates was measured in RAW 264.7 
cells using the MTT assay. The MTT assay has been widely used to assess 
compound toxicity in a range of different cell lines. The MTT (3-(4,5-
dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide) substrate is added to 
cultured cells and can be incubated for up to 4 hours. Viable cells that are 
metabolically active can convert MTT into a purple-coloured formazan product. 
The amount of formazan can be measured spectrophotometrically measured at 
570nm. Dead cells lose the ability to convert MTT into formazan (Riss et al., 
2013). Here alkaline-extracted BSG protein hydrolysates produced using Corolase 
PP/Flavourzyme (A2) and Alcalase/Flavourzyme (A4), as well as the alkaline-
extracted BSG protein hydrolysate produced using Corolase PP/Flavourzyme and 
subjected to SGID (S2), demonstrated significant cytotoxicity in RAW 264.7 cells 
(Table 3). However, even at the highest concentration of the S2 hydrolysate tested 
(0.02% w/v), cell viability was 72.6% compared to untreated control cells. 
McCarthy et al. (2013a; 2013b) noted that alkaline-extracted BSG protein 
hydrolysates produced using either Corolase PP, Flavourzyme or Alcalase had a 
dose-dependent effect on U937 cell viability. Results presented here showed that
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the IC50 value for some BSG protein hydrolysates could not be determined, 
suggesting that RAW 264.7 cells have a high tolerance to incubation with this set 
of BSG protein hydrolysates (Tables 3-4). Karnjanapratum et al. (2016) found 
that, following the assessment of the antiproliferative effects of gelatin 
hydrolysates from unicorn leatherjacket skin, RAW 264.7 cells demonstrated less 
cytotoxic effects compared with U937 and HepG2 cells. Also, Udenigwe et al. 
(2009) found that low molecular weight flaxseed peptide fractions did not show 
toxic effects when assessed in RAW 264.7 cells. 
A number of different in vitro tests have been used to evaluate the bioactivity 
of various isolated active compounds, with cell culture models being favoured as 
a rapid screening tool. Compared to animal studies and clinical trials, cell culture 
models are easier to manipulate and more reproducible (Saadi et al., 2015). As 
part of this research, the anti-inflammatory activity of BSG protein hydrolysates 
(0.01% w/v) was assessed in LPS-stimulated RAW 264.7 cells. 
Immunomodulation concerns the suppression or stimulation of human immune 
functions (Udenigwe and Aluko, 2012). Cytokines are secreted by different cell 
types with IL-6, IL-1 and TNF-α being produced during inflammatory states. 
These cytokines are often targeted for the purpose of therapeutic intervention 
(Scheller et al., 2011). IL-6 is known as being an independent risk factor for 
coronary artery disease (Kleemann et al., 2008). Results presented here showed 
that in LPS-stimulated RAW 264.7 macrophages, a number of hydrolysates 
displayed anti-inflammatory activity. Both macrophages and T-lymphocytes 
generate a multitude of both pro- and anti-inflammatory cytokines (Kleemann et 
al., 2008). Monocytes and macrophages produce TNF-α which displays pro-
inflammatory effects in atherosclerosis and other metabolic and inflammatory 
disorders such as obesity and insulin resistance (Kleemann et al., 2008).  
Figure 1 shows that alkaline-extracted BSG hydrolysates A1 and A2 displayed 
IL-6-reducing potential. These hydrolysates were produced using Prolyve 
1000/Protease P and Corolase PP/Flavourzyme combinations, respectively. Their 
direct enzyme hydrolysis equivalents (E1 and E2), did not have any significant 
impact on LPS-stimulated IL-6 secretion, suggesting that alkaline hydrolysis is a 
more effective method at producing BSG protein hydrolysates with anti-
inflammatory activity. The 10kDa permeate U6 was also effective, reducing IL-6 
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secretion to 58.1% of the LPS control cells. This hydrolysate was generated via 
alkaline hydrolysis using Alcalase/Flavourzyme, followed by ultrafiltration. The 
equivalent BSG protein hydrolysates produced using alkaline hydrolysis (A4) and 
alkaline hydrolysis followed by SGID (S4), did not significantly decrease IL-6 
production, suggesting that, in certain cases, ultrafiltration may be required to 
elicit an anti-inflammatory effect. Techniques such as membrane ultrafiltration 
and size-exclusion chromatography are applied to concentrate peptides of set 
molecular weight ranges, particularly to generate fractions with low molecular 
weight peptides that can resist further proteolytic digestion in vivo (Udenigwe and 
Aluko, 2012). It has been shown that molecular weight is a variable factor 
determining the immunomodulatory properties of proteins from different sources 
(Ko and Jeon, 2015; Kim et al., 2016). McCarthy et al. (2013b) evaluated the 
anti-inflammatory activity of alkaline-extracted BSG protein hydrolysates and 
their accompanying fractionated hydrolysates in ConA-stimulated Jurkat T cells 
and identified that the >5kDa retentate fractions, as well as unfractionated 
hydrolysates reduced IFN-γ production to a greater extent than the low molecular 
weight fractionated samples. Results also presented here showed that there was no 
significant reduction in LPS-induced IL-6 production when RAW 264.7 cells 
were incubated with SGID-treated BSG protein hydrolysates. SGID treatments 
have been utilised previously to evaluate BSG protein hydrolysate bioactivity 
following addition to foods. Fortification of a snack bar with BSG protein 
hydrolysates (unfractionated and >5 kDa retentate), which had previously 
demonstrated anti-inflammatory activity, significantly reduced ConA-stimulated 
IFN-γ production in Jurkat T cells following in vitro digestion (McCarthy et al., 
2015). Likewise, fortification of a yoghurt drink with the >5 kDa hydrolysate 
reduced IL-2 secretion, following SGID treatment. Crowley et al. (2015) reported 
that ConA-treated Jurkat T cells had reduced IL-6 secretion when treated with 
milk fortified with unfractionated and >5 kDa BSG protein hydrolysates and 
subjected to SGID. The two hydrolysates had previously demonstrated anti-
inflammatory activity. The antioxidant and anti-inflammatory effects of cookies 
baked with different wheat flours, in HepG2 cells following in vitro digestion, 
was assessed by Valli et al. (2016). Lower IL-8 production and the higher IL-10 
levels were noted in cells supplemented with digested cookies, compared with 
unsupplemented cells. A multi-compartmental in vitro model, simulating the 
167 
 
upper gastrointestinal (GI) tract, was used to digest wheat fractions (Mateo Anson 
et al., 2010). The bioaccessible aleurone fractions were able to reduce LPS-
stimulated TNF-α production in U937 macrophages. 
None of the BSG protein hydrolysates significantly impacted on TNF-α 
production. A number of other studies have reported on the anti-inflammatory 
potential of protein hydrolysates from various cereal grain sources including 
amaranth (Montoya-Rodriguez et al., 2014a; Montoya-Rodriguez et al., 2014b; 
Montoya-Rodriguez and Gonzalez de Meija, 2015), corn gluten (Mochizuki et al., 
2010) and rice (Boonloh et al., 2015). Montoya-Rodriguez et al. (2014a) noted 
that amaranth hydrolysates elicit an anti-inflammatory effect via the inhibition of 
p65 NF-κB subunit expression in LPS-stimulated in THP-1 macrophages and 
RAW 264.7 macrophages. In a 2,4,6-trinitrobenzene sulfonic acid-induced rat 
colitis model, Mochizuki et al. (2010) found that the oral administration of an 
enzymatic hydrolysate of maize gluten (zein) reduced the mucosal levels of 
inflammatory markers, histamine and myeloperoxidase activity. The oral 
administration of alkaline or enzyme-extracted rice bran protein hydrolysates to 
male Sprague-Dawley rats on a high carbohydrate-high fat diet led to a reduction 
in mRNA expression of proinflammatory cytokines, IL-6, TNF-α, Nos-2 and 
Mcp-1 in the intra-abdominal fat cells (Boonloh et al., 2015). It was proposed that 
the decrease in these cytokines may be connected to the Ppar-γ upregulation 
which is involved in fatty acid uptake and glucose metabolism. Other components 
in the extract enhancing the bioactivity of the hydrolysate fractions were also 
speculated.  
Following on from the assessment of the immunomodulatory ability of BSG 
protein hydrolysates, the cellular antioxidant potential of the samples was 
determined. The GSH, SOD and CAT assays were employed to determine the 
impact of hydrolysates on GSH content and cellular antioxidant activity in HepG2 
cells. Oxidative stress can include radical formation, a reduction in antioxidant 
production, disruption in cellular redox balance and oxidative injury to cellular 
components, leading to damage to cell membranes, via protein or membrane lipid 
oxidation or DNA damage (Power et al., 2013). Bioactive peptides can exert their 
antioxidant properties via reactive oxygen species (ROS) scavenging or 
quenching and the reduction of ROS-triggered oxidation of lipids, proteins and 
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DNA (Udenigwe and Aluko, 2012). Owing to their anti-inflammatory effects, the 
hydrolysates A1, A2 and U6 were chosen for analysis of their antioxidant 
potential. The activity of the enzymes CAT and SOD as well as the content of the 
antioxidant GSH were also analysed in HepG2 cells (Figures 3-5). All of the 
hydrolysates significantly protected against the H2O2-induced GSH decrease. 
GSH is classed as a thiol which contains a tripeptide (Cysteine–Glutamic acid–
Glycine) and is primarily produced in the liver from the amino substrates (Power 
et al., 2013). None of the hydrolysates protected against the oxidant-induced 
decrease in SOD activity. The 10kDa permeate produced using Alcalase and 
Flavourzyme, U6, significantly protected against H2O2-generated decrease in 
CAT activity. SOD and CAT along with glutathione peroxidase (GPx), form part 
of the antioxidant defence system in vivo working in cooperation. The enzymes 
function by impeding oxidising species and thereby preventing cellular 
biomolecular damage (Power et al., 2013).  
It must be noted that in vitro assessment of a bioactive compound’s activity is 
not always directly linked to their physiological action in vivo owing to issues 
such as bioavailability, in vivo reactivity, in vivo stability and tissue storage which 
cannot be accounted for with in vitro systems (Sarmadi and Ismail, 2010). 
However, owing to their high throughput, reproducibility and relatively low cost, 
in vitro assays are still a useful experimental approach when determining the 
bioactivity of food compounds.   
 
Conclusions 
In conclusion, alkaline hydrolysis was a more effective method than direct 
enzyme hydrolysis at producing bioactive BSG protein hydrolysates. Both 
alkaline-extracted BSG protein hydrolysates and alkaline-extracted BSG protein 
hydrolysates subjected to ultrafiltration, display both antioxidant (GSH content) 
and anti-inflammatory activity. These BSG fractions may be of potential use for 
the development of functional food products. 
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Chapter 7 
Effects of brewers’ spent grain (BSG) phenolic extracts on 
hydrogen peroxide (H2O2)-induced apoptosis and lipid 
peroxidation in SK-N-BE(2) neuronal cells. 
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Abstract 
Reactive oxygen species (ROS), including hydrogen peroxide (H2O2) are often 
implicated in the neurological damage featured in many neurodegenerative 
diseases. Antioxidants are thought to elicit both neuroprotective and 
neuroregenerative effects, via the reduction or reversal of cellular damage and by 
delaying the advancement of neuronal cell loss. Brewers’ spent grain (BSG), a 
major by-product of the brewing industry, is known as a source of phenolic 
compounds with cellular antioxidant activity. The neuroprotective potential of 
BSG phenolic extracts was investigated in SK-N-BE(2) cells treated with H2O2. 
Pale BSG extracts protected against the H2O2-induced toxicity in SK-N-BE(2) 
cells, as assessed by MTT and Neutral Red Uptake (NRU) assays. Extracts from 
both black and pale BSG significantly decreased the number of apoptotic cells. 
Black and pale BSG extracts protected against the H2O2-induced increase in 
thiobarbituric acid reactive substances (TBARS). These fractions may have 
potential as functional food components to prevent and treat neurodegenerative 
diseases. 
 
Introduction 
Neurodegenerative diseases are characterised by the loss of nerve cells from the 
brain and spinal cord leading to either functional loss (ataxia) or sensory 
dysfunction (dementia) (Uttara et al., 2009). Mitochondrial dysfunction and 
oxidative stress play a key role in the development of neurodegenerative disorders 
(Sheikh et al., 2013). Oxidative stress can damage biological molecules, resulting 
in apoptotic or necrotic cell death and eventually leading to neurological damage 
associated with Alzheimer’s disease (AD), Parkinson’s disease (PD), 
Huntington’s disease (HD), amyotropic lateral sclerosis (ALS) and cerebral 
ischemic stroke (CIS). Reactive oxygen species (ROS), including hydrogen 
peroxide (H2O2), are often implicated in contributing to the damage (Ismail et al., 
2012; Morelli et al., 2014). Evidence suggests that lipid peroxidation is an 
important mechanism of neurodegeneration in AD (Butterfield and Lauderback, 
2002). Unsaturated lipids contained in neuronal cells are susceptible to 
peroxidation and oxidative modification (Uttara et al., 2009). For example, the 
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brain is rich in polyunsaturated fatty acids (PUFA), such as arachidonic and 
docosohexanoic acid, which are highly oxidizable (Butterfield et al., 2002). The 
thiobarbituric acid reactive substances (TBARS) assay is used to determine lipid 
peroxidation (Butterfield and Lauderback, 2002) and is commonly used 
throughout neurodegenerative research (Fukui et al., 2012; Okoko and Ere, 2012). 
Biological antioxidants and antioxidant enzymes regulate ROS generation in 
normal cells (Morelli et al., 2014). Antioxidants are thought to elicit both 
neuroprotective (preventing apoptosis) and neuroregenerative effects, via the 
reduction or reversal of cellular damage and by delaying the advancement of 
neuronal cell loss (Pacifico et al., 2014). Compounds such as flavonoid 
polyphenols, non-flavonoid polyphenols, phenolic acids and organosulfur 
compounds are known for their antioxidant properties (Sultana, 2012). There is 
evidence to suggest that food-derived antioxidants are useful compounds aimed at 
reducing neurodegenerative disorders. Hydroxycinnamic acids (HCAs) such as p-
coumaric, caffeic, ferulic, and sinapic acids are a major class of phenolic acids 
widely found in tea leaves, coffee, red wine, fruits, vegetables and whole grains 
cereals. HCAs are powerful antioxidant compounds and are known in particular 
for their preventive and/or therapeutic role in diseases associated with oxidative 
stress (e.g., atherosclerosis, inflammatory injury, cancer, and cardiovascular 
diseases) (Teixeira et al., 2013). 
The major by-product of the brewing industry is brewers’ spent grain (BSG). 
BSG consists of the seed coat–pericarp–husk layers that encased the original 
barley grain (Mussatto et al., 2014; Lynch et al., 2016). BSG is an abundant 
source of phenolic compounds with antioxidant activity, which can be isolated 
using various extraction methods, including enzymatic extraction (Mussatto et al., 
2014). HCAs have been demonstrated as the main phenolic compounds present in 
BSG, with ferulic acid, in particular, being present in substantial amounts 
(McCarthy et al., 2013). The phenolic component of BSG has previously 
demonstrated antioxidant activity in cell culture models (McCarthy et al., 2012; 
McCarthy et al., 2014; Crowley et al., 2017). The purpose of this research was to 
assess the neuroprotective potential of BSG phenolic extracts using a neuronal 
cell culture model. The BSG phenolic extracts selected for this research had 
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previously demonstrated cellular antioxidant activity in U937 cells and HepG2 
cells (Crowley et al., 2017). 
 
Materials and Methods 
Materials 
All materials were purchased from Sigma-Aldrich Ireland Limited (Co. Wicklow, 
Ireland), unless otherwise stated. SK-N-BE(2) cells were purchased from the 
European Collection of Animal Cell Cultures (ECACC, Salisbury, UK). 
 
Preparation of phenolic extracts 
The preparation of BSG phenolic extracts was previously described by Crowley et 
al. (2017). The phenolic preparation from black, wet BSG was designated BW2; 
from black, dry BSG were BD1 and BD2; from pale, dry BSG were PD1, PD2 
and PD3 and from pale, wet BSG PW2 and PW3. 
 
Cell culture 
SK-N-BE(2) cells, a human neuroblastoma cell line, were grown and maintained 
in Dulbecco’s Modified Eagle’s Medium (DMEM) supplemented with 10% foetal 
bovine serum (FBS) and plated at a seeding density of 0.5 x 10
-5
, 1 x 10
-5
 and 2 x 
10
-5
 cells mL
-1
 for cell viability, TBARS and apoptosis assays, respectively. Cells 
were grown at 37°C in a 5% CO2 atmosphere. Reduced serum media (2.5% FBS) 
was used for all experiments. 
 
Cell viability  
The effect of BSG extracts on SK-N-BE(2) cell viability was measured using the 
MTT and Neutral Red Uptake (NRU) assays. Cells were incubated for 24 hours at 
37˚C with extracts at concentrations of 0 to 20% (v/v). The MTT assay kit (MTT I 
177 
 
proliferation kit, Roche Diagnostics, UK) was then used to measure cell viability. 
The (3-(4, 5-Dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assay 
was added to cells and left to incubate for 4 hours, before addition of the 
solubilisation solution. The plates were allowed to incubate overnight and the 
absorbance was measured at 570 nm using a microplate reader (VarioskanFlash, 
Thermo Scientific, Waltham, MA). Cell viability was determined as a percentage 
of the control, untreated cells. The inhibitory concentration-50 (IC50) value, the 
concentration of a compound that reduces cell viability to 50% of the untreated, 
control cells, was determined for each of the extracts.   
For the NRU assay, cells were again incubated for 24 hours at 37˚C with 
extracts at concentrations of 0 to 20% (v/v). Media was then removed and the 
neutral red dye (0.004% w/v) was added. Cells were then incubated for a further 3 
hours to allow uptake of the dye. Dye was then removed and cells were washed 
with PBS. Ice-cold glacial acetic acid (1% v/v) was then added to cells. After 15 
minutes, the plate was agitated and the absorbance was measured at 540 nm using 
a microplate reader. Cell viability was determined as a percentage of the control, 
untreated cells. 
 
Effects of BSG phenolic extracts on H2O2-induced cytotoxicity 
The effects of BSG phenolic extracts on H2O2-induced toxicity was measured in 
SK-N-BE(2) cells using the MTT and NRU assays. For the MTT assay, cells were 
pretreated with either BSG phenolic extracts BW2 and BD1-2 (0.5% v/v) or PD1-
3 and PW2-3 (4% v/v) or ferulic acid (2 mM) for 24 hours. Media was then 
removed and replaced with fresh media containing H2O2 (40 µM). Following 
further 24 hour incubation, the MTT solution was added to cells and left to 
incubate for 4 hours, before addition of the solubilisation solution. The plates 
were allowed to incubate overnight and the absorbance was measured at 570 nm 
using a microplate reader. Cell viability was determined as a percentage of the 
control, untreated cells. 
For the NRU assay, cells were pretreated with either BSG phenolic extracts 
BW2, BD1-2, PD1-3 and PW2-3 (20% v/v) or ferulic acid (2 mM) for 24 hours. 
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Media was then removed, replaced with fresh media containing H2O2 (20 µM) 
and incubated for a further 24 hours. Media was then removed and replaced with 
neutral red dye. Cells were then incubated for a further 3 hours to allow uptake of 
the dye. Dye was then removed and cells were washed with PBS. Ice-cold glacial 
acetic acid was then added to cells. After 15 minutes, the plate was agitated and 
the absorbance was measured at 540 nm using a microplate reader. Cell viability 
was determined as a percentage of the control, untreated cells. 
 
Determination of apoptosis  
The effect of BSG phenolic extract pretreatment on H2O2-induced apoptosis was 
measured by fluorescence microscopy after staining with Hoechst 33342. SK-N-
BE(2) cells were incubated with either BSG phenolic extracts BW2 and BD1-2 
(0.5% v/v) or PD1-3 and PW2-3 (4% v/v) or ferulic acid (2 mM). After 24 hour 
incubation, the media was removed and replaced with fresh media containing 
H2O2 (100 µM). Cells were incubated for a further 24 hours and were then 
harvested by centrifugation (200 g, 10 minutes) to form a pellet. Hoechst 33342 
stain (5 µg mL
-1
 PBS) was added, and the samples were incubated at 37°C for 30 
minutes. Stained samples were placed on a microscope slide and examined under 
UV light (330–380 nm) using a Nikon fluorescence microscope (200x 
magnification). A total of 300 cells in each sample were analysed, and the 
percentage of condensed/fragmented (apoptotic) nuclei was calculated. 
 
Thiobarbituric acid reactive substances (TBARS) 
TBARS was measured as an index of lipid peroxidation by a modification of the 
method of Kornburst & Mavis (1980). SK-N-BE(2) cells were incubated with 
either BSG phenolic extracts BW2 and BD1-2 (0.5% v/v) or PD1-3 and PW2-3 
(4% v/v) or ferulic acid (2 mM). After 24 hour incubation, the media was 
removed and replaced with fresh media containing H2O2 (100 µM). Following 24 
hour incubation the media was removed and cells were scraped in a solution of 
KCl (1.15% w/v). Cells were then pulse sonicated at 13 amps/s and lipid 
peroxidation was then induced in the samples by the addition of FeS04 (5 mM) 
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and ascorbic acid (2 mM) in an 80 mM Tris maleate buffer (pH 7.4). A solution of 
TBA (0.375% w/v), TCA (15% w/v) and HCl (0.25 N) was added to the samples 
followed by vortexing and boiling for a period of 15 minutes. Lipid peroxides 
react with this solution resulting in the formation of a pink fluorochrome 
(malondialdehyde; MDA) which was determined spectrophotometrically. The 
solutions were then allowed to cool and were centrifuged (200 g, 10 minutes). The 
supernatant fraction was removed and the absorbance was measured at 535 nm. 
The MDA concentrations (nmol MDA mg protein
-1
) of the samples were 
calculated using an extinction coefficient of 1.56 x 10
5
 M
-1
 cm
-1
 (Beuge & Aust, 
1978). TBARS were expressed as percentage of untreated, control cells. The 
protein content of each sample was determined by the bicinchoninic acid (BCA) 
assay, as described by Smith et al. (1985). 
 
Statistical analysis 
All data represent the mean ± standard error (SE) of at least three independent 
experiments. Statistical analysis was performed using a one-way analysis of 
variance (ANOVA) followed by Dunnett’s test using GraphPad Prism 4 
(GraphPad software, La Jolla, CA).  
 
Results 
Cell viability  
The effects of BSG phenolic extracts on SK-N-BE(2) cell viability was assessed 
using the MTT and NRU assays (Tables 1-2). As seen with the MTT assay (Table 
1), black BSG extracts (BW2, BD1 and BD2) significantly reduced cell viability 
across the concentration range tested. Similarly, the pale BSG extract PD1 also 
significantly reduced SK-N-BE(2) cell viability at concentrations above 0.5% 
(v/v). No cytotoxic effects were noted with the NRU assay (Table 2).  
 
 
180 
 
Table 1: Effect of Brewers’ spent grain (BSG) phenolic extracts (0-20% (v/v)) on cell viability in SK-N-BE(2) cells as measured by (3-(4, 5-
Dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assay. 
 0.5% 1% 2% 2.5% 4% 6% 8% 10% 15% 20% IC50 (% v/v) 
BD1 60.0 ± 4.2* 60.9 ± 4.6* 59.2 ± 5.0* 58.4 ± 4.0* 55.8 ± 4.7* 53.1 ± 2.9* 56.4 ± 4.2* 56.1 ± 4.2* 55.3 ± 2.1* 42.0 ± 4.0* 22.1 
BD2 62.3 ± 6.9* 56.4 ± 5.2* 54.1 ± 4.5* 56.0 ± 6.0* 55.1 ± 4.4* 59.9 ± 5.0* 55.8 ± 3.8* 56.0 ± 4.4* 56.0 ± 4.5* 52.8 ± 3.4* n/d 
PD1 81.4 ± 3.1* 76.8 ± 3.3* 78.9 ± 5.6* 81.4 ± 5.5* 80.0 ± 5.4* 83.4 ± 4.7* 74.2 ± 3.3* 83.1 ± 0.3* 75.9 ± 2.4* 75.7 ± 4.3* n/d 
PD2 110.5 ± 12.4 109.7 ± 13.9 115.6 ± 11.4 116.3 ± 8.9 115.2 ± 8.7 117.1 ± 11.8 111.4 ± 10.7 114.5 ± 9.8 113.0 ± 14.5 105.0 ± 9.1 n/d 
PD3 116.3  ± 4.9 120.7 ± 5.9 120.4 ± 8.2 108.5 ± 9.9 108.2 ± 9.0 103.5 ± 13.8 106.4 ± 3.7 114.2 ± 8.5 107.2 ± 11.7 98.6 ± 10.0 n/d 
BW2 57.7 ± 1.9* 55.0 ± 3.6* 55.5 ± 1.5* 53.1 ± 1.9* 55.3 ± 3.6* 51.1 ± 4.0* 52.4 ± 4.0* 52.4 ± 4.3* 49.4 ± 5.5* 42.2 ± 6.6* 9.2 
PW2 97.6 ± 6.9 93.2 ± 9.4 94.5 ± 6.4 90.2 ± 8.3 87.0 ± 9.8 88.3 ± 4.5 84.0 ± 4.8 89.3 ± 17.1 77.5 ± 8.2 70.0 ± 12.8 n/d 
PW3 92.0 ± 1.8 88.3 ± 9.3 83.0 ± 6.9 74.4 ± 4.0* 76.7 ± 3.2* 85.7 ± 5.5 78.7 ± 2.4* 86.1 ± 5.4 82.6 ± 5.5 73.3 ± 4.5* 86.6 
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Values are mean ± SE of three independent experiments, expressed as percentage relative to untreated SK-N-BE(2) cells. BW2 represent the 
extract from black, wet BSG; BD1-2 represents extracts from black, dry BSG; PD1-3 represents extracts from pale, dry BSG; PW2-3 represents 
extracts from pale, wet BSG. Statistical analysis by ANOVA followed by Dunnett’s Test. * Denotes statistically significant difference in cell 
viability, relative to untreated SK-N-BE(2) cells (P<0.05).
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Table 2: Effect of Brewers’ spent grain (BSG) phenolic extracts (0-20% (v/v)) on cell viability in SK-N-BE(2) cells as measured by Neutral Red 
Uptake (NRU) assay 
 0.5% 1% 2% 2.5% 4% 6% 8% 10% 15% 20% IC50 (% v/v) 
BD1 106.1 ± 15.4 114.6 ± 6.3 122.6 ± 10.7 121.8 ± 4.0 134.3 ± 7.0* 107.9 ± 4.2 112.2 ± 1.5 132.3 ± 11.2 109.4 ± 0.5 90.4 ± 2.6 n/d 
BD2 95.9 ± 14.0 103.5 ± 16.2 109.5 ± 4.5 112.9 ± 10.5 118.5 ± 10.2 113.2 ± 11.1 100.1 ± 22.0 107.0 ± 16.5 119.6 ± 14.0 94.0 ± 13.1 n/d 
PD1 115.0 ± 10.7 118.2 ± 6.8 104.6 ± 20.3 128.1 ± 9.8 118.2 ± 17.0 118.2 ± 13.9 125.9 ± 3.4 114.4 ± 10.2 95.4 ± 9.8 75.9 ± 17.8 n/d 
PD2 86.4 ± 11.2 105.8 ± 6.6 106.7 ± 10.5 108.3 ± 16.0 100.0 ± 14.0 102.9 ± 16.8 105.0 ± 16.6 95.1 ± 14.4 75.4 ± 14.4 73.6 ± 9.2 25.8 
PD3 90.4 ± 4.3 92.0 ± 2.0 100.4 ± 16.6 106.6 ± 11.0 116.4 ± 7.1 101.2 ± 5.4 117.5 ± 10.7 107.7 ± 14.4 84.9 ± 19.3 65.7 ± 14.2 n/d 
BW2 114.2 ± 8.4 124. 0 ± 1.9 136.6 ± 13.4* 125.1 ± 2.0 138.8 ± 2.4* 137.7 ± 6.0* 129.2 ± 4.3 134.4 ± 4.9 128.2 ± 11.7 77.7 ± 12.2 n/d 
PW2 103.9 ± 8.2 103.3 ± 14.2 108.7 ± 7.1 96.6 ± 8.4 73.9 ± 6.6 80.5 ± 8.6 83.9 ± 10.0 74.9 ± 7.3 76.5 ± 17.0 64.5 ± 13.2 37.2 
PW3 121.6 ± 12.0 122.0 ± 11.5 132.7 ± 18.1 120.3 ± 8.6 115.9 ± 16.5 111.5 ± 19.4 118.5 ± 16.6 110.0 ± 14.0 82.2 ± 11.8 72.4 ± 3.0 23.4 
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Values are mean ± SE of three independent experiments, expressed as percentage relative to untreated SK-N-BE(2) cells. BW2 represent the 
extract from black, wet BSG; BD1-2 represents extracts from black, dry BSG; PD1-3 represents extracts from pale, dry BSG; PW2-3 represents 
extracts from pale, wet BSG. Statistical analysis by ANOVA followed by Dunnett’s Test. * Denotes statistically significant difference in cell 
viability, relative to untreated SK-N-BE(2) cells (P<0.05).
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Effects of BSG phenolic extracts on H2O2-induced cytotoxicity 
The dose-dependent effects of H2O2 on cell viability were firstly assessed in SK-
N-BE(2) cells (Figure 1-2). At 40µM H2O2, cell viability was decreased to 44.8% 
of untreated SK-N-BE(2) cells, as measured by the MTT assay (Figure 1). 
Cell viability was reduced to 50.5% of untreated SK-N-BE(2) cells, when 
treated with 20µM H2O2, as assessed by the NRU assay (Figure 2). As a result of 
this, 40µM and 20µM H2O2 were chosen for further assessment in the MTT and 
NRU assays, respectively. The protective effect of BSG phenolic extract 
pretreatment against H2O2-induced cytotoxicity was investigated using the MTT 
and NRU assays (Figures 3-4). At a concentration of 4% (v/v), pale BSG extracts 
PD1, PD2, PD3 and PW3 protected against the oxidant-induced toxicity in SK-N-
BE(2) cells, as assessed by the MTT assay (Figure 3). The positive control, ferulic 
acid (2 mM) also protected against the H2O2-induced reduction in cell viability. 
BSG phenolic extracts were used at a higher concentration (20% v/v) in the NRU 
assay (Figure 4). Extracts PD1 and PD2 demonstrated protective effects against 
the H2O2-induced decrease in neutral red uptake. A protective effect was also 
noted with ferulic acid (2 mM). 
 
Effects of BSG phenolic extracts on H2O2-induced apoptosis 
The dose-dependent effects of H2O2 on apoptosis in SK-N-BE(2) cells was 
initially assessed at a concentration range of 0-200µM (Figure 5). 100 µM H2O2 
was subsequently used to induce apoptosis in SK-N-BE(2) cells (Figures 6-7). 
This led to distinctive cell shrinkage and blebbing, the associated characteristics 
of apoptosis (Figure 7B). The protective effect of BSG phenolic extract 
pretreatment was determined by staining cells with Hoechst 33342 and assessing 
their nuclear morphology using a fluorescent microscope. Extracts BW2 (0.5% 
v/v), PD2 (4% v/v) and PW2 (4% v/v) significantly decreased the number of 
apoptotic cells, similar to the positive control, ferulic acid (2 mM) (Figure 7C-F).  
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Figure 1: Dose-dependent effects of H2O2 (0-50µM) on SK-N-BE(2) cell 
viability as assessed by (3-(4, 5-Dimethylthiazol-2-yl)-2,5-diphenyltetrazolium 
bromide (MTT) assay. Cells were treated with H2O2 for 24 hours. Values are 
mean ± SE of at least three independent experiments. Statistical analysis by 
ANOVA followed by Dunnett’s Test. * Denotes statistically significant difference 
in cell viability, relative to untreated SK-N-BE(2) cells (P<0.05). 
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Figure 2: Dose-dependent effects of H2O2 (0-50µM) on SK-N-BE(2) cell 
viability as assessed by NRU assay. Cells were treated with H2O2 for 24 hours. 
Values are mean ± SE of at least three independent experiments. Statistical 
analysis by ANOVA followed by Dunnett’s Test. * Denotes statistically 
significant difference in cell viability, relative to untreated SK-N-BE(2) cells 
(P<0.05). 
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Figure 3: Effect of BSG phenolic extract or ferulic acid pretreatment on SK-N-
BE(2) cell viability following 24 hour incubation with 40 µM H2O2 as measured 
by (3-(4, 5-Dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assay. 
Cells were pretreated with BSG extracts BW2, BD1-2 (0.5% v/v), PD1-3, PW2-3 
(4% v/v) or ferulic acid (2 mM) for 24 hours, followed by treatment with H2O2 for 
a further 24 hours. Values are mean ± SE of at least three independent 
experiments. Statistical analysis by ANOVA followed by Dunnett’s Test. * 
Denotes statistically significant difference in cell viability, relative to untreated 
SK-N-BE(2) cells (P<0.05). 
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Figure 4: Effect of BSG phenolic extract or ferulic acid pretreatment on SK-N-
BE(2) cell viability following 24 hour incubation with 20 µM H2O2 as measured 
by NRU assay. Cells were pretreated with BSG extracts BW2, BD1-2, PD1-3 or 
PW2-3 (20% v/v) or ferulic acid (2 mM) for 24 hours, followed by treatment with 
H2O2 for a further 24 hours. Values are mean ± SE of at least three independent 
experiments. Statistical analysis by ANOVA followed by Dunnett’s Test. * 
Denotes statistically significant difference in cell viability, relative to untreated 
SK-N-BE(2) cells (P<0.05). 
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Figure 5: Dose-dependent effects of H2O2 (0-200µM) on % apoptosis in SK-N-
BE(2) cells. Cells were treated with H2O2 for 24 hours. Values are mean ± SE of 
at least three independent experiments. Statistical analysis by ANOVA followed 
by Dunnett’s Test. * Denotes statistically significant difference in % apoptosis, 
relative to untreated SK-N-BE(2) cells (P<0.05). 
 
 
 
 
 
* * 
* 
0
5
10
15
20
25
30
35
0 50 75 100 150 200
%
 A
p
o
p
to
ti
c 
ce
ll
s 
H₂O₂ (µM) 
190 
 
 
Figure 6: Effect of BSG phenolic extract or ferulic acid pretreatment on H2O2-
induced apoptosis in SK-N-BE(2) cells. Cells were pretreated with BSG extracts 
BW2, BD1-2 (0.5% v/v), PD1-3, PW2-3 (4% v/v) or ferulic acid (2 mM) for 24 
hours, followed by treatment with 100 µM H2O2 for a further 24 hours. Values are 
mean ± SE of at least three independent experiments. Statistical analysis by 
ANOVA followed by Dunnett’s Test. * Denotes statistically significant difference 
in cell viability, relative to untreated SK-N-BE(2) cells (P<0.05). 
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Figure 7: Effect of BSG phenolic extract or ferulic acid pretreatment on cell 
morphology of H2O2-treated SK-N-BE(2) cells. Cells were pretreated with BSG 
extracts BW2, BD1-2 (0.5% v/v), PD1-3, PW2-3 (4% v/v) or ferulic acid (2 mM) 
for 24 hours, followed by treatment with 100 µM H2O2 for a further 24 hours. 
Morphological changes of SK-N-BE(2) cells observed by fluorescence 
microscope after staining with Hoechst 33342. (A) Untreated control cells. (B) 
Cells treated with H2O2 alone, displaying cell shrinkage and blebbing as indicated 
by red arrows. (C) Cells pretreated with BW2 before H2O2 exposure. (D) Cells 
pretreated with PD2 before H2O2 exposure. (E) Cells pretreated with PW2 before 
H2O2 exposure. (F) Cells pretreated with ferulic acid before H2O2 exposure. 
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Effects of BSG phenolic extracts on H2O2-induced lipid peroxidation 
Lipid peroxidation was induced in SK-N-BE(2) cells by 100 µM H2O2 (Figure 8). 
This led to a statistically significant (P<0.05) increase in TBARS compared to the 
untreated, control cells. The protective effect of BSG phenolic extract 
pretreatment against oxidant-induced lipid peroxidation was assessed using the 
TBARS assay. Black BSG extracts (BW2, BD1 and BD2) and the pale extract 
PD2 protected against the H2O2-induced increase in TBARS. A protective effect 
was also noted with ferulic acid (2mM). 
 
Discussion 
Oxidative stress occurs as a result of the change in pro-oxidant/antioxidant 
homeostasis leading to the production of ROS and free radicals with potentially 
harmful effects on neuronal cells. ROS production is particularly prevalent in the 
brain and neuronal tissue (Uttara et al., 2009). Brain and neuronal tissue are 
especially sensitive to oxidative stress (Uttara et al., 2009; Sheikh et al., 2013), 
with the brain notably consuming a lot of oxygen, being rich in lipids and having 
low antioxidant defence activity (Uttara et al., 2009).  
Various pharmacological compounds are known to have beneficial effects 
targeted at neurodegenerative disorders. Treatments with natural antioxidants such 
as polyphenols provide a novel alternative approach by delivering neuroprotective 
effects through diet or dietary supplements (Albarracin et al., 2012). Recently, 
evidence has emerged on the potential neuroprotective effects of a wide range of 
food-derived compounds (Chu et al., 2009; Vuong et al., 2010; Ismail et al., 
2012). Here, the neuroprotective effects of phenolic extracts from the brewing 
industry by-product, BSG, were investigated using a neuronal cell culture model. 
The BSG phenolic extracts chosen had previously demonstrated cellular 
antioxidant potential protecting against H2O2-induced DNA damage in U937 cells 
and H2O2-induced decrease in glutathione (GSH) content, superoxide dismutase 
(SOD) and catalase (CAT) activity in HepG2 cells (Crowley et al., 2017).  
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Figure 8: Effect of BSG phenolic extract or ferulic acid pretreatment on H2O2-
induced lipid peroxidation in SK-N-BE(2) cells. Cells were pretreated with BSG 
extracts BW2, BD1-2 (0.5% v/v), PD1-3, PW2-3 (4% v/v) or ferulic acid (2 mM) 
for 24 hours, followed by treatment with 100 µM H2O2 for a further 24 hours. 
Values are mean ± SE of at least three independent experiments. Statistical 
analysis by ANOVA followed by Dunnett’s Test. * Denotes statistically 
significant difference in cell viability, relative to untreated SK-N-BE(2) cells 
(P<0.05). 
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The neuroblastoma cell line, SK-N-BE(2) has been widely used in 
neurodegenerative research (Pacifico et al., 2014; Sanchez-Mut et al., 2014; 
Zarrouk et al., 2015). Here, SK-N-BE(2) cells were used to study the protective 
effects of BSG phenolic extracts on H2O2-induced toxicity, apoptosis and lipid 
peroxidation. Firstly, the effects of the BSG phenolic extracts alone on SK-N-
BE(2) cell viability was assessed using the MTT and NRU assays. The cells were 
seeded for 24 hours to allow them to attach to plate wells. Following this, the cells 
were exposed to BSG phenolic extracts (0-20% v/v) for a further 24 hours. The 
MTT assay showed that phenolic extracts derived from black BSG significantly 
reduced cell viability in a dose-dependent manner (Table 1). A similar effect on 
cell viability of these phenolic extracts was noted in another adherent cell line, 
HepG2 (Crowley et al., 2017). No cytotoxic effects were noted with BSG 
phenolic extracts, using the NRU assay (Table 2). The two assays measure 
different aspects of viability. Viability usually describes the percentage of cells 
which express live cell characteristics such as the uptake/exclusion of a dye. The 
NRU assay assesses the ability of cells to retain the dye inside the lysosomes with 
the amount of retained dye being proportional to the number of viable cells. The 
integrity of the lysosomes, with the accompanying dye binding, is a cell viability 
indicator (Repetto et al., 2008). The MTT assay measures the ability of viable 
cells with active metabolism to convert MTT into a purple coloured formazan 
product. Dead cells are unable to convert MTT into formazan, so the colour 
formation is a useful and convenient marker of viable cells (Riss et al., 2013). As 
a consequence of these results, the protective effects of BSG phenolic extracts 
against H2O2-induced cytotoxicity was assessed using black extracts at; 0.5% 
(v/v) for MTT assay and 20% (v/v) for NRU assay and pale extracts at; 4% (v/v) 
for MTT assay and 20% (v/v) for NRU assay.  
Following on from this, the protective effects of phenolic extract pretreatment 
against H2O2-stimulated toxicity in SK-N-BE(2) cells was assessed using the 
MTT and NRU assays. Pretreatment approaches with a number of plant 
compounds have previously been used to assess the protective effects against 
H2O2-induced cytotoxicity in neuronal cells (Vuong et al., 2010; Law et al., 2014; 
Ismail et al., 2016). To assess the impact of BSG phenolic extracts on H2O2-
induced cytotoxicity, SK-N-BE(2)  cells were pretreated with black (0.5% v/v for 
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MTT; 20% v/v for NRU) and pale (4% v/v for MTT; 20% v/v for NRU) extracts 
for 24 hours, followed by H2O2 exposure for a further 24 hours. Wide-ranging 
concentrations of H2O2 have been used to induce toxicity in neuronal cell lines 
(Chen et al., 2009; Morelli et al., 2014; Han et al., 2014). Here, H2O2 
concentrations of 40µM and 20µM, induced a 50% reduction in SK-N-BE(2) cell 
viability, in the MTT and NRU assays, respectively (Figures 1-2). The pale BSG 
extracts PD1, PD2, PD3 and PW3 all demonstrated a protective effect against 
H2O2-induced cytotoxicity as assessed by the MTT assay. The protective effect of 
PD3 or PW3 was not seen in the NRU assay however. The protective ability of 
extracts PD1 and PD2 in both assays suggests that they have an ability to actively 
reduce the toxic effects caused by H2O2 in SK-N-BE(2) cells. Several other 
studies have demonstrated the protective effects of plant extracts against oxidant-
induced toxicity in neuronal cells. Hydroalcoholic extracts of daylily flowers 
protected against corticosterone- and glutamate-induced decreases in PC12 cell 
viability, in a dose-dependent manner (Tian et al., 2017). Ismail et al. (2012) 
demonstrated that germinated brown rice in H2O2-induced toxicity in SH-SY5Y 
cells. Pretreatment of PC12 and L132 cells with an extract from Bacopa monniera 
demonstrated protective effects against H2O2-induced cell death, restoring 
viability to 85.15 % (PC12 cells) and 83.43 % (L132 cells) of control cells 
(Pandareesh et al., 2016).  
Next, the impact of BSG phenolic extract pretreatment on H2O2-generated 
apoptosis was assessed in SK-N-BE(2) cells. As well as mitochondrial 
dysfunctions and excitotoxicity, apoptosis caused by ROS, such as H2O2, can 
damage biological molecules, resulting in apoptotic or necrotic cell death and 
subsequently leading to neurodegenerative diseases (Uttara et al., 2009; Morelli et 
al., 2014). Many other studies have used H2O2 to generate apoptosis in neuronal 
cells (Chen et al., 2009; Han et al., 2014; Ismail et al., 2016). Here, preliminary 
experiments demonstrated that 100µM H2O2 induced significant levels of 
apoptosis in SK-N-BE(2) cells (Figure 5). H2O2 can induce apoptosis via 
activation of the mitogen-activated protein kinase (MAPKs) cascades and 
mitochondrial release of cytochrome c into the cytoplasm (Chen et al., 2009; 
Ismail et al., 2012). Subsequent to this, there is a breakdown of mitochondrial 
membrane potential (MMP) and caspase activation. Morphological change is first 
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seen as phosphatidylserine (PS) translocation to the outer leaflet of the cell 
membrane, leading to cell shrinkage, blebbing and DNA fragmentation (Ismail et 
al., 2012). The protective effects of BSG phenolic extracts was assessed by pre-
treating cells with extracts (0.5% v/v black BSG, 4% v/v pale BSG) for 24 hours, 
followed by incubation with 100µM H2O2 for a further 24 hours. Treatment of 
cells with H2O2 alone led to increased cell shrinkage and blebbing (Figure 6 and 
Figure 7B). Pre-treatments of cells with extracts BW2, PD2 and PW2 as well as 
the positive control, ferulic acid (2mM), significantly protected against H2O2-
induced apoptosis (Figures 6 and Figure 7C-F). The protective effect of ferulic 
acid, a major constituent of BSG, has previously been demonstrated. The pre-
treatment of HEK293 cells with ferulic acid prior to H2O2 exposure protected 
against the cell shrinkage, chromatin condensation and nuclear fragmentation 
effects generated by the oxidant (Bian et al., 2015). Similarly, ferulic acid 
inhibited hypoxia-stimulated apoptosis in PC12 cells. The protective effects were 
thought to occur via the attenuation of ROS generation during hypoxia and the 
subsequent down-regulation of MAPKs and caspase-3 expression (Lin et al., 
2015). 
A number of different plant-derived compounds have demonstrated protective 
effects against oxidant-induced apoptosis in neuronal cells. Ismail et al. (2012) 
showed that pre-treating SH-SY5Y cells with germinated brown rice protected 
against H2O2-induced cell death by preventing PS translocation, resulting in the 
cell membrane staying intact. Another study from the same author (Ismail et al., 
2016), this time on thymoquinone (bioactive component of black caraway) and a 
thymoquinone-rich fraction, showed that pre-treating SH-SY5Y cells with both 
compounds resulted in a reduction H2O2-induced apoptosis. The activation of 
ERK1/2 gene expression by the compounds of action following oxidant insult was 
speculated as one of its survival mechanisms. Similarly, Chu et al. (2009) 
demonstrated that the protective effects of coffee against H2O2-induced primary 
neuronal cell death may be mediated by modulating the activation of ERK1/2 and 
JNK1/2 signalling pathways. Fermented blackberry juice protected N2a 
neuroblastoma cells against H2O2-induced oxidative stress via the activation of 
p38- and JNK-dependent survival pathways and blocking MEK1/2- and ERK1/2-
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mediated cell death (Vuong et al., 2010). Further research is required to identify 
the exact neuroprotective mechanisms of BSG phenolic extracts. 
Lipid peroxidation plays a role in the etiology of atherosclerosis and 
neurodegenerative diseases. ROS generated by H2O2 can react with 
glycophospholipids, fatty acids and other essential lipids present in mitochondrial 
and cell membranes resulting in lipid peroxides and other radicals which can 
reproduce end products such as acrolein, MDA and 4-hydroxynonenal (HNE) 
(Butterfield and Lauderback, 2002; Pandareesh et al., 2016). The reaction of these 
compounds with enzymatic, transport or structural proteins, leads to oxidative 
damage or membrane modification, resulting in the alteration of synaptic 
membranes and subsequently neuronal cell death (Butterfield and Lauderback, 
2002). In the AD brain, lipid peroxidation is extensive. As a therapeutic strategy, 
antioxidant compounds that can access the brain have the potential to block free 
radical-induced lipid peroxidation (Butterfield et al., 2002). Here the ability of 
BSG phenolic extract pretreatment to protect against H2O2-induced lipid 
peroxidation was assessed in SK-N-BE(2) cells by the TBARS assay. Results 
demonstrated that incubation of cells with 100µM H2O2 significantly increased the 
level of lipid peroxidation compared to untreated, control cells (Figure 8). No 
significant increases in lipid peroxidation were noted following 24 hour pre-
incubation with extracts BW2, BD1, BD2 and PD2, suggesting that these fractions 
contain neuroprotective properties. The positive control, ferulic acid, also 
demonstrated a protective effect. It has previously been shown that BSG is a rich 
source of ferulic acid (McCarthy et al., 2013). Lin et al. (2015) found that ferulic 
acid significantly inhibited hypoxia-stimulated lipid peroxidation in PC12 cells. 
Pretreatment of cortical neuronal cells with ferulic acid ethyl ester significantly 
attenuated amyloid β-peptide (1–42)-induced lipid peroxidation (Sultana et al., 
2005). One of the disadvantages of the TBARS assay is the reaction of non-lipid 
molecules with thiobarbituric acid and thus it is therefore considered a nonspecific 
marker of membrane lipid peroxidation (Butterfield and Lauderback, 2002). It has 
however been widely used throughout neurodegenerative research (Fukui et al., 
2012; Pandareesh et al., 2016).  
BSG phenolic extracts have previously demonstrated antioxidant potential in 
U937 cells and HepG2, protecting against H2O2-induced DNA damage and H2O2-
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induced decreases in cellular antioxidant content and activity (Crowley et al., 
2017). Here, SK-N-BE(2) cells were pretreated with BSG phenolic extracts before 
being exposed to H2O2 and the subsequent effects on cell viability, apoptosis and 
lipid peroxidation were measured. Extracts BW2, PD1 and PD2 all demonstrated 
significant neuroprotective effects, suggesting that these fractions may have 
potential as functional food components to prevent and treat neurodegenerative 
diseases. However, further research is required to identify the exact components 
eliciting bioactivity and the specific molecular mechanisms that are involved. 
 
Conclusions 
To conclude, extracts from both black and pale BSG demonstrated significant 
neuroprotective effects, indicating that these fractions may be useful as functional 
food ingredients to prevent and treat neurodegenerative diseases. Future research 
should focus on identifying the specific components eliciting bioactivity and the 
molecular pathways that are involved. 
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Chapter 8 
The inhibitory potential of phenolic extracts and protein 
hydrolysates derived from brewers’ spent grain (BSG) on 
proliferation of cancer cell lines in culture. 
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Abstract  
Many treatments are effective at treating and controlling cancer, however some 
adverse side effects can occur, in particular, with chemotherapy. Plant-derived 
products represent an alternative form of treatment with lesser side effects. 
Brewers’ spent grain (BSG) is known as a source of hydroxycinnamic acids, 
which are an important group of antioxidant compounds, but these compounds are 
also known to have inhibitory activity in the proliferation of cancer cell lines. The 
impact of BSG phenolic extracts and protein hydrolysates on cell proliferation 
was assessed in the cell lines; Jurkat T cells, RAW 264.7 cells, MCF-7 cells, 
HepG2 cells and U937 cells. Inhibitory concentrations (IC50) could be calculated 
for more of the phenolic extracts than for the protein hydrolysates, indicating their 
greater cytotoxic effects. The phenolic extract from pale, dry BSG (PD3) 
demonstrated a proapoptotic effect in U937 cells increasing the formation of 
apoptotic cells and DNA fragmentation. To conclude, BSG phenolic extracts 
demonstrated greater antiproliferative ability than BSG protein hydrolysates. 
However, the apoptotic effects of BSG phenolic extracts were, in general, found 
to be low. 
 
Introduction 
Cancer is a multi-stage disease resulting from environmental, chemical, physical, 
metabolic, and genetic factors involved in the induction and progression of the 
disease in either a direct and/or indirect manner. The stages involved include 
initiation, promotion, progression, invasion and metastasis. The promotion of a 
tumor consists of the active proliferation of cells forming a multi-cellular 
premalignant tumor cell population (Dai and Mumper, 2010). Apoptosis is a form 
of cell death which is regulated by a variety of cellular signalling pathways. It is 
characterised by nuclear condensation and fragmentation, cleavage of 
chromosomal DNA into fragments and the formation of apoptotic bodies. Tumors 
can carry mutations which inactivate apoptotic pathways leading to the 
persistence of tumor cells (Edinger and Thompson, 2004).  
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Many treatments are effective at treating and controlling cancer, however some 
adverse side effects can occur, in particular, with chemotherapy. Plant-derived 
products represent an alternative form of treatment with lesser side effects 
(Ahmed et al., 2016). For example, it is recognised that fruit and vegetable 
consumption is associated with a reduced cancer risk, owing to its high 
polyphenol content (Roleira et al., 2015). Compounds such as phenolics have the 
potential to curb tumor formation and growth by inducing cell cycle arrest and 
apoptosis (Dai and Mumper, 2010). Phenolic compounds are ubiquitous in the 
plant kingdom and are one of the most important groups of secondary metabolites 
of plants. They contain at least one aromatic ring with one or more hydroxyl 
groups and their established antioxidant activity owes to their ability to chelate 
metals by the referred groups. The anticancer activity of phenolic compounds is 
generally associated with phenolic antioxidant content (Roleira et al., 2015). 
Protein components from plant sources have also demonstrated anticancer effects 
in different cell lines (Enrique and Lizette, 2017).  
Brewers’ spent grain (BSG) is the insoluble part (mainly the seed coat–
pericarp–husk) of barley grain remaining after the mashing step in the brewing 
process. With the large amounts produced annually, present low market value and 
being a nutritionally valuable co-product, BSG is being recognised as having 
potential use as a source of functional food components (Lynch et al., 2016). BSG 
protein hydrolysates have previously shown anti-inflammatory activity in Jurkat T 
cells (McCarthy et al., 2013a; McCarthy et al., 2013b). Additionally, phenolic 
extracts from BSG have demonstrated cellular antioxidant potential in U937 cells 
and HepG2 cells (Crowley et al., 2017 and Chapter 3). BSG is known as a source 
of hydroxycinnamic acids (McCarthy et al., 2013c), which are an important group 
of antioxidant compounds, known to have inhibitory activity in the proliferation 
of cancer cell lines (Roleira et al., 2015). The purpose of this research was to 
assess the antiproliferative potential of phenolic extracts and protein hydrolysates 
from BSG in cell lines from a cancerous origin. These cell lines used include 
RAW 264.7 cells - a murine macrophage cell line, Jurkat T cells - a human 
leukemic cell line, MCF-7 cells – a human breast cancer cell line, U937 cells - a 
human leukemic monocytic lymphoma cell line and HepG2 cells - a human liver 
carcinoma cell line. The MTT assay was used to assess cell proliferation. The 
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Hoechst staining and DNA fragmentation assays were used to measure apoptosis 
in U937 cells. All BSG phenolic extracts and protein hydrolysates studied in this 
thesis were included for analysis in this chapter.  
 
Materials and methods 
Materials 
BSG was obtained from a single batch which was brewed in November 2009, 
vacuum-packed and stored at -20
o
C in polypropylene bags until use. Shearzyme 
500 L (declared activity 500 Fxu g
-1
) and Ultraflo Max (declared activity 470 Fxu 
g
-1
) were sourced from Novozymes A/S, Bagsværd, Denmark. Depol 740L 
(declared activity 945 u g
-1
) was purchased from Biocatalysts Ltd., Cardiff, UK. 
Alcalase 2.4L and Flavourzyme
® 
500L were purchased from Sigma Chemical Co. 
(Dorset, UK), Brewer’s Clarex™ (Aspergillus niger prolyl endoproteinase) was 
received from Dutch State Mines (DSM, Heerlen, Netherlands), Corolase
® 
PP was 
supplied by AB Enzymes (Darmstadt, Germany) and Prolyve 1000 (Pro1k) was 
kindly provided by Lyven Enzymes Industrielles (Caen, France). Jurkat T cells, 
RAW 264.7 cells, MCF-7 cells, U937 cells and HepG2 cells were obtained from 
the European Collection of Animal Cell Cultures (ECACC, Salisbury, UK). All 
other chemicals were purchased from Sigma, unless otherwise stated. 
 
Preparation of phenolic extracts 
The preparation of BSG phenolic extracts was previously described by Crowley et 
al. (2017) and also detailed in Chapter 3 of thesis. Phenolic preparations from 
black, wet BSG were designated BW1-4; from black, dry BSG were designated 
BD1-2; from pale, wet BSG were designated PW1-5 and from pale, dry BSG 
were designated PD1-3 (Table 1, Chapter 3). 
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Generation of the alkaline-extracted protein hydrolysates 
The alkaline extracted hydrolysates (44% w/w protein) were prepared as 
previously described (Connolly et al., 2013). The samples were then subjected to 
hydrolysis using combinations of Alcalase (Alc), Corolase PP (CorPP), 
Flavourzyme (Fla), Prolyve 1000 (Pro) and/or Protease P (Pro) producing the 
hydrolysates AlcFla, AlcPro, CorPPFla and ProPro. These alkaline-extracted BSG 
protein hydrolysates were labelled A1-A4, respectively (See Table 1, Chapter 6).  
 
Simulated gastrointestinal digestion (SGID) of alkaline-extracted protein 
hydrolysates 
SGID of BSG alkaline-extracted hydrolysates was performed according to Walsh 
et al. (2004). The samples were labelled S1-S4 (See Table 1, Chapter 6).   
 
Generation of the enzyme-extracted protein hydrolysates (E1-E4) 
The enzyme-extracted hydrolysates were labelled E1-E4 and are more fully 
described in Table 1, Chapter 6. 
 
Membrane fractionation of alkaline-extracted protein hydrolysates 
The hydrolysates were labelled U1-U6 and are more fully described in Table 2, 
Chapter 6.  
 
Generation of the protein hydrolysates using combinations of Alcalase, Brewers 
Clarex and Flavourzyme (A-J) 
The hydrolysates generated using combinations of Alcalase, Brewers Clarex and 
Flavourzyme were labelled A-J and are more fully described in Table 1, Chapter 
5. 
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Cell culture 
Jurkat T cells and U937 cells were maintained in antibiotic-free Roswell Park 
Memorial Institute (RPMI)-1640 medium supplemented with 10% (v/v) fetal 
bovine serum (FBS) and plated at a density of 1 x 10
5
 and 2 x 10
5
 cells mL
-1
 for 
the cell proliferation assay, respectively. U937 cells were plated at a density of 1 x 
10
5
 and 2 x 10
6
 cells mL
-1
 for the Hoechst staining and DNA fragmentation assay, 
respectively. RAW 264.7 cells, MCF-7 cells and HepG2 cells were grown in 
Dulbecco’s Modified Eagle Medium (DMEM) media supplemented with 10% 
FBS. Cells were seeded at a density of 0.2 x 10
5
 and 0.5 x 10
5
 cells mL
-1
 for the 
cell proliferation assay, respectively. Cells were maintained at 37°C in a 5% CO2 
atmosphere. Reduced serum media (2.5% FBS) was used for all experiments. 
 
Cell Proliferation 
The (3-(4, 5-Dimethylthiazol-2-yl)-2, 5-diphenyltetrazolium bromide (MTT) 
assay was used to measure the effect of the extracts on cell proliferation in all cell 
lines. Cells were incubated for 24 h at 37°C with BSG extracts at concentrations 
of 0 to 20% (v/v) (phenolic extracts) or 0 to 0.2% (w/v) (protein extracts). The 
MTT assay kit (MTT I proliferation kit, Roche Diagnostics, West Sussex, UK) 
was then used to measure cell proliferation. Absorbance was determined at 570 
nm using a microplate reader (VarioskanFlash, Thermo Scientific, Waltham, MA) 
and cell proliferation was calculated as a percentage of the control, untreated cells. 
An inhibitory concentration-50 (IC50) value, the concentration of a compound that 
reduces cell proliferation to 50% of the untreated control cells, was determined for 
each of the BSG samples.  
 
Determination of apoptosis  
The nuclear morphology of U937 cells treated with BSG phenolic extracts (IC50 
values detailed in Crowley et al. (2017) and Table 3, Chapter 3) or Doxorubicin 
(0.5 µg mL
-1
) was measured by fluorescence microscopy after staining with 
Hoechst 33342. After 24 hour incubation, approximately 2 x 10
5 
cells mL
-1 
were 
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harvested by centrifugation (200 g, 10 minutes) to form a pellet. Hoechst 33342 
stain (5 µg mL
-1
 PBS) was added and the samples were incubated at 37°C for 30 
minutes. Stained samples were placed on a microscope slide and examined under 
UV light (330–380 nm) using a Nikon fluorescence microscope (200x 
magnification). A total of 300 cells in each sample were analysed and the 
percentage of condensed/fragmented (apoptotic) nuclei was calculated. 
 
DNA fragmentation assay 
Detection of small DNA fragments was carried out as previously described 
(O’Callaghan et al., 2010). Briefly, 2 x 105 cells mL-1 were harvested and the 
pellets were lysed; RNAse A (0.25 mg mL
-1
) was added and the samples were 
incubated at 50°C for 1 h. Proteinase K (5 mg mL
-1
) was added and the samples 
were incubated at 50°C for a further hour. Both the samples and a 100– 1500 bp 
DNA standard (Promega, Medical Supply Co. Ltd, Dublin, Ireland) were loaded 
to the wells of a 1.5% agarose gel and electrophoresis was performed in TBE 
buffer (0.45 M tris(hydroxymethyl) aminomethane, 0.45 M boric acid, and 2 mM 
EDTA, pH 8), at 3 V cm
-1
. The gel was visualised using a UV transilluminator 
(312 nm) and photographed using an image analysis system. 
 
Statistical analysis 
All data represent the mean ± standard error (SE) of at least three independent 
experiments. Statistical analysis was performed using a one-way analysis of 
variance (ANOVA) followed by Dunnett’s test using GraphPad Prism 4 
(GraphPad software, La Jolla, CA).  
 
Results 
Antiproliferative effects of BSG phenolic extracts 
The antiproliferative effects of BSG phenolic extracts were assessed in the Jurkat, 
RAW and MCF-7 cell lines. In Jurkat T cells, dose-dependent antiproliferative 
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effects were noted with the addition of BSG phenolic extracts (Table 1). Phenolic 
extracts from black, wet BSG (BW1-BW4), were more cytotoxic to this cancer 
cell line than other extracts, as noted by the lower IC50 values (1.4 – 3.1% v/v).  
With the exception of the black BSG control (BW1), all black BSG extracts 
demonstrated statistically significant (P<0.05) toxic effects in RAW 264.7 cells, 
across the concentration range tested (Table 2). The extract, PW3, from pale, wet 
BSG also demonstrated cytotoxic effects at all concentrations. Extracts PW2 and 
PW3 were produced using the same volume of carbohydrase, 100 µLg
-
BSGdw 
Depol 740L. PW3 was produced using a pH 7, while PW2 was generated using 
pH5. However, extract PW2 did not demonstrate any cytotoxic effects, suggesting 
that the change in pH may have had a significant impact on the extract’s toxicity 
profile. Apart from PW3, IC50 values could not be calculated for extracts from 
wet, pale BSG.  
All black BSG phenolic extracts exhibited dose-dependent antiproliferative 
effects in MCF-7 cells (Table 3). The phenolic extracts had a lesser impact on 
MCF-7 cells compared to RAW cells, as noted by the inability to calculate IC50 
values for all extracts apart from BW2, in MCF-7 cells.  
 
Antiproliferative effects of BSG protein hydrolysates 
The impact of BSG protein hydrolysates on the cell proliferation was assessed in 
the cell lines; Jurkat T cells, U937 cells, HepG2 cells and MCF-7 cells (Tables 4-
14). Protein hydrolysates produced using either alkaline or enzyme hydrolysis 
(A1-E4) were assessed in Jurkat T cells at a concentration range between 0-0.2% 
(w/v) (Table 4). Dose-dependent decreases in cell proliferation were noted with 
alkaline-extracted hydrolysates (A1-A4) and enzyme-extracted hydrolysates (E1-
E4). The impact of alkaline-extracted hydrolysates subjected to SGID (S1-S4), on 
Jurkat T cell proliferation, was far less, considering that IC50 values could not be 
calculated for these extracts. Alkaline-extracted hydrolysates subjected to 
membrane fractionation (U1-U6) did not have any significant impact on the 
proliferation of Jurkat T cells (Table 5).
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Table 1: Effect of brewers’ spent grain (BSG) phenolic extracts (0-20% (v/v)) on cell proliferation in Jurkat T cells as measured by 
(3-(4, 5-Dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assay. 
 0.5% 1% 2% 2.5% 4% 6% 8% 10% 15% 20% IC50 
BW1 55.1 ± 4.1* 55.1 ± 13.5* 52.1 ± 10.1* 44.5 ± 14.8* 42.0 ± 21.2* 41.6 ± 7.9* 15.7 ± 9.7* 0.0 ± 0.0* 5.9 ± 5.9* 0.0 ± 0.0* 1.4 
BW2 69.5 ± 6.5 64.9 ± 9.4 54.3 ± 27.3 63.1 ± 10.8 63.7 ± 3.0 48.7 ± 13.7* 31.8 ± 11.9* 28.9 ± 4.1* 0.0 ± 0.0* 1.3 ± 1.3* 3.1 
BW3 66.1 ± 6.2 66.9 ± 13.8 57.4 ± 9.8 58.8 ± 22.2 48.6 ± 19.2 34.5 ± 19.3 33.1 ± 23.8 43.8 ± 17.8 19.3 ± 19.3* 7.7 ± 4.5* 2.9 
BW4 57.4 ± 6.2 49.5 ± 2.0* 76.7 ± 7.9 39.4 ± 12.3* 60.6 ± 11.3 60.8 ± 21.7 16.7 ± 16.7* 6.2 ± 6.2* 0.0 ± 0.0* 15.7 ± 15.7* 2.1 
BD1 56.5 ± 9.0 54.8 ± 1.7* 39.9 ± 8.4* 52.7 ± 12.4* 45.1 ± 19.3* 64.5 ± 9.2 46.1 ± 6.3* 57.1 ± 5.9 62.1 ± 18.2 37.2 ± 8.5* n/d 
BD2 61.0 ± 4.3 66.7 ± 2.2 58.7 ± 6.8 65.5 ± 19.9 51.6 ± 13.4* 64.0 ± 14.2 48.0 ± 15.3* 30.2 ± 11.3* 11.5 ± 7.7* 0.1 ± 0.1* 3.5 
PW1 88.2 ± 2.5 79.5 ± 10.1 84.5 ± 7.6 87.3 ± 12.1 87.8 ± 9.6 86.3 ± 10.4 90.7 ± 4.2 84.7 ± 2.7 80.2 ± 5.7 90.7 ± 13.9 n/d 
PW2 90.8 ± 11.9 89.2 ± 14.6 91.4 ± 20.4 87.3 ± 10.5 81.4 ± 6.6 80.5 ± 12.0 88.4 ± 9.7 81.0 ± 5.3 68.1 ± 10.3 48.9 ± 7.6* n/d 
PW3 111.0 ± 2.5 112.8 ± 1.3 114.1 ± 5.4 114.2 ± 6.8 100.1 ± 1.2 95.0 ± 4.0 74.2 ± 7.9* 80.4 ± 1.7* 77.2 ± 1.6* 69.1 ± 0.3* 29.7 
PW4 87.9 ± 5.3 89.4 ± 6.6 79.0 ± 5.4 108.0 ± 22.3 94.2 ± 12.7 74.9 ± 7.3 88.6 ± 18.5 84.9 ± 13.5 49.0 ± 12.9* 49.0 ± 4.1* n/d 
PW5 99.5 ± 14.8 63.1 ± 3.9 86.0 ± 2.8 98.9 ± 15.2 79.9 ± 5.3 76.2 ± 17.6 66.2 ± 10.2 70.8 ± 7.0 44.6 ± 12.0* 49.5 ± 15.6* 19.5 
PD1 108.1 ± 13.6 120.2 ± 14.5 105.7 ± 7.4 107.5 ± 10.0 103.9 ± 8.3 94.6 ± 9.3 80.8 ± 10.4 84.2 ± 16.8 93.6 ± 11.6 64.8 ± 10.1 n/d 
PD2 113.8 ± 10.0 108.0 ± 11.5 94.2 ± 2.2 90.5 ± 2.9 88.9 ± 2.0 94.8 ± 4.6 73.0 ± 8.3 67.7 ± 7.6* 72.8 ± 5.6 51.4 ± 12.6* 22.7 
PD3 108.4 ± 5.1 124.2 ± 7.2* 113.1 ± 6.0 117.2 ± 6.1 105.5 ± 4.7 104.5 ± 2.5 100.7 ± 5.7 96.9 ± 3.6 85.6 ± 3.2 79.3 ± 7.5 29.6 
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Values are mean ± SE of three independent experiments, expressed as a percentage relative to untreated Jurkat T cells. BW1-4 
represent extracts from black, wet BSG; BD1-2 represents extracts from black, dry BSG; PW1-5 represents extracts from pale, wet 
BSG and PD1-3 represents extracts from pale, dry BSG. Statistical analysis by ANOVA followed by Dunnett’s Test. * Denotes 
statistically significant difference in cell proliferation, relative to untreated Jurkat T cells (P<0.05). n/d: IC50 was not determinable for 
the range of concentrations tested.
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Table 2: Effect of brewers’ spent grain (BSG) phenolic extracts (0-20% (v/v)) on cell proliferation in RAW 264.7 cells as measured 
by (3-(4, 5-Dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assay. 
 0.5% 1% 2% 2.5% 4% 6% 8% 10% 15% 20% IC50 
BW1 50.0 ± 5.2 71.1 ± 23.6 45.6 ± 11.1 47.2 ± 7.3 60.5 ± 17.0 65.2 ± 19.9 67.1 ± 19.1 51.1 ± 9.7 61.6 ± 20.2 59.7 ± 11.3 0.05 
BW2 40.9 ± 9.2* 46.2 ± 2.0* 46.4 ± 3.4* 41.4 ± 2.6* 50.7 ± 1.5* 47.5 ± 5.3* 54.4 ± 3.2* 46.0 ± 0.4* 59.5 ± 6.5* 49.7 ± 6.6* 7.0 
BW3 54.2 ± 4.6* 54.3 ± 8.9* 49.1 ± 7.3* 49.2 ± 6.5* 50.2 ± 6.8* 47.1 ± 4.0* 49.8 ± 8.7* 56.6 ± 9.0* 53.8 ± 3.2* 54.0 ± 2.2* n/d 
BW4 44.1 ± 6.8* 55.2 ± 7.2* 46.2 ± 1.9* 42.9 ± 4.7* 53.8 ± 5.1* 52.6 ± 3.6* 53.8 ± 1.2* 51.9 ± 5.6* 50.3 ± 4.6* 56.1 ± 6.0* 3.0 
BD1 58.1 ± 8.0* 48.0 ± 7.4* 45.0 ± 9.7* 43.9 ± 5.1* 42.8 ± 7.2* 50.8 ± 10.3* 54.0 ± 8.7* 44.7 ± 2.9* 54.9 ± 9.5* 61.2 ± 16.1* 3.1 
BD2 51.6 ± 5.8* 48.5 ± 9.8* 45.3 ± 4.2* 44.8 ± 2.8* 44.7 ± 3.9* 49.4 ± 7.8* 53.1 ± 7.0* 65.9 ± 15.3* 51.1 ± 5.1* 55.6 ± 5.2* 2.8 
PW1 105.0 ± 2.2 109.3 ± 1.2 109.1 ± 6.5 118.9 ± 18.4 124.0 ± 16.9 112.1 ± 11.3 123.2 ± 8.4 104.7 ± 4.3 122.2 ± 19.7 129.1 ± 25.7 n/d 
PW2 140.5 ± 9.5 141.1 ± 20.2 135.4 ± 1.2 136.6 ± 6.2 138.1 ± 14.2 136.9 ± 3.2 138.9 ± 11.0 124.4 ± 5.1 132.6 ± 23.9 141.0 ± 19.5 n/d 
PW3 72.7 ± 12.2* 70.4 ± 7.5* 53.9 ± 6.6* 51.2 ± 2.9* 42.2 ± 2.2* 46.5 ± 5.8* 50.1 ± 5.9* 48.7 ± 5.1* 45.1 ± 4.3* 47.6 ± 5.6* 6.1 
PW4 95.8 ± 19.5 107.6 ± 6.8 84.7 ± 8.3 83.0 ± 4.5 76.3 ± 9.7 100.6 ± 8.8 74.7 ± 4.9 85.7 ± 12.6 74.8 ± 7.9 60.9 ± 10.2 n/d 
PW5 100.7 ± 9.0 88.9 ± 17.8 70.5 ± 10.9 68.7 ± 12.0 68.5 ± 11.4 73.7 ± 11.2 68.0 ± 9.3 63.9 ± 11.7 62.7 ± 6.7 70.4 ± 14.4 n/d 
PD1 99.8 ± 22.4 98.7 ± 29.7 101.1 ± 28.2 104.7 ± 30.4 92.2 ± 19.6 65.0 ± 2.6 64.7 ± 13.9 45.8 ± 6.8 60.9 ± 18.2 46.3 ± 6.8 14.8 
PD2 88.1 ± 8.4 88.4 ± 10.2 81.8 ± 5.2 78.8 ± 11.3 74.4 ± 11.7 56.6 ± 7.7* 56.5 ± 7.6* 53.9 ± 8.3* 47.5 ± 6.0* 39.9 ± 7.1* 11.9 
PD3 91.4 ± 10.1 87.0 ± 6.9 89.8 ± 4.4 85.4 ± 5.7 78.1 ± 13.1 71.9 ± 9.0 61.0 ± 3.1* 57.2 ± 2.5* 60.2 ± 10.9* 47.5 ± 1.6* 18.6 
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Values are mean ± SE of three independent experiments, expressed as a percentage relative to untreated RAW 264.7 cells. BW1-4 
represent extracts from black, wet BSG; BD1-2 represents extracts from black, dry BSG; PW1-5 represents extracts from pale, wet 
BSG and PD1-3 represents extracts from pale, dry BSG. Statistical analysis by ANOVA followed by Dunnett’s Test. * Denotes 
statistically significant difference in cell proliferation, relative to untreated RAW 264.7 cells (P<0.05). n/d: IC50 was not determinable 
for the range of concentrations tested. 
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Table 3: Effect of brewers’ spent grain (BSG) phenolic extracts (0-20% (v/v)) on cell proliferation in MCF-7 cells as measured by 
(3-(4, 5-Dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assay. 
 0.5% 1% 2% 2.5% 4% 6% 8% 10% 15% 20% IC50 
BW1 82.5 ± 3.7 88.0 ± 12.0 64.2 ± 5.0* 67.3 ± 3.8* 68.1 ± 6.8* 66.1 ± 6.2* 65.6 ± 4.4* 72.4 ± 7.2 71.8 ± 10.0 66.7 ± 12.2* n/d 
BW2 74.2 ± 9.3 67.9 ± 5.5* 60.8 ± 4.4* 64.0 ± 5.3* 57.6 ± 4.1* 58.5 ± 4.6* 60.7 ± 2.1* 39.4 ± 8.5* 49.4 ± 10.5* 41.9 ± 15.7* 10.9 
BW3 79.3 ± 2.6 66.4 ± 7.3* 68.8 ± 8.6 63.3 ± 7.4* 65.7 ± 8.3* 65.1 ± 3.2* 51.6 ± 9.5* 58.2 ± 10.6* 59.0 ± 5.9* 48.6 ± 11.1* n/d 
BW4 68.7 ± 7.6 63.8 ± 11.1 60.7 ± 5.5* 60.8 ± 8.0* 57.4 ± 7.7* 58.6 ± 8.6* 57.5 ± 12.9* 56.7 ± 7.8* 55.7 ± 9.3* 49.8 ± 13.7* n/d 
BD1 83.9 ± 8.4 74.2 ± 6.0 68.2 ± 12.3 66.3 ± 4.3 70.9 ± 12.1 74.9 ± 7.3 71.8 ± 13.8 65.7 ± 6.9 66.6 ± 10.5 56.5 ± 5.6* n/d 
BD2 68.7 ± 6.0 69.4 ± 7.2 58.6 ± 5.8* 62.4 ± 5.1* 56.0 ± 5.1* 60.5 ± 4.0* 63.3 ± 10.1* 57.3 ± 9.1* 52.7 ± 18.3* 53.9 ± 9.5* n/d 
PW1 106.4 ± 3.5 94.6 ± 1.7 93.6 ± 4.9 92.8 ± 3.1 87.9 ± 13.9 87.0 ± 3.5 91.5 ± 4.5 94.9 ± 3.0 85.5 ± 1.3 70.7 ± 12.9* n/d 
PW2 94.4 ± 9.7 94.5 ± 11.7 89.5 ± 11.5 87.5 ± 13.9 108.5 ± 14.5 103.1 ± 11.2 90.1 ± 4.0 94.8 ± 8.8 92.0 ± 3.5 72.6 ± 18.4 n/d 
PW3 95.0 ± 6.1 94.0 ± 7.5 95.5 ± 6.0 88.1 ± 10.6 85.7 ± 16.1 93.0 ± 0.5 93.2 ± 2.0 92.0 ± 4.0 100.0 ± 3.8 95.6 ± 5.4 n/d 
PW4 88.2 ± 8.4 93.8 ± 12.7 87.9 ± 11.2 88.0 ± 9.8 83.6 ± 7.4 79.0 ± 18.4 98.1 ± 23.7 87.2 ± 12.8 101.1 ± 16.4 67.9 ± 15.8 n/d 
PW5 95.2 ± 10.2 83.9 ± 6.9 82.1 ± 4.7 84.1 ± 6.7 91.8 ± 10.5 90.3 ± 11.0 80.2 ± 7.6 84.8 ± 15.0 87.3 ± 7.2 62.1 ± 11.6* n/d 
PD1 90.3 ± 6.0 86.5 ± 4.2 79.5 ± 4.6 75.5 ± 4.9 69.1 ± 2.7* 74.7 ± 5.9 76.4 ± 10.1 72.8 ± 4.7* 66.8 ± 12.3* 72.4 ± 9.6* n/d 
PD2 99.4 ± 3.7 96.5 ± 5.1 83.8 ± 2.5 83.5 ± 2.9 75.3 ± 5.1* 79.6 ± 3.6 82.6 ± 7.3 70.5 ± 8.8* 82.3 ± 5.1 81.0 ± 7.4 n/d 
PD3 90.6 ± 3.2 90.7 ± 3.8 81.0 ± 3.0 78.4 ± 6.5 83.5 ± 10.7 91.5 ± 9.6 87.8 ± 4.9 85.3 ± 3.4 96.7 ± 11.1 72.0 ± 19.3 n/d 
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Values are mean ± SE of three independent experiments, expressed as a percentage relative to untreated MCF-7 cells. BW1-4 
represent extracts from black, wet BSG; BD1-2 represents extracts from black, dry BSG; PW1-5 represents extracts from pale, wet 
BSG and PD1-3 represents extracts from pale, dry BSG. Statistical analysis by ANOVA followed by Dunnett’s Test. * Denotes 
statistically significant difference in cell proliferation, relative to untreated MCF-7 cells (P<0.05). n/d: IC50 was not determinable for 
the range of concentrations tested. 
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Table 4: Effects of brewers’ spent grain (BSG) protein hydrolysates A1-E4 (0-0.2% (w/v)) on cell proliferation in the Jurkat T cells 
as measured by (3-(4, 5-Dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assay. 
 0.005% 0.01% 0.02% 0.025% 0.04% 0.06% 0.08% 0.1% 0.15% 0.2% IC50 
A1 100.8±9.6 95.9±4.5 85.6±1.9 99.4±5.2 81.5±21.8 45.3±20.0* 18.6±0.4* 21.5±3.9* 25.1±4.3* 21.4±11.2* 0.06 
S1 64.7±11.2 58.9±13.1* 62.0±13.2* 59.4±7.8* 71.9±6.0 60.7±10.2* 69.5±6.1 72.6±10.4 65.3±6.8 41.4±8.2* n/d 
E1 68.2±16.2 60.1±16.0 50.2±17.1 47.0±12.5* 52.8±12.7 53.0±8.7 46.6±13.6 52.1±12.7 30.6±9.8* 29.8±12.7* 0.04 
A2 102.6±5.8 99.9±13.0 90.8±16.1 86.0±14.4 109.9±14.1 58.9±22.9 29.7±15.2* 13.3±2.5* 19.1±3.1* 16.4±5.0* 0.07 
S2 62.1±18.7 67.9±19.7 77.3±24.3 75.0±16.8 80.2±16.4 81.7±16.5 85.9±16.3 67.3±19.1 91.5±22.7 75.7±17.6 n/d 
E2 78.0±15.4 69.3±12.0 58.0±14.5 62.5±11.4 70.7±20.7 63.1±4.9 62.3±4.9 61.4±8.4 71.1±12.1 63.6±6.5 n/d 
A3 93.1±7.2 95.3±4.8 91.1±1.3 94.9±4.1 105.7±3.5 72.0±13.8 53.4±24.2* 9.4±2.4* 27.2±5.7* 11.4±5.1* 0.08 
S3 69.0±12.4 63.1±11.3 64.6±10.5 65.7±13.8 66.6±12.2 62.3±10.7 69.0±8.7 65.5±11.3 62.3±13.5 59.2±5.8 n/d 
E3 77.0±15.3 71.5±17.8 71.5±18.6 63.3±15.0 54.6±12.3 49.5±10.5 64.1±13.3 59.6±15.3 41.5±13.3* 35.5±10.6* 0.1 
A4 95.1±19.6 108.0±14.7 110.3±9.0 103.5±11.9 116.3±14.4 66.7±14.6 42.1±3.2* 25.7±9.8* 33.0±8.6* 16.2±0.3* 0.08 
S4 75.7±14.5 64.8±15.7 69.1±13.7 62.6±15.2 68.1±11.2 62.4±10.4 70.6±11.7 70.9±8.9 65.2±19.0 58.4±8.2 n/d 
E4 58.2±9.9 50.6±12.1* 53.3±11.3* 54.9±13.0* 50.9±13.9* 51.5±11.7* 48.6±12.8* 49.5±12.0* 47.5±10.1* 39.5±6.0* 0.05 
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Values are mean ± SE of at least three independent experiments. Statistical analysis was by ANOVA followed by Dunnett’s test. * 
Denotes significant difference (P<0.05) in cell proliferation relative to untreated control Jurkat T cells. n/d: IC50 was not determinable 
for the range of concentrations tested. A1 is a BSG protein hydrolysate prepared via alkaline hydrolysis and subjected to further 
hydrolysis by ProPro. S1 is A1 subjected to SGID. E1 is prepared via direct enzyme hydrolysis by ProPro. A2 is a BSG protein 
hydrolysate prepared via alkaline hydrolysis and subjected to further hydrolysis by CorPPFla. S2 is A2 subjected to SGID. E2 is 
prepared via direct enzyme hydrolysis by CorPPFla. A3 is a BSG protein hydrolysate prepared via alkaline hydrolysis and subjected 
to further hydrolysis by AlcPro. S3 is A3 subjected to SGID. E3 is prepared via direct enzyme hydrolysis by AlcPro. A4 is a BSG 
protein hydrolysate prepared via alkaline hydrolysis and subjected to further hydrolysis by AlcFla. S4 is A4 subjected to SGID. E4 is 
prepared via direct enzyme hydrolysis by AlcFla. 
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Table 5: Effects of brewers’ spent grain (BSG) protein hydrolysates U1-U6 (0-0.2% (w/v)) on cell proliferation in the Jurkat T cells 
as measured by (3-(4, 5-Dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assay. 
 0.005 0.01 0.02 0.025 0.04 0.06 0.08 0.1 0.15 0.2 IC50 
U1 85.5±3.2 99.6±5.3 87.7±13.5 95.6±11.8 92.8±8.6 91.6±5.9 90.9±20.8 79.7±16.6 59.7±13.4 75.4±9.0 0.5 
U2 81.5±7.8 93.0±11.6 94.9±9.4 97.4±9.3 105.4±8.7 95.3±8.1 88.3±14.7 109.8±13.0 104.9±9.4 99.3±18.9 n/d 
U3 86.3±8.4 92.7±11.3 93.5±7.4 84.4±16.6 96.0±12.1 86.9±3.4 87.2±10.5 86.1±9.3 67.3±3.9 81.7±15.3 n/d 
U4 92.9±13.1 106.9±14.5 112.5±15.1 93.2±21.1 95.1±10.1 106.6±12.5 102.0±7.4 91.5±17.5 84.5±11.5 87.6±3.2 0.5 
U5 94.9±23.4 108.8±14.5 104.1±19.9 110.8±2.7 95.6±1.4 99.8±19.9 77.5±17.1 89.6±5.7 95.6±2.0 82.5±14.7 0.7 
U6 72.8±9.9 89.1±15.1 99.7±21.3 104.7±18.2 100.6±24.5 93.0±9.5 94.9±22.5 100.5±23.7 84.6±21.2 81.7±15.3 n/d 
Values are mean ± SE of at least three independent experiments. Statistical analysis was by ANOVA followed by Dunnett’s test. n/d: 
IC50 was not determinable for the range of concentrations tested. U1 is a 30kDa Retentate prepared via alkaline hydrolysis and 
subjected to further hydrolysis by CorPPFla. U2 is a 30kDa Retentate prepared via alkaline hydrolysis and subjected to further 
hydrolysis by AlcFla. U3 is a 30kDa Permeate prepared via alkaline hydrolysis and subjected to further hydrolysis by CorPPFla. U4 
is a 30kDa Permeate prepared via alkaline hydrolysis and subjected to further hydrolysis by AlcFla. U5 is a 10kDa Permeate 
prepared via alkaline hydrolysis and subjected to further hydrolysis by CorPPFla. U6 is a 10kDa Permeate prepared via alkaline 
hydrolysis and subjected to further hydrolysis by AlcFla. 
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Table 6: Effects of brewers’ spent grain (BSG) protein hydrolysates A1-E4 (0-0.2% (w/v)) on cell proliferation in the U937 cells as 
measured by (3-(4, 5-Dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assay. 
 0.005 0.01 0.02 0.025 0.04 0.06 0.08 0.1 0.15 0.2 IC50 
A1 81.3 ± 8.1 84.6 ± 11.9 84.9 ± 9.3 95.4 ± 9.4 87.8 ± 4.8 72.6 ± 12.4 63.1 ± 10.1 33.8 ± 11.9* 29.9 ± 7.2* 36.9 ± 9.5* 0.1 
S1 71.6 ± 9.7* 71.0 ± 4.7* 63.8 ± 4.4* 66.5 ± 6.5* 65.5 ± 3.0* 63.3 ± 4.8 * 57.9 ± 12.2* 71.9 ± 4.6* 71.5 ± 6.8* 70.4 ± 5.3* n/d 
E1 86.2 ± 4.1 86.6 ± 8.2 89.1± 13.3 78.0 ± 9.5 70.9 ± 7.9 69.8 ± 8.2* 58.7 ± 8.8* 70.9 ± 7.6 47.8 ± 3.4* 42.9 ± 4.7* 0.18 
A2 77.8 ± 6.3 76.3 ± 3.1 86.2 ±6.3 93.1 ± 7.3 103.1 ± 10.3 90.5 ± 12.3 76.9 ± 21.3 34.2 ± 14.1* 17.2 ± 4.1* 17.4 ± 2.6* 0.1 
S2 86.9 ± 9.8 88.7 ± 14.2 89.1 ± 7.4 86.3 ± 13.6 91.4 ± 9.7 91.1 ± 10.5 96.0 ± 9.9 90.4 ± 10.0 95.1 ± 15.2 77.3 ± 9.4 n/d 
E2 82.2 ± 4.4 83.2 ± 8.6 80.9 ± 2.9 81.4 ± 3.5 79.4 ± 2.9 86.9 ± 6.0 67.6 ± 7.4* 74.3 ± 3.0 91.2 ± 14.6 94.4 ± 15.5 n/d 
A3 72.0 ± 6.1 75.2 ± 3.5 89.3 ± 7.6 87.0 ± 1.9 101.1 ± 5.3 81.0 ± 13.7 89.6 ± 14.6 73.7 ± 18.8 14.0 ± 1.7* 14.0 ± 2.4* 0.12 
S3 101.3 ± 4.4 89.8 ± 2.6 99.1 ± 9.4 80.2 ± 7.0 89.6 ± 5.4 83.1 ± 4.4 88.7 ± 3.6 85.9 ± 5.8 91.0 ± 10.9 84.1 ± 10.3 n/d 
E3 78.1 ± 6.4 77.9 ± 8.9 76.5 ± 3.0 74.7 ± 5.7 68.5 ± 4.9* 61.6 ± 15.3* 64.2 ± 5.5* 64.7 ± 3.6* 62.5 ± 7.6* 60.9 ± 8.8* 0.87 
A4 76.6 ±10.2 91.8 ± 7.5 88.2 ± 6.5 100.1 ± 6.6 109.4 ± 10.5 90.3 ± 25.7 82.5 ± 20.8 71.0 ± 17.7 24.2 ± 8.2* 27.4 ± 9.3* 0.12 
S4 87.8 ± 5.3 82.7 ± 6.3 85.8 ± 5.2 73.8 ± 6.1 72.8 ± 3.8 62.7 ± 18.5* 89.5 ± 10.2 76.8 ± 5.8 81.2 ± 7.2 81.0 ± 4.3 n/d 
E4 66.7 ± 3.4* 70.7 ± 8.6* 59.9 ± 4.8* 60.0 ± 2.5* 57.6 ± 9.4* 55.5 ± 2.8* 64.5 ± 7.8* 63.5 ± 6.0* 59.9 ± 4.7* 61.6 ± 5.2* n/d 
221 
 
Values are mean ± SE of at least three independent experiments. Statistical analysis was by ANOVA followed by Dunnett’s test. * 
Denotes significant difference (P<0.05) in cell proliferation relative to untreated control U937 cells. n/d: IC50 was not determinable 
for the range of concentrations tested. A1 is a BSG protein hydrolysate prepared via alkaline hydrolysis and subjected to further 
hydrolysis by ProPro. S1 is A1 subjected to SGID. E1 is prepared via direct enzyme hydrolysis by ProPro. A2 is a BSG protein 
hydrolysate prepared via alkaline hydrolysis and subjected to further hydrolysis by CorPPFla. S2 is A2 subjected to SGID. E2 is 
prepared via direct enzyme hydrolysis by CorPPFla. A3 is a BSG protein hydrolysate prepared via alkaline hydrolysis and subjected 
to further hydrolysis by AlcPro. S3 is A3 subjected to SGID. E3 is prepared via direct enzyme hydrolysis by AlcPro. A4 is a BSG 
protein hydrolysate prepared via alkaline hydrolysis and subjected to further hydrolysis by AlcFla. S4 is A4 subjected to SGID. E4 is 
prepared via direct enzyme hydrolysis by AlcFla. 
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Table 7: Effects of brewers’ spent grain (BSG) protein hydrolysates U1-U6 (0-0.2% (w/v)) on cell proliferation in the U937 cells as 
measured by (3-(4, 5-Dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assay. 
 0.005 0.01 0.02 0.025 0.04 0.06 0.08 0.1 0.15 0.2 IC50 
U1 91.5 ± 7.8 97.0 ± 5.1 93.8 ± 4.9 99.3 ± 1.6 88.1 ± 10.1 98.1 ± 3.7 84.8 ± 2.3 68.9 ± 13.8 48.7 ± 24.6* 71.0 ± 4.1 0.26 
U2 69.6 ± 14.1 76.9 ± 13.1 74.9 ± 9.3 81.3 ± 13.6 66.6 ± 7.1 89.6 ± 11.2 87.6 ± 10.3 69.8 ± 5.0 70.6 ± 16.6 24.6 ± 23.6* 0.54 
U3 102.6 ± 15.8 97.7 ± 18.2 86.7 ± 17.6 83.0 ± 10.4 86.8 ± 10.2 78.5 ± 7.7 68.7 ± 11.5 78.0 ± 13.2 87.1 ± 15.4 91.2 ± 20.2 n/d 
U4 100.2 ± 11.5 120.0 ± 3.7 121.9 ± 6.7 102.7 ± 6.9 100.8 ± 3.4 113.4 ± 5.6 124.0 ± 16.1 104.5 ± 9.2 113.6 ± 11.5 98.3 ± 5.0 n/d 
U5 90.2 ± 7.4 108.1 ± 14.7 94.1 ± 13.7 111.3 ± 14.7 101.0 ± 12.0 96.7 ± 23.4 104.7 ± 13.1 94.5 ± 10.8 99.5 ± 16.7 92.3 ± 15.8 n/d 
U6 112.4 ± 6.2 131.9 ± 16.8 130.7 ± 14.5 139.9 ± 25.0 122.9 ± 9.3 122.7 ± 3.8 112.8 ± 5.9 111.7 ± 6.5 114.4 ± 7.1 109.2 ± 10.0 n/d 
Values are mean ± SE of at least three independent experiments. Statistical analysis was by ANOVA followed by Dunnett’s test. * 
Denotes significant difference (P<0.05) in cell proliferation relative to untreated control U937 cells. n/d: IC50 was not determinable 
for the range of concentrations tested. U1 is a 30kDa Retentate prepared via alkaline hydrolysis and subjected to further hydrolysis by 
CorPPFla. U2 is a 30kDa Retentate prepared via alkaline hydrolysis and subjected to further hydrolysis by AlcFla. U3 is a 30kDa 
Permeate prepared via alkaline hydrolysis and subjected to further hydrolysis by CorPPFla. U4 is a 30kDa Permeate prepared via 
alkaline hydrolysis and subjected to further hydrolysis by AlcFla. U5 is a 10kDa Permeate prepared via alkaline hydrolysis and 
subjected to further hydrolysis by CorPPFla. U6 is a 10kDa Permeate prepared via alkaline hydrolysis and subjected to further 
hydrolysis by AlcFla. 
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Table 8: Effects of brewers’ spent grain (BSG) protein hydrolysates A-J (0-0.2% (w/v)) on cell proliferation in the U937 cells as 
measured by (3-(4, 5-Dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assay. 
 0.005 0.01 0.02 0.025 0.04 0.06 0.08 0.1 0.15 0.2 IC50 
A 84.9 ± 6.1 76.9 ± 0.8 80.5 ± 3.2 75.7 ± 5.9 72.9 ± 10.7 73.2 ± 9.7 75.9 ± 10.7 77.2 ± 12.7 76.1 ± 13.4 72.9 ± 9.0 n/d 
B 78.8 ± 1.2 82.8 ± 5.6 75.2 ± 3.0 89.1 ± 17.7 102.0 ± 11.8 96.8 ± 22.4 90.4 ± 16.4 103.8 ± 26.4 109.2 ± 34.6 106.5 ± 40.8 n/d 
C 78.3 ± 11.3 81.6 ± 17.4 90.7 ± 17.1 81.7 ± 6.8 77.3 ± 2.5 60.8 ± 28.7 81.3 ± 10.6 87.6 ± 4.8 89.0 ± 7.0 73.0 ± 11.3 n/d 
D 84.6 ± 8.0 88.8 ± 10.4 92.9 ± 19.2 93.0 ± 18.7 93.0 ± 11.6 100.5 ± 11.6 90.6 ± 16.0 89.8 ± 15.9 65.1 ± 32.4 96.9 ± 10.0 n/d 
E 61.6 ± 5.5* 75.5 ± 8.4 86.8 ± 8.2 82.4 ± 10.7 76.4 ± 11.1 82.0 ± 8.7 87.0 ± 9.1 89.2 ± 12.1 95.1 ± 8.7 89.6 ± 7.5 n/d 
F 60.3 ± 3.5 63.5 ± 9.6 70.3 ± 12.3 78.0 ± 12.8 61.9 ± 13.9 80.1 ± 9.9 70.1 ± 13.1 77.7 ± 12.2 75.7 ± 13.4 74.9 ± 10.9 n/d 
G 67.1 ± 9.6 66.4 ± 9.6 68.5 ± 10.0 70.8 ± 9.7 76.8 ± 16.8 67.7 ± 11.3 65.4 ± 7.7 69.9 ± 7.4 76.0 ± 10.4 69.3 ± 6.7 n/d 
H 71.1 ± 15.0 75.0 ± 13.8 73.0 ± 15.2 76.6 ± 19.2 83.8 ± 14.2 77.3 ± 14.2 86.6 ± 11.1 88.5 ± 10.9 91.2 ± 20.4 94.7 ± 17.8 n/d 
I 72.1 ± 6.3 76.3 ± 5.0 83.9 ± 10.8 77.4 ± 11.0 74.8 ± 10.8 81.8 ± 7.7 71.1 ± 9.5 75.8 ± 4.0 58.7 ± 20.0 78.5 ± 12.5 n/d 
J 76.8 ± 8.7 82.9 ± 13.0 78.2 ± 11.2 88.0 ± 16.9 81.3 ± 18.4 85.3 ± 12.6 91.5 ± 9.8 85.0 ± 13.4 81.3 ± 15.1 82.0 ± 17.0 n/d 
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Values are mean ± SE of at least three independent experiments. Statistical analysis was by ANOVA followed by Dunnett’s test. * 
Denotes significant difference (P<0.05) in cell proliferation relative to untreated control U937 cells. n/d: IC50 was not determinable 
for the range of concentrations tested. A is unhydrolysed BSG protein. B is BSG protein treated with Shearzyme, Ultraflo Max, 
Depol 740L, Brewers Clarex and Flavourzyme. C is BSG protein treated with Depol 740L, Brewers Clarex and Flavourzyme. D is 
BSG protein treated with Shearzyme, Ultraflo Max, Brewers Clarex and Flavourzyme. E is BSG protein treated with Shearzyme, 
Ultraflo Max, Depol 740L, Alcalase and Flavourzyme. F is BSG protein treated with Depol 740L, Alcalase and Flavourzyme. G is 
BSG protein treated with Shearzyme, Ultraflo Max, Alcalase and Flavourzyme. H is BSG protein treated with Shearzyme, Ultraflo 
Max, Depol 740L, Alcalase, Brewers Clarex and Flavourzyme. I is BSG protein treated with Depol 740L, Alcalase, Brewers Clarex 
and Flavourzyme. J is BSG protein treated with Shearzyme, Ultraflo Max, Alcalase, Brewers Clarex and Flavourzyme. 
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Table 9: Effects of brewers’ spent grain (BSG) protein hydrolysates A1-E4 (0-0.2% (w/v)) on cell proliferation in the HepG2 cells as 
measured by (3-(4, 5-Dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assay. 
 0.005 0.01 0.02 0.025 0.04 0.06 0.08 0.1 0.15 0.2 IC50 
A1 65.4 ± 6.8* 71.7 ± 4.4* 82.1 ± 3.8 76.3 ± 2.1* 78.8 ± 3.7* 83.3 ± 3.4 90.5 ± 3.4 80.1 ± 7.3 67.3 ± 7.0* 53.9 ± 5.7* n/d 
S1 87.2 ± 5.6 101.0 ± 21.5 103.6 ± 29.9 94.6 ± 19.1 93.4 ± 15.6 101.2 ± 19.8 91.6 ± 22.0 91.8 ± 20.6 92.6 ± 21.5 91.2 ± 15.0 n/d 
E1 73.1 ± 8.5 69.5 ± 11.0 55.6 ± 11.0* 49.2 ± 8.1* 56.0 ± 5.9* 60.0 ± 6.9* 59.2 ± 9.2* 62.5 ± 5.7* 67.5 ± 3.9* 58.8 ± 6.6* n/d 
A2 57.7 ± 5.5* 50.4 ± 7.6* 57.5 ± 7.9* 52.1 ± 4.7* 51.8 ± 8.2* 76.3 ± 15.1 71.9 ± 4.2 62.1 ± 7.9* 60.6 ± 12.3* 38.9 ± 4.4* n/d 
S2 104.7 ± 11.8 84.6 ± 7.1 80.0 ± 12.8 66.5 ± 7.7 80.5 ± 7.4 88.0 ± 4.1 85.0 ± 2.7 85.2 ± 7.7 100.7 ± 8.6 82.6 ± 12.8 n/d 
E2 70.0 ± 7.3* 73.7 ± 3.5* 59.3 ± 7.3* 56.0 ± 6.2* 58.6 ± 4.3* 62.6 ± 4.6* 66.0 ± 3.6* 68.5 ± 2.7* 76.1 ± 3.2* 62.6 ± 5.9* n/d 
A3 65.1 ± 7.5* 58.2 ± 8.7* 50.4 ± 9.4* 51.8 ± 12.0* 48.3 ± 10.3* 66.0 ± 10.6* 58.6 ± 5.7* 61.2 ± 4.0* 58.4 ± 7.9* 48.6 ± 3.2* n/d 
S3 107.4 ± 8.4 97.8 ± 15.8 84.0 ± 33.5 78.9 ± 12.7 95.3 ± 27.5 63.4 ± 4.8 95.8 ± 22.0 92.3 ± 20.9 102.5 ± 28.5 93.4 ± 14.8 n/d 
E3 92.0 ± 9.7 86.8 ± 6.0 71.4 ± 4.2 67.8 ± 8.6 60.3 ± 4.7* 73.4 ± 9.6 81.8 ± 8.1 85.6 ± 12.2 77.5 ± 8.8 74.1 ± 8.1 n/d 
A4 64.6 ± 5.8* 54.4 ± 7.6* 52.5 ± 6.3* 49.1 ± 9.8* 50.6 ± 8.5* 65.3 ± 5.9* 56.3 ± 6.2* 63.0 ± 5.1* 61.0 ± 6.2* 47.2 ± 6.6* n/d 
S4 103.2 ± 4.6 105.3 ± 10.7 87.8 ± 11.3 81.6 ± 8.6 83.5 ± 3.2 90.6 ± 9.1 80.5 ± 3.9 93.4 ± 8.3 97.5 ± 11.4 90.6 ± 11.7 n/d 
E4 82.6 ± 3.2 84.9 ± 4.3 78.5 ± 4.0 74.9 ± 9.6 72.0 ± 7.0 74.9 ± 9.6 70.2 ± 5.6 88.3 ± 12.9 83.3 ± 8.3 69.1 ± 6.7* n/d 
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Values are mean ± SE of at least three independent experiments. Statistical analysis was by ANOVA followed by Dunnett’s test. * 
Denotes significant difference (P<0.05) in cell proliferation relative to untreated control HepG2 cells. n/d: IC50 was not determinable 
for the range of concentrations tested. A1 is a BSG protein hydrolysate prepared via alkaline hydrolysis and subjected to further 
hydrolysis by ProPro. S1 is A1 subjected to SGID. E1 is prepared via direct enzyme hydrolysis by ProPro. A2 is a BSG protein 
hydrolysate prepared via alkaline hydrolysis and subjected to further hydrolysis by CorPPFla. S2 is A2 subjected to SGID. E2 is 
prepared via direct enzyme hydrolysis by CorPPFla. A3 is a BSG protein hydrolysate prepared via alkaline hydrolysis and subjected 
to further hydrolysis by AlcPro. S3 is A3 subjected to SGID. E3 is prepared via direct enzyme hydrolysis by AlcPro. A4 is a BSG 
protein hydrolysate prepared via alkaline hydrolysis and subjected to further hydrolysis by AlcFla. S4 is A4 subjected to SGID. E4 is 
prepared via direct enzyme hydrolysis by AlcFla. 
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Table 10: Effects of brewers’ spent grain (BSG) protein hydrolysates U1-U6 (0-0.2% (w/v)) on cell proliferation in the HepG2 cells 
as measured by (3-(4, 5-Dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assay. 
 0.005 0.01 0.02 0.025 0.04 0.06 0.08 0.1 0.15 0.2 IC50 
U1 69.7 ± 6.3* 64.4 ± 2.9* 62.8 ± 3.5* 60.0 ± 3.4* 52.6 ± 1.7* 76.3 ± 8.4 67.3 ± 2.6* 78.9 ± 15.3 76.7 ± 10.4 68.6 ± 7.9* n/d 
U2 84.9 ± 6.8 83.9 ± 13.2 79.2 ± 16.8 81.1 ± 17.9 74.5 ± 20.4 85.7 ± 21.7 85.3 ± 16.6 65.6 ± 5.1 60.3 ± 8.5 57.7 ± 7.6 0.7 
U3 109.2 ± 3.0 117.5 ± 23.3 88.5 ± 12.4 87.5 ± 9.6 97.9 ± 12.8 95.5 ± 7.2 95.4 ± 6.9 95.7 ± 12.0 88.0 ± 13.4 106.4 ± 7.7 n/d 
U4 79.9 ± 8.9 77.8 ± 16.3 79.8 ± 16.4 76.2 ± 20.2 77.8 ± 19.4 102.1 ± 14.0 85.1 ± 16.7 67.3 ± 3.8 68.0 ± 1.7 59.5 ± 9.4 n/d 
U5 72.6 ± 7.0 69.3 ± 2.1 64.8 ± 3.2 60.9 ± 1.8 58.9 ± 6.6 82.9 ± 12.4 95.2 ± 25.6 102.4 ± 24.5 75.3 ± 16.3 62.6 ± 11.0 n/d 
U6 75.4 ± 11.8 64.4 ± 2.9 70.8 ± 4.5 65.4 ± 7.3 61.7 ± 9.5 105.8 ± 21.3 93.8 ± 24.5 78.9 ± 15.3 76.7 ± 10.4 68.6 ± 7.9 n/d 
Values are mean ± SE of at least three independent experiments. Statistical analysis was by ANOVA followed by Dunnett’s test. * 
Denotes significant difference (P<0.05) in cell proliferation relative to untreated control HepG2 cells. n/d: IC50 was not determinable 
for the range of concentrations tested. U1 is a 30kDa Retentate prepared via alkaline hydrolysis and subjected to further hydrolysis by 
CorPPFla. U2 is a 30kDa Retentate prepared via alkaline hydrolysis and subjected to further hydrolysis by AlcFla. U3 is a 30kDa 
Permeate prepared via alkaline hydrolysis and subjected to further hydrolysis by CorPPFla. U4 is a 30kDa Permeate prepared via 
alkaline hydrolysis and subjected to further hydrolysis by AlcFla. U5 is a 10kDa Permeate prepared via alkaline hydrolysis and 
subjected to further hydrolysis by CorPPFla. U6 is a 10kDa Permeate prepared via alkaline hydrolysis and subjected to further 
hydrolysis by AlcFla. 
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Table 11: Effects of brewers’ spent grain (BSG) protein hydrolysates A-J (0-0.2% (w/v)) on cell proliferation in the HepG2 cells as 
measured by (3-(4, 5-Dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assay. 
 0.005 0.01 0.02 0.025 0.04 0.06 0.08 0.1 0.15 0.2 IC50 
A 78.2±0.5 72.6±6.1 71.4±5.1 66.1±7.9 68.7±3.8 70.8±9.4 70.8±3.2 37.3±15.8* 24.1±8.2* 46.4±30.4 0.1 
B 84.5±9.2 87.7±12.9 76.4±3.3 76.1±7.4 73.3±2.1 78.8±5.3 80.8±9.4 54.5±16.8 50.0±30.7 47.8±29.0 0.2 
C 81.5±0.2 104.7±17.9 88.2±2.1 88.0±8.0 123.7±2.2 91.3±0.3 89.3±8.1 96.2±8.4 104.7±12.3 104.7±7.5 n/d 
D 101.5±3.3 84.1±3.6 82.5±6.0 75.6±17.9 83.9±14.7 88.3±9.3 88.0±7.9 109.6±15.3 107.8±9.6 113.7±4.1 n/d 
E 70.1±11.4 65.5±6.8 64.9±10.3 61.1±14.0 57.3±7.3 62.8±10.3* 63.7±6.0 68.3±11.9 64.3±5.9 69.9±18.3 n/d 
F 73.8±9.6 74.8±10.2 62.1±4.9* 64.6±11.9 65.9±11.2 68.9±11.6 73.9±8.6 73.0±9.6 78.2±6.2 82.5±8.4 n/d 
G 92.7±11.3 76.1±7.6 58.2±1.4* 60.8±7.6* 66.1±6.9* 69.1±5.6* 69.5±2.8* 70.6±9.1 78.5±4.5 80.9±15.6 n/d 
H 76.0±10.8 67.5±7.4 61.2±5.4 62.5±8.2 62.0±9.8 86.3±22.6 66.0±3.6 71.7±4.5 72.0±6.9 83.1±2.4 n/d 
I 94.8±2.6 98.8±6.6 82.5±1.1 90.9±5.6 93.3±10.0 85.6±2.0 95.3±5.1 69.3±21.5 54.1±32.4 59.7±37.4 0.24 
J 78.0±9.4 105.5±30.5 75.7±3.0 81.5±10.4 72.7±6.0 79.6±6.8 78.6±4.1 77.0±6.8 79.0±12.0 85.3±12.6 n/d 
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Values are mean ± SE of at least three independent experiments. Statistical analysis was by ANOVA followed by Dunnett’s test. * 
Denotes significant difference (P<0.05) in cell proliferation relative to untreated control HepG2 cells. n/d: IC50 was not determinable 
for the range of concentrations tested. A is unhydrolysed BSG protein. B is BSG protein treated with Shearzyme, Ultraflo Max, 
Depol 740L, Brewers Clarex and Flavourzyme. C is BSG protein treated with Depol 740L, Brewers Clarex and Flavourzyme. D is 
BSG protein treated with Shearzyme, Ultraflo Max, Brewers Clarex and Flavourzyme. E is BSG protein treated with Shearzyme, 
Ultraflo Max, Depol 740L, Alcalase and Flavourzyme. F is BSG protein treated with Depol 740L, Alcalase and Flavourzyme. G is 
BSG protein treated with Shearzyme, Ultraflo Max, Alcalase and Flavourzyme. H is BSG protein treated with Shearzyme, Ultraflo 
Max, Depol 740L, Alcalase, Brewers Clarex and Flavourzyme. I is BSG protein treated with Depol 740L, Alcalase, Brewers Clarex 
and Flavourzyme. J is BSG protein treated with Shearzyme, Ultraflo Max, Alcalase, Brewers Clarex and Flavourzyme. 
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Table 12: Effects of brewers’ spent grain (BSG) protein hydrolysates A1-E4 (0-0.2% (w/v)) on cell proliferation in the MCF-7 cells 
as measured by (3-(4, 5-Dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assay. 
 0.005 0.01 0.02 0.025 0.04 0.06 0.08 0.1 0.15 0.2 IC50 
A1 83.8±4.0 80.1±3.1 84.4±9.1 79.9±5.8 85.9±7.1 83.1±5.8 76.4±5.6 73.9±6.3 60.4±10.1* 39.0±10.7* 0.26 
S1 80.4±12.9 73.8±5.7 71.8±8.4 67.4±5.5* 64.4±3.0* 68.1±10.0* 66.0±4.8* 61.1±7.2* 75.0±5.1 71.0±7.3 n/d 
E1 78.9±1.1 80.1±9.4 72.8±5.5 73.6±12.8 71.6±8.9 76.9±10.5 72.4±6.5 79.0±13.9 75.3±15.8 76.8±12.9 n/d 
A2 86.1±5.5 86.3±4.0 82.9±7.6 80.2±4.0 91.8±4.5 80.3±9.8 67.8±10.4* 62.0±9.5* 43.6±1.3* 50.2±12.0* 0.18 
S2 75.8±7.6* 71.8±1.7* 73.5±1.1* 64.1±6.2* 71.4±4.8* 66.4±6.3* 75.4±2.4* 80.6±5.3* 79.5±5.2* 77.7±3.5* n/d 
E2 93.6±17.3 91.0±12.2 96.7±14.5 91.0±13.9 82.9±10.5 83.4±11.3 84.4±12.0 91.0±13.4 88.4±22.4 98.2±16.9 n/d 
A3 86.0±14.7 96.0±15.9 86.7±15.4 85.9±10.0 88.7±7.6 88.5±1.9 60.7±18.5 81.8±10.2 57.3±6.4 59.0±8.2 0.31 
S3 80.0±3.8 73.5±7.5* 72.9±3.4* 68.6±1.3* 83.1±7.2 79.8±7.4 82.4±6.8 73.5±7.1* 75.3±6.9* 74.2±5.7* n/d 
E3 91.2±5.0 87.3±7.4 84.6±3.4 84.1±3.4 79.1±0.4 83.9±6.1 93.1±14.0 84.2±5.9 91.7±13.8 93.9±9.2 n/d 
A4 90.5±18.7 93.2±24.7 89.8±22.5 93.0±12.7 106.1±14.5 116.7±21.0 100.2±4.5 96.5±10.3 62.3±9.6 32.4±8.1* 0.17 
S4 85.6±2.0 101.4±2.9 97.3±2.8 95.7±1.9 95.3±2.7 87.9±5.6 81.3±7.1 96.5±1.4 84.0±10.6 83.1±8.9 n/d 
E4 94.0±9.1 92.0±18.9 90.9±23.4 81.6±19.6 91.7±6.1 89.7±5.9 81.2±15.3 92.9±20.5 95.6±0.2 96.0±14.7 n/d 
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Values are mean ± SE of at least three independent experiments. Statistical analysis was by ANOVA followed by Dunnett’s test. * 
Denotes significant difference (P<0.05) in cell proliferation relative to untreated control MCF-7 cells. n/d: IC50 was not determinable 
for the range of concentrations tested. A1 is a BSG protein hydrolysate prepared via alkaline hydrolysis and subjected to further 
hydrolysis by ProPro. S1 is A1 subjected to SGID. E1 is prepared via direct enzyme hydrolysis by ProPro. A2 is a BSG protein 
hydrolysate prepared via alkaline hydrolysis and subjected to further hydrolysis by CorPPFla. S2 is A2 subjected to SGID. E2 is 
prepared via direct enzyme hydrolysis by CorPPFla. A3 is a BSG protein hydrolysate prepared via alkaline hydrolysis and subjected 
to further hydrolysis by AlcPro. S3 is A3 subjected to SGID. E3 is prepared via direct enzyme hydrolysis by AlcPro. A4 is a BSG 
protein hydrolysate prepared via alkaline hydrolysis and subjected to further hydrolysis by AlcFla. S4 is A4 subjected to SGID. E4 is 
prepared via direct enzyme hydrolysis by AlcFla. 
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Table 13: Effects of brewers’ spent grain (BSG) protein hydrolysates U1-U6 (0-0.2% (w/v)) on cell proliferation in the MCF-7 cells 
as measured by (3-(4, 5-Dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assay. 
 0.005 0.01 0.02 0.025 0.04 0.06 0.08 0.1 0.15 0.2 IC50 
U1 100.1±4.1 101.3±1.3 94.9±2.6 105.0±7.2 90.8±3.6 96.0±14.4 97.4±5.3 111.0±1.7 61.4±12.1 35.9±20.7* 0.17 
U2 99.2±11.2 92.4±11.2 93.1±7.9 101.3±5.7 104.6±1.9 93.3±4.1 94.8±18.1 88.8±3.9 93.0±10.8 93.5±19.0 n/d 
U3 89.8±2.5 87.9±11.5 87.3±2.7 94.6±12.6 81.0±4.5 71.1±7.5 59.9±19.8 72.0±10.4 59.2±5.9 60.6±11.4 0.3 
U4 98.8±2.8 96.0±4.0 93.2±4.2 98.2±14.0 83.3±11.1 97.8±12.6 90.5±12.2 94.4±18.3 62.3±13.0 67.1±10.5 0.29 
U5 92.0±3.9 83.6±2.4 86.6±1.5 94.6±12.8 93.6±12.8 87.8±1.5 77.6±1.0 80.6±4.4 79.3±2.9 70.7±3.8* 2.2 
U6 96.9±9.6 83.0±6.6 74.3±10.3 80.5±1.5 77.1±0.6 82.6±4.0 83.6±4.4 83.4±0.9 65.1±11.8* 77.7±5.6 n/d 
Values are mean ± SE of at least three independent experiments. Statistical analysis was by ANOVA followed by Dunnett’s test. * 
Denotes significant difference (P<0.05) in cell proliferation relative to untreated control MCF-7 cells. n/d: IC50 was not determinable 
for the range of concentrations tested. U1 is a 30kDa Retentate prepared via alkaline hydrolysis and subjected to further hydrolysis by 
CorPPFla. U2 is a 30kDa Retentate prepared via alkaline hydrolysis and subjected to further hydrolysis by AlcFla. U3 is a 30kDa 
Permeate prepared via alkaline hydrolysis and subjected to further hydrolysis by CorPPFla. U4 is a 30kDa Permeate prepared via 
alkaline hydrolysis and subjected to further hydrolysis by AlcFla. U5 is a 10kDa Permeate prepared via alkaline hydrolysis and 
subjected to further hydrolysis by CorPPFla. U6 is a 10kDa Permeate prepared via alkaline hydrolysis and subjected to further 
hydrolysis by AlcFla. 
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Table 14: Effects of brewers’ spent grain (BSG) protein hydrolysates A-J (0-0.2% (w/v)) on cell proliferation in the MCF-7 cells as 
measured by (3-(4, 5-Dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assay. 
 0.005 0.01 0.02 0.025 0.04 0.06 0.08 0.1 0.15 0.2 IC50 
A 71.5±1.0* 71.1±13.2* 61.4±5.9* 58.0±2.3* 59.7±0.2* 60.0±1.8* 60.0±1.4* 63.6±2.6* 69.9±0.9* 72.9±2.6* n/d 
B 70.9±6.2 82.6±18.0 65.0±3.0* 61.2±5.4* 63.5±2.4* 59.6±0.5* 58.7±0.2* 64.8±0.5* 61.7±5.4* 70.0±5.0* n/d 
C 76.8±9.1 84.6±9.2 86.1±15.5 71.0±11.4 78.6±23.2 81.8±23.4 86.8±15.0 77.9±9.9 86.8±20.3 85.3±14.4 n/d 
D 79.7±1.3 93.3±19.6 77.6±5.5 74.5±10.4 74.3±3.4 69.5±2.1 69.9±2.7 81.1±0.1 77.4±2.1 81.6±6.6 n/d 
E 90.0±23.2 88.7±20.7 90.0±19.2 70.9±13.5 79.7±21.0 81.6±18.6 81.7±16.2 83.9±19.0 88.4±16.4 95.6±12.0 n/d 
F 85.3±10.4 70.4±8.6 67.0±9.6 70.3±8.3 78.8±10.7 73.7±8.1 79.0±13.1 83.1±9.2 92.2±15.7 91.7±9.0 n/d 
G 79.4±12.1 72.9±8.3 65.4±9.3 67.0±4.5 69.8±9.5 68.9±8.2 70.6±8.3 76.9±7.6 74.5±8.2 78.5±9.9 n/d 
H 81.8±3.4 61.7±14.8* 57.5±14.6* 53.9±6.2* 63.9±2.6 61.1±4.5* 77.3±10.5 59.9±0.9* 66.4±2.1 75.6±9.0 n/d 
I 70.3±3.2 78.6±5.9 76.7±9.8 82.8±12.8 68.3±5.2 84.4±8.7 84.5±7.0 84.9±8.9 85.7±13.0 105.2±15.0 n/d 
J 92.0±15.6 80.7±14.0 76.8±11.1 85.9±15.9 78.8±8.4 90.2±16.1 74.9±4.4 95.8±9.9 92.9±14.0 119.6±23.4 n/d 
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Values are mean ± SE of at least three independent experiments. Statistical analysis was by ANOVA followed by Dunnett’s test. * 
Denotes significant difference (P<0.05) in cell proliferation relative to untreated control MCF-7 cells. n/d: IC50 was not determinable 
for the range of concentrations tested. A is unhydrolysed BSG protein. B is BSG protein treated with Shearzyme, Ultraflo Max, 
Depol 740L, Brewers Clarex and Flavourzyme. C is BSG protein treated with Depol 740L, Brewers Clarex and Flavourzyme. D is 
BSG protein treated with Shearzyme, Ultraflo Max, Brewers Clarex and Flavourzyme. E is BSG protein treated with Shearzyme, 
Ultraflo Max, Depol 740L, Alcalase and Flavourzyme. F is BSG protein treated with Depol 740L, Alcalase and Flavourzyme. G is 
BSG protein treated with Shearzyme, Ultraflo Max, Alcalase and Flavourzyme. H is BSG protein treated with Shearzyme, Ultraflo 
Max, Depol 740L, Alcalase, Brewers Clarex and Flavourzyme. I is BSG protein treated with Depol 740L, Alcalase, Brewers Clarex 
and Flavourzyme. J is BSG protein treated with Shearzyme, Ultraflo Max, Alcalase, Brewers Clarex and Flavourzyme. 
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In a similar manner to the effects on Jurkat T cells, alkaline- and enzyme-
extracted hydrolysates (A1-A4, E1 and E3) exerted dose-dependent effects on 
U937 cell proliferation (Table 6). Additionally, as was the case in Jurkat T cells, 
IC50 values could not be determined for SGID-treated hydrolysates (S1-S4), in 
U937 cells. It is also noteworthy, that IC50 values for A1-A4 and E1-E4 were 
higher in U937 cells compared to Jurkat T cells. Apart from U1 and U2, no 
significant effects on U937 cell proliferation were noted with membrane 
fractionation-treated hydrolysates (Table 7). Apart from hydrolysate E, enzyme-
extracted hydrolysates (A-J) did not have any significant effects on the 
proliferation of U937 cells (Table 8). 
HepG2 cell proliferation was determined following incubation with BSG 
protein hydrolysates A1-E4, U1-U6 or A-J (Tables 9-11). Significant (P<0.05) 
decreases in cell proliferation across the concentration range tested, were noted 
with extracts E2 and A4 (Table 9). Apart from U1, the ultrafiltration-generated 
hydrolysates did not have a significant impact on HepG2 cell proliferation (Table 
10). The overall impact of hydrolysates produced using different enzyme 
combinations (A-J), on HepG2 cell proliferation, was low (Table 11). Only 
samples A, E, F and G produced significant (P<0.05) decreases in cell 
proliferation. 
MCF-7 cells were exposed to hydrolysates A1-E4 for 24 hours and the effects 
on cell proliferation were then measured (Table 12). In a similar pattern to Jurkat 
T cells and U937 cells, alkaline-extracted hydrolysates (A1-A4) demonstrated 
dose-dependent effects on MCF-7 cells. The IC50 values of these hydrolysates 
were also higher, when compared with corresponding values in Jurkat T cells and 
U937 cells. Furthermore, as was the case with other cell lines, IC50 values for S1-
S4 could not be determined. MCF-7 cells treated with U1, U5 and U6 at 0.2%, 
0.2% and 0.15% (w/v) respectively, showed significant decreases in cell 
proliferation (Table 13). Among the enzyme-extracted hydrolysates (A-J) 
administered to MCF-7 cells, only hydrolysates A, B and H had significant effects 
on cellular proliferation (Table 14). 
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Apoptosis 
The IC50 values of BSG phenolic extracts in U937 cells were previously 
determined (Crowley et al., 2017 and Table 3, Chapter 3). U937 cells were treated 
with BSG phenolic extracts (IC50 values) or Doxorubicin (0.5 µg mL
-1
) for 24 
hours and the number of apoptotic cells were counted. Figure 1 shows that only 
extract PW3 and the cancer-treatment drug, Doxorubicin, significantly induced 
apoptosis in U937 cells. The increase in fragmented DNA (a key feature of 
apoptosis) is seen in Figure 2. 
 
Discussion 
Ethnicity, age, lifestyle and diet are all factors that can have a significant impact 
on cancer expression and progression (Roleira et al., 2015). Excessive 
proliferation, an inability to initiate apoptosis under normal conditions and an 
extended or immortalised life span are the main characteristics of malignant cells 
(Dai and Mumper, 2010). Certain compounds such as phenolics are known to 
have an ability to halt this progressive proliferation. Any disruption of the cell 
cycle specific proteins by phenolics may alter the continuous proliferation (Dai 
and Mumper, 2010). Studies have shown that observed cytotoxic effects of 
phenolic compounds is generally related to cell cycle arrest proceeded by 
apoptosis (Roleira et al., 2015). Cells undergoing apoptosis can be recognised and 
removed by phagocytosis (Edinger and Thompson, 2004). Among the 
morphological features of apoptosis are caspase activation, chromatin 
condensation and DNA fragmentation (Edinger and Thompson, 2004; Dai and 
Mumper, 2010). In many studies involving phenolic compounds, correlations are 
observed between the antiproliferative activity and the antioxidant activity, 
suggesting that oxidative mechanisms are involved in cancer cell proliferation. 
Additionally, it has been noted that extracts with a higher phenolic content, tended 
to demonstrate higher antioxidant and cytotoxic activities (Roleira et al., 2015). 
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Figure 1: Effect of BSG phenolic extracts (IC50 values) or Doxorubicin (0.5 µg 
mL
-1
) on apoptosis in U937 cells. BW1-4 represent extracts from black, wet BSG; 
BD1-2 represents extracts from black, dry BSG; PW1-5 represents extracts from 
pale, wet BSG and PD1-3 represents extracts from pale, dry BSG. Cells were 
treated with BSG extracts or Doxorubicin for 24 hours and were then harvested by 
centrifugation and stained with Hoechst 33342. 300 cells were examined at 200X 
magnification, and the percentage of condensed and fragmented nuclei was 
calculated. Values are mean ± SE of at least three independent experiments. 
Statistical analysis by ANOVA followed by Dunnett’s Test. * Denotes 
statistically significant difference in apoptosis, relative to untreated U937 cells 
(control) (P<0.05).
* 
* 
0
5
10
15
20
25
30
35
40
45
%
 A
p
o
p
to
ti
c 
ce
ll
s 
238 
 
         M            1             2             3 
 
Figure 2: Apoptotic potential of BSG phenolic extract PD3 and Doxorubicin in 
U937 cells (DNA fragmentation). Lane M: 100– 1500 bp DNA standard. Lane 1: 
control (untreated cells). Lane 2: PD3 (45% v/v). Lane 3: Doxorubicin (0.5 µg 
mL
-1
).
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Here, the antiproliferative potential of phenolic extracts and protein 
hydrolysates from BSG were assessed in the cancer cell lines; Jurkat T cells, 
RAW 264.7 cells, MCF-7 cells, U937 cells and HepG2 cells. The antiproliferative 
effects of the BSG samples were assessed using the MTT assay in all cell lines, 
while the apoptotic potential of BSG phenolic extracts were measured in U937 
cells using the Hoechst staining and DNA fragmentation assays. The MTT assay 
measures the reduction of yellow tetrazolium salt (MTT) by the mitochondrial 
enzymes of metabolically active cells resulting in the formation of an insoluble 
purple product known as formazan. The number of living cells is directly 
proportional to the amount of formazan product formed. Results are expressed as 
a percentage compared to the control cells not exposed to test compounds 
(Prabhakar et al., 2015). The measurement of apoptosis induction in cancer cell 
lines is a valid indication of a compound’s potential to perform as a 
chemotherapeutic agent (Kenny et al., 2013). The DNA fragmentation assay 
entails the isolation of apoptotic DNA fragments via lysing the isolated nuclei of 
apoptotic cells using a detergent such as NP-40. Apoptotic DNA fragments 
released can be separated by gel electrophoresis (Prabhakar et al., 2015). 
The BSG phenolic extracts assessed here were produced using an enzyme-
extraction method previously outlined by Crowley et al. (2017) and described in 
Chapter 3. The extracts were assessed for their antiproliferative potential in Jurkat 
T cells, RAW 264.7 cells and MCF-7 cells (Tables 1-3). Dose-dependent 
decreases in Jurkat T cell proliferation were noted with black phenolic extracts 
(Table 1). McCarthy et al. (2014) similarly reported that alkaline-extracted BSG 
phenolic extracts had a concentration-dependent effect on Jurkat T cell 
proliferation. Results presented here, demonstrated that IC50 values for black 
phenolic extracts were likewise low when compared with IC50 values previously 
reported in another suspension cell line; U937 cells (Crowley et al., 2017). The 
IC50 values of pale BSG phenolic extracts assessed here were higher than values 
reported with BSG phenolic extracts produced using alkaline hydrolysis 
(McCarthy et al., 2014). 
The adherent cell lines, RAW 264.7 cells and MCF-7 cells were also used to 
measure the impact of phenolic extracts on cell proliferation. Phenolic extracts 
were more toxic in RAW 264.7 cells compared to MCF-7 cells, as indicated by 
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the lower IC50 values (Tables 2-3). This contrast may be explained by their 
difference in sensitivity to the extracts and the specific origin of the cells; RAW 
264.7 cells are a murine macrophage cell line, while MCF-7 cells are derived 
from human metastatic breast tissue. Melo et al. (2015) identified a number of 
phenolic compounds in winery by-products and reported that extracts from Petit 
Verdot pomace and Chenin Blanc rachis significantly decreased RAW 264.7 cell 
proliferation at higher concentrations. Different parts of the Jatropha curcas plant 
were assessed for their cytotoxic effects in RAW 264.7 cells (Othman et al., 
2015). The authors found that almost 95% of the cell growth was inhibited by a 
crude extract from the plant root, while a hexane partition from the plant also 
inhibited cell growth. Terpenoids were identified in the partition, which the 
authors note have been reported to show cytotoxic effects towards animal cells 
lines. A number of other studies have utilised MCF-7 cells to assess the cytotoxic 
effects of plant extracts (Lopez et al., 2013; Ahmed et al., 2016; Parra Pessoa et 
al., 2016). Parra Pessoa et al. (2016) reported that ethanolic seed extracts from 
Licania rigida and Licania tomentosa were not cytotoxic to MCF-7 and Caco-2 
cells. 
Protein hydrolysates from BSG were also assessed in cancer cell lines (Tables 
4-14). Treatment of Jurkat T cells with alkaline-extracted hydrolysates and 
enzyme-extracted hydrolysates led to a dose-dependent decrease in cell 
proliferation (Table 4). McCarthy et al. (2013b) noted a similar pattern in Jurkat T 
cells with alkaline-extracted BSG protein hydrolysates, where an increase in 
hydrolysate concentration led to a decrease in cell proliferation. BSG protein 
hydrolysates subjected to SGID (S2-S4) did not have any significant impact on 
Jurkat T cells. In another study utilising suspension cells, Wang et al. (2008) 
showed that soy protein hydrolysate produced by SGID inhibited L1210 leukemia 
cell growth in a dose-dependent manner. The BSG protein hydrolysates (A1-E4) 
had a lesser impact on U937 cell proliferation (Table 6) compared with Jurkat T 
cells, as seen with the higher IC50 values. Alkaline-extracted BSG protein 
hydrolysates (A1-A4) had a dose-dependent effect on U937 cell proliferation 
(Table 6). A similar pattern on U937 cell proliferation was noted by McCarthy et 
al. (2013a; 2013b), using a different set of alkaline-extracted BSG protein 
hydrolysates. U937 cells were previously used to show the antiproliferative 
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activity of peptides derived from anchovy sauce (Lee et al., 2004), where results 
showed that the peptide fraction induced apoptosis in U937 cells. 
In HepG2 cells, IC50 values could not be calculated for hydrolysates A1-E4 
(Table 6). Out of the BSG protein hydrolysates subjected to ultrafiltration, only 
the 30kDa retentate produced by Corolase PP and Flavourzyme (U1) 
demonstrated significant toxic effects (Table 7). The 10kDa permeate produced 
using Alcalase and Flavourzyme (U6) did not have any significant impact on 
HepG2 cell proliferation. In another report, BSG protein hydrolysates generated 
using brewers’ spent yeast (BSY) proteases, Neutrase and Alcalase, were assessed 
for their effects on HepG2 cell proliferation (Vieira et al., 2017). The < 10 kDa 
fraction produced using Alcalase significantly decreased cell proliferation, 
whereas the BSY< 10 kDa fraction significantly increased proliferation. The 
antiproliferative potential of other low molecular weight food peptide fractions 
has previously been reported. Rice bran was used to generate bioactive GI-
resistant peptides, resulting in <5 and 5-10 kDa fractions, which were able to 
inhibit the growth of HepG2 cells more effectively than the non-resistant peptide 
fractions (Kannan et al., 2008). Peptide fractions (<10 and 10-30kDa) from 
shrimp shell whites and langostino shells significantly inhibited the growth of 
HepG2 cells (Kannan et al., 2011). Low molecular weight fractions (< 3 kDa) of 
loach protein hydrolysates were found to be more effective at inhibiting the 
HepG2 cell proliferation than higher molecular weight fractions (You et al., 
2011).  
The antiproliferative effects of BSG protein hydrolysates were also assessed in 
MCF-7 cells (Tables 12-14). A dose-dependent decrease in MCF-7 cell 
proliferation was seen with alkaline-extracted BSG protein hydrolysates (A1-A4) 
(Table 12). Ma et al. (2015) showed that bioactive peptides in walnut residual 
protein were released during papain hydrolysis and had a dose-dependent 
cytotoxic effect in MCF-7 cells. The purified peptide had an amino acid sequence 
of CTLEW with a molecular weight of 651.2795 Da. The 30kDa retentate (U1) 
and 10kDa permeates U5 and U6, demonstrated cytotoxic effects at higher 
concentrations in MCF-7 cells (Table 13). It was found that a loach protein 
hydrolysate and its <3kDa fraction significantly inhibited the proliferation of 
viable MCF-7 cells compared to the higher molecular weight fractions, with lower 
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levels of proliferation seen at higher hydrolysate concentrations (You et al., 
2011). 
The apoptotic effects of BSG phenolic extracts were further assessed in U937 
cells (Figures 1-2). U937 cells have been widely used in apoptosis research and 
were therefore chosen for this investigation. The BSG phenolic extract, PD3, at 
45% (v/v), was the only BSG sample able to significantly increase the number of 
apoptotic U937 cells (Figure 1). The cancer treatment drug, Doxorubicin, also 
increased the number of apoptotic cells to 33.4%. The proapoptotic effects of 
Doxorubicin have already been demonstrated in U937 cells (Kenny et al., 2013). 
Apoptosis is a form of programmed cell death, where unwanted cells are removed 
from the body (Prabhakar et al., 2015). Cells that have undergone apoptosis 
typically show chromatin condensation and DNA fragmentation (Dai and 
Mumper, 2010). In the DNA fragmentation assay, the extract produced the 
characteristic laddering appearance of apoptotic cells noted in Figure 2. The 
absence of proapoptotic effects of the other phenolic extracts may be explained by 
the lower IC50 values used. Extract PD3 has previously demonstrated cellular 
antioxidant ability, protecting against H2O2-induced DNA damage in U937 cells 
and H2O2-induced decreases in glutathione content and superoxide dismutase 
activity in HepG2 cells (Crowley et al., 2017 and Figures 1-3, Chapter 3). 
Therefore, the apoptotic effect here may be related to its antioxidant activity. It 
has previously been shown that ferulic acid is the major hydroxycinnamic acid of 
BSG (McCarthy et al., 2013c). The apoptotic effects of ferulic acid have 
previously been demonstrated in HepG2 cells by Prabhakar et al. (2015). Ferulic 
acid demonstrated apoptotic potential as evidenced by cell shrinkage, cell 
budding, discrete nuclei fragments, Bax upregulation and Bcl-2 downregulation. 
Park et al. (2008) showed that the phenolic compound, esculetin, induced 
apoptosis in U937 cells via Bcl-2 regulation and caspase activity. Further 
investigation is required to confirm the exact molecular mechanisms involved in 
the apoptotic effects of PD3. Also the specific components within the extract 
responsible for the apoptotic effects will need to be identified.  
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Conclusions 
To conclude, BSG phenolic extracts demonstrated greater antiproliferative ability 
in cell lines, compared with BSG protein hydrolysates. In general, the suspension 
cell lines, Jurkat T cells and U937 cells, displayed a greater sensitivity to the BSG 
extracts. Similarly, with regard to the BSG phenolic extract, the animal-derived 
RAW 264.7 cells were more sensitive to extracts compared to the human breast 
cancer cell line, MCF-7.  The black BSG phenolic extracts generally displayed 
greater antiproliferative activity in cells compared to extracts derived from pale 
BSG. This may be due to Maillard reaction products generated during the roasting 
of barley grains. However, the apoptotic effects of BSG phenolic extracts were, in 
general, found to be low, suggesting that apoptosis is not the primary mechanism 
by which the extracts exert their antiproliferative effects.  
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Cereal grains are produced by plants of the grass family Poaceae. These include 
wheat, triticale, rye, barley, oats, maize, rice, sorghum and millet (Wrigley, 2010). 
Cereal grains are known to be a source of macronutrients, minerals and vitamins 
(Carnevali et al., 2014). Additionally, cereal grains possess a number of 
biologically active substances such as arabinoxylans (AX), β-glucans, cellulose, 
lignans, lignin, sterols, tocopherols, tocotrienols, alkylresorcinols, phenolic acids 
and microelements (Bartlomiej et al., 2012). Barley constitutes approximately 5 to 
8 percent of world cereal production and is favoured for beer production with 
wheat flour commonly used as an adjunct (Batey, 2010; Edney, 2010). Brewers’ 
spent grain (BSG) is the insoluble part of the barley grain remaining after the 
mashing step in the brewing process. BSG consists of the seed coat–pericarp–husk 
layers that encased the original barley grain (Lynch et al., 2016). Owing to the 
large quantities produced annually, current low market value, growing 
environmental awareness and the appreciation that BSG is a nutritionally valuable 
co-product, further uses regarding the health benefits of BSG are currently being 
investigated (Lynch et al., 2016). 
The purpose of this research was to investigate the potential health benefits of 
the phenolic and protein components of BSG, using in vitro cell culture models. 
Previous research on BSG had assessed the bioactivity of phenolic extracts and 
protein hydrolysates derived from BSG using an alkaline extraction procedure. 
The phenolic extracts and protein hydrolysates examined here were generated 
using an extraction procedure utilising food-grade carbohydrase and proteinase 
enzymes. Alkaline-extracted phenolic and protein fractions from BSG have 
previously demonstrated antioxidant and anti-inflammatory activity. Enzyme 
extraction may offer an alternative to common solvent extraction procedures and 
owing to their natural origin may be more acceptable for use in functional food 
products.  
The first experimental chapter (Chapter 2) in this thesis examined a BSG 
protein-enriched isolate extracted using an alkaline extraction method and 
hydrolysed using Alcalase (U) and 3 fractions prepared from U using membrane 
fractionation; a 5 kDa retentate (U >5), a 5kDa permeate (U <5) and a 3 kDa 
permeate (U <3), which were added to low-fat milk.  The anti-inflammatory 
potential of these hydrolysates was previously reported in McCarthy et al. 
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(2013a). The supplemented milk samples were then subjected to simulated 
gastrointestinal digestion (SGID) and the anti-inflammatory potential of the 
resultant digestates was investigated in concanavalin-A (ConA)-stimulated Jurkat 
T cells and lipopolysaccharide (LPS)-stimulated murine macrophage RAW 264.7 
cells. Interleukin 6 (IL-6) production was significantly decreased (P<0.05) in 
stimulated Jurkat T cells in the presence of BSG protein hydrolysate-
supplemented milk digestates, with no apparent effect on interferon gamma (IFN-
γ) or IL-2 secretion. The BSG protein hydrolysate, U, and its 5kDa retentate (U 
>5), were previously shown to have anti-inflammatory effects, by reducing the 
production of IFN-γ in ConA-stimulated Jurkat T cells, when added directly to 
cells (McCarthy et al., 2013a). This may indicate that the concentration of BSG 
hydrolysates added to milk may need to be increased in order to elicit a significant 
effect on IFN-γ production. None of the digested milk samples had a significant 
effect on the production of IL-6, IL-1β or tumor necrosis factor alpha (TNF-) in 
LPS-stimulated RAW 264.7 cells, possibly highlighting a cell specific effect. 
Functional foods containing bioactive ingredients need to demonstrate an ability 
to retain their bioactivity following digestion. A number of factors, including the 
food matrix chosen, can impact on the anti-inflammatory activity of BSG protein 
hydrolysates following their addition into a food vehicle and subjection to 
gastrointestinal digestion. However, further research, including additional 
inflammatory markers, is necessary to optimise the anti-inflammatory effect of 
BSG hydrolysate-supplemented food products. One particular challenge to the 
commercialisation of bioactive protein hydrolysates is the lack of information 
available regarding their bioavailability which is the amount of an ingested 
nutrient that is absorbed and metabolised (Li-Chan, 2015). 
Enzyme extraction using cell wall degrading enzymes was utilised to generate 
phenolic compounds from both black and pale BSG. Black BSG, from dark wort 
production, is produced following the roasting of barley grain at 200°C. Pale BSG 
is obtained from the standard brewing process (Connolly et al., 2013; Piggott et 
al., 2014). Hydroxycinnamic acids (HCAs) are the principal class of phenolic 
compounds found in BSG, with ferulic acid being present in the highest amounts 
(McCarthy et al., 2013b). HCAs are known for their antioxidant activity and 
research has shown that HCAs can be used as preventive and/or therapeutic agents 
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in several diseases related to oxidative stress including atherosclerosis, 
inflammatory injury, cancer and cardiovascular diseases (Teixeira et al., 2013). 
The DNA protective effects of BSG phenolic extracts were measured by their 
ability to protect against hydrogen peroxide (H2O2)-induced DNA single strand 
breaks in U937 cells using the comet assay (Chapter 3). The effects of BSG 
phenolic extracts on the cellular antioxidant status in HepG2 was assessed by 
measuring the cellular content of glutathione (GSH) and the activity of the 
enzymes superoxide dismutase (SOD) and catalase (CAT) following an oxidative 
challenge. Phenolic extracts protected against DNA damage however, the use of 
enzymes in the extraction procedure did not significantly enhance the DNA 
protective effects of the extracts. The extracts prepared using enzymes were more 
effective in protecting against a depletion of cellular antioxidant GSH content and 
SOD and CAT activity in oxidant-challenged HepG2 cells than the extracts 
prepared without enzymes. This study indicates that enzyme-extraction could be 
used in the production of novel, natural, plant-derived bioactive components for 
use in the food industry as an alternative to conventional solvent extraction. 
However, it will be necessary to fully characterise the bioactive constituents of the 
extracts however – particular with regard to the black BSG phenolic extracts, to 
elucidate the exact bioactive components responsible for the noted antioxidant 
effects. Also of consideration for future research, is the impact of phenolic 
extracts on other cell lines such as intestinal cells. This may be of greater 
relevance considering the route these compounds would take during the digestive 
process and would also provide a useful cell culture model for bioavailability 
studies.  Another important consideration is the in vivo levels of phenolic extracts 
following absorption. The concentrations used in cell lines in this study may not 
be physiologically relevant considering the reported poor bioavailability of 
phenolic compounds (Manach et al., 2005). For example, ferulic acid has poor 
water solubility and hence poor bioavailability (Mateo Anson et al., 2009). 
Following this, the ability of enzyme-extracted BSG phenolic extracts to 
enhance the antioxidant potential of flavoured water drinks before and after in 
vitro digestion was investigated (Chapter 4). In vitro digestion models offer a 
truer reflection of the health benefits of bioactive compounds, revealing the 
amount of a compound available for absorption. The addition of phenolic extracts 
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to water drinks did not significantly increase antioxidant activity. The lack of an 
enhancement effect with fortification of the drinks may be related to the low 
extract concentration (10% v/v) added to the water drinks. The antioxidant effects 
of the phenolic extracts are likely to have been diluted. Another issue noted here 
was the apparent discrepancy between the antioxidant methods used (DPPH, 
FRAP and ORAC). These conflicting results may, in future, be avoided by 
applying the relative antioxidant capacity index (RACI), which allows for the 
accurate ranking of the antioxidant capacity of foods (Sun and Tanumihardjo, 
2007). It may also be worth exploring alternative uses for BSG phenolic extracts, 
outside of human nutrition. For example, certain plant extracts are known to have 
anti-fungal activity (Kalidindi et al., 2015; Sales et al., 2016). Owing to their 
natural origin and hence environmental safety, phenolic extracts from BSG may 
have potential phytosanitary applications. 
The potential of using carbohydrase (Shearzyme, Ultraflo Max and  Depol 
740L) and proteinase (Alcalase, Brewers Clarex and Flavourzyme) enzymes to 
extract BSG protein hydrolysates with anti-inflammatory and antioxidant 
activities, was also assessed (Chapter 5). The impact of BSG protein hydrolysates 
on cytokine production in both ConA-treated Jurkat T cells and LPS-stimulated 
RAW 264.7 cells, DNA damage in H2O2-treated U937 cells and GSH content, 
SOD and CAT activity of H2O2-treated HepG2 cells was assessed. The 
carbohydrase combination of Shearzyme and Ultraflo Max and proteinase 
combination of Alcalase, Brewers Clarex and Flavourzyme was the most effective 
enzyme treatment yielding bioactive BSG hydrolysates. The unhydrolysed 
fraction also demonstrated both anti-inflammatory and antioxidant activity, 
indicating that other components present in the BSG may be responsible for its 
bioactivity. Further research is needed to fully elucidate the molecular 
mechanisms involved and the specific amino acid sequences that are responsible 
for the biological activity. The use of animal studies and clinical trials would also 
uncover any potentially negative effects associated with bioactive peptides 
(Santiago-Lopez et al., 2016). This is a necessary step in the development of more 
effective functional food products targeting specific health issues. 
The anti-inflammatory activity and antioxidant potential of hydrolysates 
generated using direct enzymatic hydrolysis procedure was investigated and 
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compared with hydrolysates produced using an alkaline-extraction method, 
alkaline-extracted hydrolysates subjected to SGID and alkaline-extracted 
hydrolysates generated using ultrafiltration (Chapter 6). Alkaline hydrolysis was 
found to be more effective than direct enzyme hydrolysis at producing bioactive 
BSG protein hydrolysates. Both alkaline-extracted BSG protein hydrolysates and 
alkaline-extracted BSG protein hydrolysates subjected to ultrafiltration, 
demonstrated both anti-inflammatory and antioxidant activity. Again, however, it 
will be necessary to characterise the specific bioactive components which are 
responsible for the noted activity. Considering the market that exists for functional 
food products aimed at reducing the effects of many chronic diseases, greater 
emphasis should be put on using relevant purifaiction and characterisation 
methods to fully identify the bioactive constituents of BSG. This may be achieved 
by methods such as affinity chromatography and gel filtration chromatography, 
which have been successfully used to purify and characterise peptides from 
chickpea protein hydrolysates (Torres-Fuentes et al., 2011).  
Oxidative stress can lead to the production of ROS and free radicals with 
potential harmful effects on neuronal cells (Uttara et al., 2009). Antioxidant 
compounds can elicit both neuroprotective (preventing apoptosis) and 
neuroregenerative effects, through the reduction or reversal of cellular damage 
and by delaying the progress of neuronal cell loss (Pacifico et al., 2014). The 
neuroprotective potential of BSG phenolic extracts was investigated in SK-N-
BE(2) cells treated with H2O2 (Chapter 7). It was found that pale BSG extracts 
protected against the H2O2-induced toxicity in SK-N-BE(2) cells, while extracts 
from both black and pale BSG significantly decreased the number of apoptotic 
cells. Black and pale BSG extracts protected against the H2O2-induced increase in 
lipid peroxidation. These results suggest that BSG phenolic fractions may have 
potential as functional food components to prevent and treat neurodegenerative 
diseases. There is a need to characterise the specific neuroprotective mechanisms 
of BSG phenolic extracts. 
The final segment of this research involved the assessment of the anti-
proliferative potential of phenolic extracts and protein hydrolysates from BSG in 
cell lines from a cancerous origin (Chapter 8). Additionally, the Hoechst staining 
and DNA fragmentation assays were used to measure the impact of BSG phenolic 
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extracts on apoptosis in U937 cells. Results indicated that BSG phenolic extracts 
demonstrated greater antiproliferative ability in cell lines, compared with BSG 
protein hydrolysates. Additionally phenolic extracts derived from black BSG 
generally displayed greater antiproliferative activity in cells compared to extracts 
derived from pale BSG. This may be connected to Maillard reaction products 
generated during the roasting of barley grains. While BSG phenolic extracts 
demonstrated antiproliferative effects, the samples’ apoptotic effects were, in 
general, found to be low compared with the cancer treatment drug Doxorubicin, 
indicating that apoptosis is not the primary mechanism by which the extracts exert 
their antiproliferative effects. 
 
Conclusions 
In conclusion, the research conducted illustrates the potential of BSG as a source 
of functional food ingredients. Phenolic extracts derived from BSG demonstrated 
strong antioxidant potential in different cell lines, while enzyme hydrolysis-
derived BSG protein hydrolysates showed both anti-inflammatory and antioxidant 
activity in cellular models. More research needs to be carried out however, in 
identifying the specific phenolic and protein components that are responsible for 
the noted bioactivity. Future studies should focus on the inclusion of bioactive 
extracts into different food types. Additionally, the bioavailability of the bioactive 
extracts will need to be ascertained, clarifying the ability of these compounds to 
cross the gut barrier. Alternative uses for BSG bioactive components should also 
be explored, expanding on the potential human nutrition benefits. Currently, as 
part of the wider project objectives, a human intervention study is being 
performed, assessing the impact of BSG extracts on antioxidant and anti-
inflammatory biomarkers in healthy human volunteers. Results from this study 
should add further information as to the potential use of BSG components as 
effective bioactive food ingredients.  
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